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ABSTRACT 
Acetylcholinesterase [ACNE) and butyrylcholinesterase [EChE) 
were studied in amniotic fluid in relation to the detection of 
neural tube defects CNTD), and in rectal tissue in the diagnosis 
of Hirschsprung's disease. 
An automated assay is described for measurement of AChE 
and BChE activity in amniotic Fluid, and an increase in both is found 
in the presence of NTD. Analysis of AChE molecular forms by 
sucrose density sedimentation revealed three species with differing 
sedimentation coefficients and molecular masses: monomeric 
G1[4. OS, 78KOa), dimeric G2[5.5S, 126KOa) and tetrameric 
G4(10.35,256KDa). The tetramer, G4 is NTD specific and is 
largely responsible for the increase in activity seen in the 
quantitative assessment of'total AChE and for the abnormal band 
identifiable by polyacrylamide gel electrophoresis in pregnancies 
affected by NTO. Evidence is presented which indicates that G4 
is a soluble species secreted from nerve trunks exposed as a 
result of the lesion. 
SChE activity, the likely source of which is fetal plasma 
is shown to be a less specific indicator of NTD. 
These results represent the first description of the 
structural molecular heterogeneity of AChE and SChE forms in 
amniotic fluid. 
AChE activity was measured in rectal biopsy specimens from 
213 patients in whom a diagnosis of Hirschsprung's disease was 
suspected. The results from this, the largest study so far 
reported, indicate the value of AChE measurement in the detection 
of the disease. 
The molecular forms of AChE and SChE were investigated in 
resected bowel segments from patients with Hirschsprung's disease. 
Four species of AChE were identified: G1[3.55,74KOa), 
G2[S. OS, 131KDa), 64(9.23,275KOa] and the asymmetric form 
A12(16.83,811KDa). 
In all cases there was an increase (4-14 fold] in G4-AChE 
activity in the aganglionic cola-rectum. The evidence indicates 
that this is derived from hypertrophied nerve trunks present 
in the affected zone. The increase in G4-AChE was largely 
responsible for the increase in total AChE activity in rectal 
biopsy specimens from patients with Hirschsprung's disease. 
BChE molecular forms showed no consistent changes in 
Hirschsprung's disease. 
Characterisation of the molecular forms of AChE by gel 
filtration and with respect to their thermal stability, sensitivity 
to Triton X-100 and response to substrate inhibition is also 
investigated. 
'. 
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Section 1: The Cholinesterases 
1.1 History 
The existence of a cholinesterase was first 
proposed by Dale in 1914 who, describing the behaviour 
of animals previously injected with acetylcholine 
[ACh] wrote "In the blood at body temperature it 
seems not improbable that an esterase contributes 
to the removal of the active ester [ACh] from the 
circulation and the restoration of the original 
condition of sensitiveness". Subsequently, Loewi 
and Navratil [1926] were able to show that eserine 
delayed this recovery, they attributed this to 
inhibition of the enzyme normally responsible for 
destroying ACh. However, it was not until 1932 
that Stedman et al prepared the first crude extract 
of cholinesterase from horse serum. 
Alles and Hawes, [1940] showed that human 
blood contained two qualitatively different 
cholinesterases, one associated with erythrocytes, 
the other with serum. The erythrocyte associated 
enzyme resembled the type described later in brain 
by Mendel and Rudney, [1943a] and thought to act 
specifically on choline esters, they therefore 
suggested the term "specific" or "true"-cholinesterase. 
Later Augustinsson and Nachmansohn, [1949] introduced 
the term acetylcholinesterase to describe this enzyme. 
-3- 
In contrast, the serum enzyme was relatively non- 
specific with an ability to split other esters 
such as tributyrin and it was suggested by Mendel 
and Rudney, (1943b] that this be provisionally 
called "pseudocholinesterase". 
Since this initial work, there has been a 
continuing widespread interest in the cholinesterases 
for two main reasons. Firstly their involvement 
in the function of nerve and muscle cells and 
secondly the importance of their inhibitors as 
insecticides and potential nerve poisons of 
military significance. Interest was initially 
focused upon the catalytic properties and histo- 
chemical localisation of these enzymes, however, 
in the past decade the importance of their molecular 
heterogeneity has prompted much interest and recent 
review articles reflect this trend [Massouli¬ and 
Bon, 1982 and Brimijoin, 19833. 
The undoubted physiological importance of 
these enzymes, and the many remaining unanswered 
questions which surround them, guarantee continued 
interest in this field. 
1.2 Types and nomenclature 
The cholinesterases have been defined as 
hydrolases which, under optimal conditions, 
catalyse the hydrolysis of choline esters at a 
higher rate that that of other esters and which 
-4- 
are inhibited by low concentrations [10-5M or 
less] of physostigmine [Silve^, 19743. 
The Enzyme Commission [1965] recommended 
acetylcholine hydrolase [3.1.1.7] as the systematic 
name for acetylcholinesterase [ACNE] and acylcholine 
acylhydrolase [3.1.1.8) for pseudocholinesterase.. 
While the trivial name acetylcholinesterase [ACNE], 
has gained widespread acceptance the use of the 
term pseudocholinesterase to describe acylcholine 
acylhydrolase has been debated from its inception. 
The main objection has been the implication that 
"pseudo"- usually means false [Glick, 19453. 
Several other terminologies have been suggested 
including non-specific, serum, 
T, S- or butyrl- 
cholinesterase or simply cholinesterase. The 
preferred substrate for the enzyme in the majority 
of mammals including man is butyrylcholine and for 
this reason, as the present work is confined to 
human material, the most unambiguous name to 
adopt is perhaps butyrylcholinesterase [BChE]; 
accordingly this term is used throughout the work. 
The differences between AChE and BChE are 
outlined in Table 1.9, some of these, particularly 
susceptibility to inhibition can be used to 
differentiate between the enzymes when measuring 
their respective activity in mixed suspension. 
. Table 1.1 The properties of 
ACNE and BChE compared 
with respect to substrate specificity, 
inhibitor sensitivity and susceptibility 
to excess substrate inhibition. 
4 
r 
a 
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Table 1.1 Properties of AChE and BChE compared 
Acetylcholinesterase Butyrylcholinesterase 
[AChEJ [BChE] 
3.1.1.7 3.1.1.8 
Preferred substrate Acetylcholine Butyryloholine 
Activity towards: - 
Methylcholine + - 
Senzoylcholine - + 
Acetyl9 methylcholine + Slight 
Inhibitors: - 
Physostigmine Inhibited Inhibited 
Iso-OMPA No inhibition Inhibited 
Ethopropazine No inhibition Inhibited 
BW284c51 Inhibited Resistant 
Inhibition by excess Yes No 
substrate 
Adapated, with additions from Silver, 1974 
-6- 
1.3 Occurrence 
AChE is widely distributed in both the 
central and the peripheral nervous systems of 
mammals. In'particular the observation that 
AChE activity in muscle appeared to be at least 
3-6 time's higher'in endplate regions [Marnay 
and Nachmansc1in, 19373 led Nachmansuhn to check 
the enzyme activity of the electric organs of 
electric fish. These are related to muscle 
and accordingly were found to contain extra- 
ordinarily high concentrations of AChE 
[Nachmanschn and Lederer, 19393, they have proven 
to' be an important source of the enzyme for 
research use. 
While there are no known examples of 
cholinergic neurones that do not contain high 
levels of AChE [Lehmann and Fibiger, 19793', 
AChE is also present in many other structures 
with no known cholinergic function; examples 
include the dopaminergic neurones of the 
substantia nigra and the noradrenergic neurones 
of the locus coeruleus [Lehmann and Fibiger, 
19793. In addition AChE is Found in cells with 
no clear neurological function including the 
endocrine cells, secreting peptide hormones 
[Chubb and Millar, 19843 and erythrocyte 
membranes. 
-7- 
BChE is found in many tissues including 
heart, liver and intestinal mucosa [Ord and 
Thompson, 1950]. The liver synthesises large 
amounts of BChE and maintains high serum 
activities of this enzyme, which is clinically 
significant more in its relation to deficiency 
in certain individuals [Section 1.7] than to 
any clear function. 
Attention has been focused on AChE, which 
has by tradition been considered to be the functional, 
or true, form of the enzyme associated with nerve 
transmission; however, BChE also occurs at 
cholinergic structures such as muscle end-plates 
[e. g. sternomastoid, diaphragm and extraoccular 
muscle]. Indeed it is the predominant form of 
cholinesterase in the end-plates of rhesus 
monkeys where it accounts for 73-83% of the total 
activity [Barnard et al, 19713. 
AChE and BChE activity have also been found 
in a number of biological fluids, such as the 
CSF-of the central nervous system and, importantly 
From the point of this study, in the amniotic 
fluid surrounding the fetus (Vincent at all 19763. 
1.4 Function 
An appreciation-of the physiological role of 
AChE in synaptic transmission has developed with 
the recognition of the importance of acetylcholine 
at the neuromuscular junction [Eccles at al, 19423. 
-8- 
AChE can control ionic currents produced in the 
post synaptic membrane by hydrolysing acetyl- 
choline, thus destroying its potential agonist 
action on the receptor [Ferry at al, 1973]. The 
enzyme may also regulate the level of stored 
synaptic acetylcholine, perhaps by producing 
a proportion of the choline used for its synthesis 
[Birks and Maclntosh, 19613. 
It is clear that AChE has an important 
function in the synaptic transmission of nerve 
impulses; the ratio of AChE: ACh on the receptor 
is carefully controlled and recurring reports 
suggest that the ratio of the enzymic active 
sites to receptor is 1: 1 in electric organ and 
muscle (Changeux et al, 1970; Karlin et al, 1971). 
Although the exact details of the role of AChE in 
nerve transmission is still debated, Neuman 
et al, [1973] have formulated an-"integral 
model" according to which acetylcholine reacts 
within the membrane to amplify the small ionic 
currents, and produce an action potential. This 
proposal is in sharp contrast to the intercellular 
action of acetylcholine presumed by the neuro- 
transmitter theory (Katz, 1969). Some evidence 
supports the integral model, notably that 
acetylcholine has never been found outside 
excitable cells unless eserine is added. However, 
q 
-9- 
there is still insufficient evidence to discount 
the more widely held neurotransmitter hypothesis. 
This controversy merely underlines the fact that 
many questions surrounding the role of AChE in 
nerve conduction at the synapse still remain to 
be answered. 
If the function of AChE at the synapse is 
not yet fully understood there is even less 
knowledge concerning the role of ACNE outside 
the synapse. Several tissues not supplied with' 
nerves, such as erythrocytes and placenta, contain 
large amounts of AChE, the function of which can 
only be speculated about. It would seem logical 
from this evidence alone to conclude that the 
physiological role of AChE is not confined to 
destruction of excess acetylcholine. 
Recently, Chubb et al, [1980] has been able to 
demonstrate that AChE has peptidase activity when 
incubated in vitro with synthetic peptide substrates. 
These substrates include substance P, the two 
enkephalins and a variety of di- and tripeptides 
(Chubb and Millar, 19843. It appears that AChE 
is able to liberate both amino- and carboxy- 
terminal amino-acids. This exopeptidase activity 
is inhibited by acetylcholine but not by puromycin 
Can inhibitor of other amino-peptidases]. It may 
well be that this ability to hydrolyse neuropeptides 
and their precursors is an important function of 
- 10 - 
AChE in non-cholinergic neurones and perhaps even 
non-neural tissue. 
BChE has no clearly established physiological 
function. Indeed, the inhibition of this enzyme 
For long periods, does not appear to produce 
consistent pharmacological effects [Massoulie' 
and Bon, 19823. In addition, well known genetic 
variants of this enzyme, resulting in very low serum 
activity and subsequent problems relating to the 
administration of scoline, have no known effects 
in the absence of this drug. 
Koelle, [1976,1977a and b] has proposed a 
hypothesis suggesting that BChE is a precursor 
of AChE and is involved in the regulation of its 
activity. This hypothesis is based, on the 
observation that sustained inhibition of BChE 
reduces the recovery of AChE after its inactivation 
by a phosphorylating inhibitor. On the other hand, 
the protection of BChE by a reversible specific 
inhibitor during treatment with a phosphorylating 
inhibitor increases the recovery of AChE in the 
ganglia. 
There are, however, arguments against the 
precursor role for SChE. ' Firstly, continued 
specific inhibition of BChE-in rats from six days after 
conception until three ' weeks after birth produces 
no observable effect on fetal development even at 
- 11 - 
muscle end-plates, and no-effect on the activity 
of AChE [Brzin et al, 19803. Secondly, the two enzymes 
are quite distinct in their thermal reactivation 
(Vigny et al, 1978) and in their immunoreactivity 
(Koelle et al, 1979). Thirdly, at least in chickens; 
the mass of BChE is smaller than AChE (Allemand 
at al, 1981]. 
The observations of Koelle (1976,1977a and bJ, 
da however demonstrate that in the cat autonomic 
ganglia, the regulation of the two enzymes appears 
to be linked. 
1.5 Catalytic Properties 
AChE is relatively difficult to extract 
From mammalian sources and most structural and 
kinetic studies have been performed on enzyme 
derived from the electric organ of the. ray Torpedo 
marmcrata and the eel Electrophorus electricus. 
Relative substrate specificies and other indicators 
suggest that AChE from a variety of species are 
closely related in their catalytic mechanism. 
The simple model of an enzyme containing 
anionic and esteratic sites described by Nachmansohn and 
Wilson in 1951. has proven very useful. A, negatively 
charged anionic subsite is involved in the binding 
of cationic substrates and inhibitors, the 
esteratic site includes a serine hydroxyl which 
is believed to be acylated during the catalytic 
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action [Schaffer at al, 19733. This. -simple model may 
be extended to include one or more peripheral 
binding sites which when occupied can affect the 
stere ochemistry of the active site (Fig. 1.1a). 
The actual molecular architecture of the 
active site is believed to include a "charge 
relay system" [Fig. 1.1b] containing an active 
serine. Many kinetic results are consistent 
with the existence of an acylated ChE intermediate 
complex which would be difficult to explain by 
alternative proposals [Krupka, 1966). AChE is 
thought to react with substrates and many 
inhibitors according to the scheme: 
HOH 
EH + ALS-' EHALý EA EH + ACH 
HL 
where EH is ACNE, the H belonging to the serine 
hydroxyl group of the active site. This undergoes 
acylation to form EA. AL is a substrate/inhibitor 
comprising an acylating group A and leaving group L. 
EHAL is a reversible Michaelis-Menten affinity 
complex [Main, 19763. 
The behaviour of AChE is consistent with 
Michaelis-Menten kinetics below the optimum substrate 
concentration but the enzyme is inhibited by higher 
concentrations of substrate, causing it to depart from 
this type of kinetics, Fig. 1.2. It is unclear whether 
the excess substrate binds the acyl-enzyme complex, 
partially inhibiting deacylation, or-whether deacylation 
Fig. 1. la Adapted from Rosenbery., 1975 -A diagramatic 
representation of AChE showing the substrate 
binding site containing anionic and esteratic 
subsites. Bis-quaternary ligands such as 
decamethonium will bind at anionic and 
peripheral sites CP1 3, multiquaternary ligands 
such as flaxedil at other peripheral sites 
[P2, P3, P4]. 
Fig. 1.1b Adapted from Main, 1976 - The "charge relay 
system" present in the anionic and esteratic 
binding subsites of-the AChE molecule with 
acetylcholine in place. 
I 
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D47 
il Fl axed 
Fig. 1. la Substrate and peripheral ligand binding in AChE 
acetylcholine 
H 
CH3 C2 C 2 CH 3 
/77777777H ---p=C N 
N6 H3Cý pC H3 
ESTERATIC 
SITE 
N 
C p---H 
C=0 
CH2 histidyl CH 2j 
rý 
seryl 
tyrosyl 
glulamyl 
ANIONIC 
SITE 
Fig. 1.1b The proposed "charge relay system" of the active 
site of ACNE 
Fig. 1.2 The effect of increasing substrate 
concentration on the activity of AChE 
from bovine erythrocytes and BChE from 
horse serum. The activity is measured 
by manometry and reaches a maximum for 
AChE at approximately 3.0mM, at higher 
concentrations the enzyme is inhibited. 
SChE shows no such maxima [Silver, 1974]. 
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Fig. 1.2 The effect of increasing substrate 
concentration on AChE and EChE activity 
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is inhibited via allosteric effects mediated from 
excess substrate binding at a peripheral anionic 
site [Hofer and Fringeli, 19811. 
Much of the foregoing discussion applies 
equally well to AChE and BChE, however substrate 
inhibition is not observed in the case of SChE, 
where, peripheral site binding of excess substrate 
appears to produce an enhanced rate of acylation 
and increased enzyme activity (Main, 19763. 
1.6 Measurement 
There have been two main approaches to 
assessment of cholinesterase activity: 
quantitative measurement of enzyme activity in 
solution or suspension, and histochemical localization 
of enzyme activity in tissue extracts. 
[i] Quantitative measurement 
Enzymic hydrolysis of a suitable substrate 
or substrate analogue can be monitored by various means: - 
a) pH change [Michel, 1949) Hydrolysis of 
acetylcholine yields a hydrogen ion 
CH3000CH2CH2N[CH333OH ChE 
HOH 
CCH333N CH2CH2OH + CH3COO- +H 
The pH change in the presence of excess substrate 
is a function of enzyme activity. This method 
although rarely used nowadays has the advantage 
of being suitable for the natural substrate, 
acetylcholine, or for any analogue. 
I 
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bJ Radiometric assay (Winteringham and Disney, 19643. 
By using a 
14C 
labelled substrate such as 
14C- 
acetylcholine, the labelled acetate evolved 
during the reaction can be measured. The method 
can be adapted for use with any radiolabelled 
substrate provided an appropriate technique is 
available to separate free acid from unhydrolysed 
substrate. 
The chief advantage of the method is its 
sensitivity enabling detection of activities. down 
to a level of only a few picomoles per hour. A 
major drawback is its relative technical difficulty 
and the poor precision compared with other methods. 
c] Spectrophotometric assays 
Perhaps the most widely used method of 
measuring cholinesterase activity is the Ellman 
reaction, based upon the hydrolysis of a thiol= 
containing substrate analogue and the detection 
of an evolved free thiol [Fig. 1.3] by reaction with 
5,5 -dithiobis-2-nitrobenzoic acid [DTNB] to produce 
the yellow anion 5-thio-2-nitrobenzoate with an 
absorbtion maximum at 412nm [Ellman at al, 19613. 
The advantages of this method are numerous; 
it is simple, cheap, and easily automated, with 
excellent precision. Provided a suitable thiol 
analogue can be made, most substrates can be used 
e. g. acetylthiocholine and butyrylthiocholine. 
Fig. 1.3 The principle of the Ellman reaction 
which is based upon the hydrolysis of a 
thiol containing substrate analogue, 
acetylthiocholine and the detection of 
the evolved free thiol by reaction with 
i 
5, - 5-dithiobis-2- nitrobenzoic acid to 
produce the yellow anion 5-thin-2- 
nitrobenzoate C 2: ). 
_-- 1 
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H2O+(C H3)NCHZCHýS000H3ý(CH3) NCH2CH2S + CH3000 + 2H 
3 
(CH)3NCH2CH2S+ RSSR->(CH3)3NCHýH2SSR + RS 3- 
(1) (2) 
R= 02NrZ 
COO' 
i 1 5,5-dithiobis-2-nitrobenzoic acid 
2 Coloured anion, 5-thin-2-nitrobenzoate ion 
Fig. 1.3 The Ellman reaction 
0 
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In all of these methods specific detection 
of either AChE or BChE in mixed suspension depends 
either upon the use of selective substrates or of 
inhibitors. Butyryl or propionylcholine and their 
analogues are specific for BChE; unfortunately 
substrates with similar specificity toward AChE 
are not available. Acetyl-ß-methylcholine is 
specific for AChE and shows 'little cross reaction 
with BChE, however, its thiol analogue does not 
appear to have the same degree of specificity 
and is hydrolysed by BChE at approximately 50% 
of the rate shown by an equivalent concentration 
of acetylthiocholine [Bonham at al, 19813. 
Selective inhibitors may be used to confer 
specificity in the assay; iso-OMPA and ethopropazine 
are relatively specific inhibitors of BChE, while 
the compound BW2B4c51 is a widely used selective 
inhibitor of AChE activity. 
[ii] Histochemical measurement 
Enzyme activity in tissue preparations can be 
demonstrated by light or electron microscopy. The 
means of visulaisation of the enzyme is usually 
dependent on the hydrolysis of the substrate to a 
product that reacts with another component in the 
medium forming an insoluble precipitate at the site 
of the enzyme activity. This product may have to 
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be converted to a coloured compound by a subsequent 
chemical reaction. 
The most frequently used of these methods 
are adaptations of the initial work by Koelle 
and Friedenwald, [1949]. Thiocholine analogue 
substrates are hydrolysed and the liberated 
thiocholine captured by Cu 
++ ions to produce an 
insoluble white precipitate of copper thiocholine 
which can be further converted to coloured products: 
2 CH3COSCH2CH2NECH333OH + CNH2CH2cool 2Cu + 
H2O ChE 
acetylthiocholine copper glycinate 
Cu[SCH2CH2N[CH3330H]2 + 2NH2CH2000H + 2CH3000H 
copper thiocholine glycine acetic acid 
A commonly 'used modification of this original 
method is that of Karnovsky and Roots, [1964]. In 
this "direct-colouring" method, thiocholine reduces 
ferricyanide which is precipitated as cupric 
ferrocyanide - CU2Fe[CN]6, ["Hatchett's Brown' 13. 
Appropriate substrates or selective inhibitors 
are used to ensure specificity. 
The production of artefacts can make the 
interpretation of histochemical results more 
difficult than those of quantitative cholinesterase 
activity. In particular, diffusion of either enzyme 
or product can cause problems and in addition, the 
I 
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substrate or inhibitor may not be able to penetrate 
certain cellular structures. Despite these short- 
comings, histochemistry is an invaluable technique 
allowing the examination of enzyme distribution 
at a cellular or subcellular level in a way not 
otherwise possible. In addition to their 
application in staining tissue preparations, these 
histochemical methods can often be applied directly 
to the location of the enzyme following electro- 
phoresis and other analytical procedures. 
1.7 Cholinesterases in disease 
Interest in the measurement of AChE in disease 
can be divided into those changes which are the 
result of neurological disorders and those which 
affect erythrocyte AChE secondary to haematological 
disease. Neurological disorders can also affect 
the level of BChE but this enzyme has more commonly 
been assessed in relation to liver disease or 
genetically related abnormality of the enzyme. 
Neurological disturbance resultin in altered AChE activity 
Neurological distrubance in Alzheimer's 
disease is accompanied by a measurable fall in 
CSF-AChE [Appleyard et al, 19833 conversely despite 
decreased cholinergic function in mania, Huntingdon's 
disease, depression and schizophrenia, levels of 
AChE in the CSF are normal [Davis at al, 19793. 
Decreased activities of AChE and in particular the 
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absence of the end-plate form of the enzyme has 
been reported in a single case of myasthenic 
syndrome [Engel at al, 19773. An interesting 
finding in dystrophic chick embryos is an increase 
in serum ACNE, however this is not evident in 
the disease in man [Sketelj at al, 19833. 
In Hirschsprung's disease where aganglionosis 
of the bowel results in nerve trunk hypertrophy 
there is an increase in the tissue levels of 
AChE [Boston et al, 1975), the basis of much of 
this work is discussed more fully later [Section 3.5Lv]] . 
Similarly, in neural tube defect affected 
pregnancies when neural tissue is exposed to the 
surrounding amniotic fluid this results in an' 
increase in the level of AChE in the amniotic fluid 
[Smith, A. O. et al, 1979). Again this is discussed in 
greater detail in Section 4.4[iii]. 
Altered AChE activity produced by haematological disease 
Haematological disorders such as paroxysmal 
nocturnal haemoglobinuria'and ABO haemolytic 
disease of the newborn [Herz at all 19723 are 
accompanied by a reduced erythrocyte AChE level. 
The activity of the red cell enzyme is also reduced 
in cases of organophosphorus poisoning where it is 
used to detect such contamination. 
Disorders resulting in reduced BChE activity 
BChE activity is most often measured in serum 
to detect abnormal genetic varianis which occur in 
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0.05% of the population CKalow and Staron, 19573. 
In these cases apnoea can result following 
administration of certain muscle relaxants e. g. 
suxamethonium, it is therefore important to identify 
these patients to avoid future problems of this 
type. 
SChE is produced in the liver and consequently 
liver disease such as viral hepatitis and alcoholic 
cirrhosis can reduce circulating BChE activity. 
This has been applied as a means of assessing liver 
function by several workers (Terzani at al, 1981; 
Sportiello et al, 19813. 
In addition to liver disease certain physic- 
logical states induced by pregnancy and oral 
contraceptive administration can also result in 
reduced serum BChE levels (Areekul and Srichairat, 
1981; Whittaker et al, 1971) by their effect upon 
hepatic synthesis. 
Other disorders including leprosy [Rea and 
Won, 1978), tetanus [Porath et al, 19773 and 
carcinoma of the lung [Kaniaris at al, 19793 are 
also known to be accompanied by reduced BChE 
activity, however the factors producing this 
depletion are not obvious in any of these diseases. 
This emphasises the need to more clearly define the 
physiological role of BChE. 
1 
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It has been suggested that BChE may be 
involved with lipid metabolism (Kutty et al, 19773 
and one report suggests that the, BChE: High density 
lipoprotein cholesterol ratio, is a useful risk 
indicator in coronary disease CKutty at al, 19813. 
In addition to these quantitative changes in 
AChE and BChE activity, several reports describe 
qualitative changes in different disease states. 
These include changes in electrophoretic motility 
in liver cirrhosis [Matsuzaki at al, 1980] and a 
changes pattern of molecular forms in brain tissue 
in Alzheimer's disease [Atack et al, 19833. 
1.8 Inhibitors 
There has been great interest in understanding 
the mechanism of cholinesterase inhibitors and in 
the design of new inhibitors. Their importance 
is both commercial, as insecticide poisons and 
military as potential nerve gas substances, for 
these reasons they have been studied perhaps more 
thoroughly than any other group of enzyme inhibitors. 
Cholinesterase inhibitors can be usefully 
classified as reversible and irreversible. 
Irreversible inhibitors 
There are two major classes of irreversible 
inhibitors - organophosphates and carbamates. These 
form acyl-enzyme intermediates in a manner similar 
to the acetyl-enzyme -intermediate formed by the 
- 24 - 
natural substrate acetylcholine, but are stable 
to hydrolysis. Among the carbamates are the 
commonly used inhibitors eserine and neostigmine 
while the organophosphates include numerous toxic 
compounds such as soman, Tabun and di-isopropyl- 
phosphorofluoridate CDFP] which have been 
manufactured as chemical warfare agents. 
Reversible inhibitors 
Reversible inhibitors form noncovalent 
bonds with active site residues; almost all contain 
at least-one positively charged nitrogen group 
which binds to. the anionic site. Larger substituent 
groups may also bind to the esteratic site or to 
peripheral subsites. 
Some reversible inhibitors compete with the 
substrate and are competitive inhibitors, others 
bind preferentially to the enzyme acyl complex 
and delay deacylation, this is a non-competitive 
form of inhibition. 
Many of the most potent inhibitors have a bis 
structure similar to d-tubocurarine and contain an 
aromatic ring. It is not clear why these structures 
improve the inhibitory properties of the molecule. 
In addition to those reversible inhibitors 
that bind at the active site some compounds such as 
gallamine bind at peripheral anionic sites where 
they exert an allosteric inhibitory effect at the 
active site. -- 
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OF particular importance in the specific 
measurement of cholinesterase are those inhibitors, 
such as the reversible inhibitor ethopropazine 
and the irreversible inhibitor iso-OMPA, that 
preferentially inhibit BChE; 
CH3 
CH2-CH-N(C2H5)2 
N 
Ethopropazine 
C3H7-N H\0 11 O/NH-C3H7 
C3H7-N H NH-C3H7 
iso-CMPA 
or inhibitors that selectively inhibit AChE 
e. g. BW284c51: 
CH3 CH3 
CH2=CH-CH2=Ný CH2-CH2-CO-CH2-CH2 ®N-CH2-CH=CH2 
CH3 CH3 
BW284cS1 
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Section 2: Molecular forms 
2.1 General Introduction 
AChE has been intensively studied over the 
past forty years and while much is now understood 
about the structure and function of this enzyme 
much remains to be elucidated. The study of the 
molecular heterogeneity of AChE has recently been 
the subject of renewed interest. 
It has been known since the early 1960s that 
both AChE and BChE exist in a number of electro- 
phoretically different forms [Bajgar and Zizkovsky, 
19713. These differences are believed to reflect 
changes in the carbohydrate content of the molecules 
rather than their amino-acid composition. 
Polymorphism based upon molecular size and 
distinguishable by sedimentation coefficient was 
first described in electric fish by Massouli6 
and Rieger, [1969] and later in mammals by Hall, 
[1973]. The study of these "molecular forms" of AChE 
has dominated research in this area over the last 
ten years. Unlike electrophoretically defined 
species, distinct quaternary structures have been 
proposed for each of these differently sedimenting 
forms and this has allowed a reasonably rational 
and physiologically significant classification 
[Massoulie and Bon, 19823. In addition there 
appears to be a considerable degree of homology 
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between the heterogeneity found in different species 
(Brzin et al, 1983]. 
Much effort has been directed to assigning 
particular cellular and sub-cellular locations to 
individual forms of the enzyme. However, while 
some species do predominate at particular sites 
[Brimijoin, 1983), they cannot be exclusively 
identified with these locations. 
AChE species also differ in their relative 
hydrophobicity suggesting the presence of a distinct 
hydrophobic sequence in some molecules which is 
probably responsible for attachment of the enzyme to 
the cell membrane [Massoulie and Bon, 19823. 
All the possible combinations of size, charge 
and hydrophobic diversity clearly create a very complex 
analytical picture, however, it may well be that the 
physiological flexibility conferred by such a system 
is indispensible to the function of the enzyme "in-vivo". 
BChE, displays an entirely parallel set of size 
isomers closely related to the AChE forms [Brimijoin, 
1983]. The significance of this heterogeneity is even 
less well understood than that of AChE. 
2.2 Structural characteristics 
The structural characteristics of the molecular 
forms of AChE have been most studied in the electric 
organs of Electrophorus and Torpedo marmorata. It 
appears that the basic building block-of the enzyme 
is a globular monomer with a molecular mass of 
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approximately 80 kilo -0altons CkDa]. This monomer can 
form a dimer via a*single interchain disulphide bond; 
the two dimers are associated to form tetramers under 
the influence of Van der Weals forces [Brimijoin, 19833. 
Tetramers may have three stranded "tails" 
attached. These can be visualised by electron 
microscopy and resemble collagen both immunologically 
and chemically as well as being hydrolysed by 
collagenase. The tails are connected directly to 
one of the dimers in the tetrameric head by means 
of a disulphide bond. Each tail can make three 
such junctims[Brimijoin, 19833. 
Six major forms of AChE are therefore possible 
[Fig. 2.1). These include a globular series of 
monomer, dimer and tetramer CGS, 62 and G4] and 
a collagen tail-containing asymmetric series 
designated A4, A8 and A12 - in each case the 
subscript denotes the number of catalytic subunits 
present in the molecular structure (Bon and 
Massoulie, 19763. Although these molecular 
inter-relationships were worked out for the. AChE 
of Electrophorus the scheme appears to be generally 
applicable to all tissues and species so far studied 
including mammalian enzyme. 
While the molecular masses of the forms 
range from 80 kOa CG1) to 1,100 kOa (A12) the 
asymmetry of the collagen tail retards the f 
sedimentation rate on ultracentrifugation and s- values 
Fig. 2.1 A diagramatic representation of the six 
major Forms of AChE in Electrophorus 
electricus [8rimijoin, 19833. " Globular 
and ap: immetric forms are shown as G1, G2, 
G4, A4, A8 and A12 repsectively. In each 
case the subscript denotes the number of 
catalytically active subunits present- 
in the molecule. 
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Fig. 2.1 The quaternary structure of the six major 
A12 
forms of AChE in Electrophorus electricus 
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show a more limited range from 3.5 to 205. 
Sedimentation coefficients of AChE forms show 
remarkably little variation among different tissue 
types and animal species [Table 2.1J. 
The larger asymmetric forms can be converted 
to monomers, dimers, tetramers and tail fragments 
revealing information about their quaternary-structure, 
(Fig. 2.21. 'In A12 From Electrophorus each of 
the three tetramers are attached to one strand 
of a collagen triple helix; half of the 60 kDa 
subunits are linked to each other via disulphide 
bridges, but not covalently linked to the tail 
[Fig. 2.2]. They are detached by Sodium dodecyl 
sulphate [SOS]. Trypsin cleaves the tail close to 
the point of attachment, releasing intact 
tetramers which sediment at 11S and appear to be 
identical to the G4 globular form. Pepsin totally 
digests the catalytic subunits leaving behind a 
fragment corresponding to the collagen tail. 
Collagenase treatment at 20°C results in the 
hydrolysis of the distal portion of the tail, 
removing about half the collagen sequence. The 
collagenous tail has a molecular mass of approximately 
135 kDa, each strand of this triple helix comprising 
approximately 45 kDa [Silman and Anglister, 19803. 
Studies of A12 species in mammalian motor-nerve 
and skeletal muscle suggest similar structural 
properties and col]agenase sensitivity. 
Table 2.1 The sedimentation coefficients of AChE and 
BChE molecular forms from different species. 
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Table 2.1 Sedimentation coefficients of AChE and BChE molecular 
forms in different species. 
G1 G2 G4 A4 A8 A12 
AChE Sedimentation coefficient: 
Fish 
Torpedo 3.6 5.6 11.0 9.4 13.8 17.5 
Electrophorus 5.3 7.7 1-1 . E3. --- 9.1 
14.2 18.4 
Amphibia 
Frog 5.4 - 11.2 - 13.6 
17.3 
Bird 
Chick 5.4 7.9 11.8 8.5 13.3 20.0 
Pigeon 4.3 6.3 -"-" --11.8 - 15.1 
19.3 
Mammals 
Cat 4.3m 5.8 10.8* 8.8 13.0 16.2 
Cow 3.9 6.7 10.7 8.7 13.0 17.1 
Man 3.5 6.0 11.0 9.5 13.3 16.7 
BChE 
Bird 
Chick nerve 4.2 6.4 11.3 - - 19.0 
Chick muscle 4.9 7.1 -11.1- - - 
18.6 
Mammal 
Mouse serum 5.0 .- . -11.0 - - - 
* 
Values denoted thus are mean values 
Table adapted from Brimijoin, [19833 with additional information from 
Chatonnet and Bacou, [1983]; Lee at al, [1982]; Edwards and Brimijoin, [1983: 
Allemand at al, [1981); Couraud at al, [1982]. 
Fig. 2.2 The manner in which: collagenase, pepsin 
trypsin and SOS cleave A12 AChE from 
Electrophorus electricus. Adapted from 
Silman and Anglister, 1980. 
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Fig. 2.2 A diagramatic representation of the 
effect of treatment with various agents 
on the quaternary structur of A12-AChE 
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In some species (Torpedo] a non-collagenous, 
structural subunit of approximately 100 kDa has 
also been identified. The 
is unclear but it may well 
the enzyme onto the surface 
may even by a component of 
Some of the globular 
and G4 appear to contain a 
function of this subunit 
be involved in locating 
a of the basal lamina and 
it (Lee and Palmer, 19823. 
molecular Forms G1, G2 
hydrophobic amino-acid 
sequence, susceptible to pronase digestion; it has 
been suggested that its removal alters the ability 
of these forms to associate with lipid membranes 
and that this sequence must be removed before 
the globular forms can have a "tail -unit"added 
CMassoulie and Bon, 19823. 
There is a strong indirect evidence, including 
their kinetic and immunological properties, that G1, 
G2,04 , A4, A8 and A12 are products of the same gene 
and vary in post-transcriptional assembly alone. 
In addition to heterogeneity due to these 
molecular associations, AChE also contains a large 
number of sialic acid containing carbohydrate residues. 
Similarly,, BChE has a substantial proportion of 
carbohydrate,, each subunit being calculated to 
contain 103 sugar residues and 508 amino acids. 
Assuming that each oligosaccharide chain contains 
two sialic acid terminii,, one can estimate that a 
minimum oFnine oliogosaccharide chains are attached 
to each subunit [Lockridge et_al, 19793. 
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ECKE molecular forms exist in a series 
homologous with those of AChE and including G1, 
G2 and G4 globular and A4, A8, A12 asymmetric 
forms (Vigny et al, 1976]. In human tissue 
monomeric G BChE has a slightly larger 
molecular mass of 90 kDa compared with AChE. G2 
is 180 kDa and G4 340 kDa. The S values of these 
forms are correspondingly marginally higher than 
their AChE counterparts [Lockridge et al, 19793. 
2.3 Distribution 
As described in Section 1.3 cholinesterases 
are widespread in both nervous and non-nervous 
tissues. It is true that while AChE can be 
demonstrated in non-cholinergic neurones the 
highest levels are found in association with 
cholinergic structures (6rzin, 19833. 
While, for a given tissue, the distribution 
of molecular forms are somewhat species dependent, 
certain generalisations can be applied to their 
distribution which are independent of this species 
variation and these are outlined below: 
Nervous tissue 
The overwhelming bulk of the AChE of nervous 
tissue is of the globular type. In mammalian brain 
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80-90% of the activity is typically of the G4 form 
with most of the remainder occurring as G. Tailed 
asymmetric forms do exist in the brain but comprise 
only about 0.02% of the total activity (Brimijoin, 
19833. Peripheral nerve is more variable although 
again G4 typically predominates with asymmetric 
forms rarely comprising more than 10% of the 
activity. Nerve axons, both pre- and post-synaptic, 
are particularly rich in the G4 species, whereas cell 
bodies, in the case of cilliary ganglia, contain a 
greater proportion of G2 [Couraud at al, iseo]. 
In order to investigate the subcellular 
distribution of the enzyme, combined 
studies have been employed. BW 284c! 
AChE inhibitor, will not enter cells 
will protect only externally located 
further irreversible inhibition with 
and Famborough, 1982J. Results from 
inhibitor 
51, a reversible 
and therefore 
enzyme from 
DFP [Rotunda 
studies such as 
this suggest that G1 and G2 forms are almost 
exclusively intracellular whereas G4 and A12 appear 
to be predominantly externally located [Brimijoin, 
1983]. 
Secretion of AChE by nerves was suggested by 
Skangiel-Kramska and Niemerka, (1975]. It was later 
demonstrated in rats that the major proportion of 
the secreted form released from phrenic-nerve was 
G4, and in every known case, even when cells are 
_ 
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richer in G1 and G2, G4 still accounts for the 
majority of secreted enzyme [Brimijoin, 19833. 
The parallelism of AChE and BChE forms can 
be seen in nervous tissue. Even neurones, which 
classically were considered to contain only AChE, 
have been shown to have BChE activity. This 
suggests some neural function for this enzyme 
[Brimijoin, 1983). 
Muscle tissue 
AChE activity from innervated skeletal 
muscle is distinctive in containing a large 
proportion of the asymmetric forms of the enzyme, 
especially A12. This A12 species predominates at 
the muscle end-plate, and is a particularly efficient 
structure for the hydrolysis of acetylcholine 
[Fig. 2.3]. Indeed Hall, in 1973 originally suggested 
that A12"AChE could be used as a marker for the 
muscle end-plate in rat. Since then, however, A12 
enzyme has been demonstrated at other sites, and 
other forms including globular species have been 
identified at the end-plate region. 
There is evidence that the AChE molecular 
form profile varies with the muscle type. There 
are large differences between fast and slow twitch 
muscle, the latter containing less G4 and more A8 - 
this may reflect differences in the ACh hydrolysis 
rates necessary-in muscle types with different. 
depolarization periods (Groswald and Dettbarn, 1983). 
Fig. 2.3 Adapted from Thompson, 1960 -A 
diagramatic representation of the 
neuromuscular junction showing the 
distribution of AChE molecular forms. 
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Asymmetric, collagenase sensitive, AChE 
forms appear to be predominantly externally 
located at the muscle end-plate and are associated 
with the basal lamina. However, between 10-20% 
of asymmetric species comprise an internal pool 
perhaps destined for secretion and incorporation 
into the extracellular matrix [Brimijoin, 19833. 
G4 in muscle cells is largely membrane bound and 
is the main form exposed on the cell surface, in 
this respect the distribution of G4 in nerve and 
muscle is similar. G, predominates intracellularly 
and is easily solubilised once cells have been 
disrupted. 
BChE exists'at the muscle end-plate as 
the A12 form and is structurally similar to the 
corresponding A12 AChE species [Jedrzejczyk at al, 
19813. In newborn rats BChE is predominant in 
the end-plate region; as the animal matures however, 
AChE activity begins to increase and BChE decline. 
At least some of this BChE activity is found in the 
numerous Schwann cells which overlie the nerve 
endings of motor end-plates. The decrease in 
BChE activity postnatally coincides with a reduction 
in the number of nerve endings which takes place 
between 10 and 15 days post partum CBrzin et al, 19813. 
Blood, cerebrospinal fluid and amniotic fluid 
Human erythrocyte membrane is rich in AChE 
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which in the presence of non-denaturing detergents 
exists solely in the G2 Form with a molecular mass 
of 151 k0a [Ott at all 19823. The enzyme is firmly 
attached to the erythrocyte membrane but can be 
removed by non-ionic detergents such as Triton 
X-100. 
Cerebrospinal fluid [CSF] 
, contains soluble 
AChE which corresponds mainly to the G4 form in 
man [Massoulie and Bon, 19823. It is probable 
that this derives by direct secretion from nerve 
tissue into the surrounding CSF [Scarsella at al 
1979]. 
Serum also contains soluble AChE in some 
species. In rat this is again predominantly G4 
[Massoulie and Bon, 19823. The preponderant 
BChE species in human serum is the tetrameric G4 
BChE [Lockridge at al, 1979]. 
Amniotic fluid contains both soluble AChE 
and BChE activity in low levels [Smith, A. O. et al, 1979, 
Milunsky at al, 1979]. The activity of both are 
increased in pregnancies affected by neural tube 
defect [NTD ] where the exposed neural tissue 
augments the activity of these enzymes in the 
amniotic fluid. The molecular forms present in 
amniotic fluid in normal and NTO affected 
pregnancies have not been previously described 
and their description and application in diagnosis 
of fetal abnormality are included within this thesis. 
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2.4 Dynamics 
AChE and BChE are not static within the cell 
but rather are synthesised, assembled, transported 
and released in a way tailored to the cell and the 
function they are to perform. Each molecular form 
is distinct in the way in which it is handled and 
processed by the cell. Interconversion between 
these forms being an integral part of this overall 
fate of the enzyme in the cell. These are. outlined 
below: 
Transport 
AChE is transported bi-directionally in nerve. 
The velocity can be calculated by nerve trunk 
transection and monitoring the rates of accumulation. 
Anterograde and reterograde rates differ, having 
been found to be about 400 and 260 mm/day respectively 
[Lubinska and Niemerko, 19713. 
Interruption of the distal flow in nerve 
axons either by local cooling, ligature or crush 
injury has allowed the accumulation rates for 
different molecular forms to be determined. A12 
although not the major intracellular form, accumulates 
most rapidly. In contrast G4 which represents 90% 
of the activity in sciatic nerve and comprises over 
80% of the distally transported enzyme, accumulates 
less rapidly than A12. G1 and G2 forms are the most 
slowly accumulating species (Brimijoin, 19793 and 
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it seems probable that they are conveyed by a 
different mechanism from the larger species. 
The proportion of A12 returned to the cell 
body by retrograde transport is only 24% of that 
distally conveyed [Brimijoin, 19793. This suggests 
that A12 is primarily destined for incorporation 
into synaptic structures at the nerve ending. A 
large proportion of G4 is stationary in the nerve 
axon and this supports the hypothesis that its 
major fate is insertion into the axolemma (Brimijoin 
et al, 1978]. 
BChE molecular forms like those of AChE 
appear to be subject to transport within the nerves. 
In chick sciatic nerve [Ccuraud et al, 19823 all of 
the A12 and some of the G4 move with the slow phase 
of axonal transport while GI and G2 remain stationary. 
This would be consistant with G1, G2 and a major 
proportion of G4 BChE being associated with the 
Schwann cells. 
Interconversion and release of AChE 
It is tempting to suggest that larger AChE 
molecular forms are assembled from GI; the initial 
translation product. Indeed evidence gained from 
observing embryonic development of molecular forms 
lends some support to this, since GI appears before 
larger forms in rat fetal brain [Reigen and Vigny, 
1976]. 
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The most convincing studies in this area 
involve irreversible inhibition of existing forms 
and observation of the order of their reappearance 
in the cell. A rapid increase of GI with delayed 
appearance of other forms is strong confirmatory 
evidence that GI is the initial building block 
[Reigen et al, 19763. Gisiger and Vigny, [1977] 
demonstrated a sequential reappearance of molecular 
forms-in the order 6 i, 04 , A12. The species A4 and A8 
are probable intermediates but were not clearly 
demonstrated - perhaps due to their low concentration. 
Not all G4 ends up as A12 and it may be that 
branches in this pathway further modify these 
molecules for insertion into the cell membrane or 
secretion. Based upon inhibitor studies and the 
subsequent reemergence of AChE in particular cell 
fractions, Rotunda and Famborough, [1982] have 
postulated an outline model for AChE secretion from 
muscle cells [Fig. 2.4]. The details may differ for 
each molecular form, depending upon its ultimate 
fate, but without pulse labelling studies or some 
alternative it is difficult to elucidate this for 
each species. 
AChE is actively secreted (Section 2.33 from 
nerve tissue. G4 in particular is secreted by 
rat superior cervical ganglia [Gisiger and Vigny, 
19773. It has been postulated that neuronal 
Fig. 2.4 Adapted from Rotunda and Fambrough, 1982 - 
A hypothetical model of AChE and acetylcholine- 
receptor metabolism in cultured muscle cells. 
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release is the probable source of the soluble 
G4 AChE found in the CSF; its concentration is 
increased by stimulation of the sciatic nerve 
(Chubb at al, 1976). This neuronal origin may"also 
account for the AChE found in amniotic fluid in 
pregnancies affected by neural tube defect and its 
presence in the extracellular space of mammalian 
central and peripheral nervous tissue. 
2.5 Extraction 
AChE molecular species may be either soluble 
or membrane bound and have different cellular 
locations so that extraction conditions vary 
depending on the location and nature of the species 
under study. 
Asymmetric forms attached by a collagen tail 
to the basal lamina or synaptic cleft material, can 
be removed by buffer systems containing high salt 
concentrations e. g. IM NaCl. Addition of EDTA 
has also been shown to aid their removal CInterossa 
et al, 19813. They can also be removed by cleavage 
of the "tail"s with collagenase and this has been 
utilised as a method of extraction in low salt 
conditions [Silman and Anglister, 19803. 
The means necessary for extraction of globular 
AChE forms depends upon the degree of membrane binding. 
Soluble species present either in extracellular matrix 
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or intracellularly can be released in low salt 
buffers e. g. 100 mM NaCl simply by adequate cell 
disruption. Membrane bound species such as the 
02 from erythocytes and the G4 in the axolemma 
require a detergent-containing medium, such as 
Triton X-100 for their removal. In rabbit sciatic 
nerve, for instance, 25-32% of AChE activity is 
solubilized by homogenisation in TRIS buffer without 
Triton, whereas the remainder requires 0.1% v/v Triton 
[Brimijoin, 19791. 
If it is necessary to solubilise all AChE 
forms, an extraction buffer containing a high salt 
concentration together with Triton and EDTA is 
capable of extracting both soluble and asymmetric 
forms, provided that cells and subcellular particles 
have been adequately disrupted for the buffer to 
gain access to all regions where AChE is located. 
When Triton is present in the extraction medium 
in excess of the critical micellar concentration 
CCMC], N 0.015%, it is possible that the enzyme 
may exist in protein - detergent complexes whose 
configuration reflects the characteristics of 
the detergent rather than the form in which the 
protein exists "in-vivo" (Rueb and Lieflander, 1981]. 
While not discounting this possibility Massouli6 
and Bon, [1982) reviewing several inhibitor studies, 
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conclude that "the composition of molecular forms 
in solution reflected the state of the enzyme 
in-situ". 
2.6 Methods of separation 
The molecular forms of AChE and BChE in the 
series G,, G2, G4 and A4, A8, A12 vary both in 
molecular mass and in molecular size (as reflected 
in the Stokes radius of each species]. In addition 
to these size differences there is electrophoretic 
heterogeneity within distinct quaternary structures 
[Lazar and Vigny, 19801. In order to classify forms 
on the basis of quaternary structure alone, methods 
which allow separation on the basis of molecular 
size or mass, and largely ignore charge differences, 
avoid a bewildering heterogeneity. 
Characteristics such as thermal stability, 
immunogenicity and selective inhibitor sensitivity 
peculiar to a particular molecular form, could 
theoretically also be used. In practice, the most 
useful techniques are those that depend upon the 
hydrodynamic properties of the different forms, such 
as density gradient sedimentation, gradient 
polyacrylamide gel electrophoresis and gel filtration. 
These are discussed in turn below: 
Density gradient sedimentation 
Density gradient sedimentation, first: applied to 
the separation of proteins by Martin and Ames, [1961] 
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was suggested by Brimijoin, [1983] . to be, "by far the most 
convenient method", for analysis of cholinesterase 
molecular forms in tissue extracts. Certainly 
over the past ten years it has gained widespread 
acceptance as the method of choice in most 
situations. 
In this technique a sample is layered on the 
top of a medium of progressively increasing density 
most commonly a sucrose gradient. This stabilizes 
the bands against convection and provides a gradient 
of increasing viscosity. The sedimentation rate CV] 
is dependent upon the size and shape of the molecule 
and the centrifugal field C )2r], where 0 is the 
angular velocity in radians per second and r is the 
radius in cm.. The sedimentation coefficient S, 
is given by the relationship: 
S=V 
W2r 
For macromolecules, S is of the order of 
10-13 seconds and the Svedberg unit [S] is defined 
as being equal. to 10-13 seconds. In order to permit 
standardisation, Svedberg and Pederson, [1940 defined 
a standard sedimentation coefficient which would 
obtain for a given macromolecule in water at 20°C 
CS20, W]. These values can be determined either by 
comparison with the migration of known markers or by 
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calculation from pre-computed tables [McEwen, 
19673. More recently Young, [1978] has adapted 
the equation of Fundig and Steensgaard, [1973] for 
use in a computer program which gives a greater 
degree of flexibility to the parameters which can 
be defined than tables would allow. 
The S values of the AChE molecular Forms are, 
with the exception of G4 and A4 [A4 is usually a 
very minor component], conveniently evenly spaced 
between 3 and 20S [Table 2.13. 
Gel filtration 
Macromolecules can be separated on the basis 
of their molecular size by the degree to which they 
partition within or are excluded from the 
stationary phase contained in a suitable gel matrix. 
The distribution coefficient [Kd] between the 
stationary and mobile phases can be calculated as: 
Kd = Ve - Vo 
Vs 
where, Ve is the elution volume of the solute, Vo 
is the void volume and Vs is the volume of the 
stationary phase. 
When the molecules under study are globular, 
elution will be inversely proportional to their 
molecular mass. However when they are asymmetric 
this relationship may be disturbed and the apparent 
molecular mass wil-l- appear larger than the true 
lecu1 
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In order to calculate the true molecular mass, 
the Stokes radius is calculated by the method of 
Ackers, (1964] or Siegel and Monty, [1966] and 
S20'w data obtained by sucrose density sedimentation. 
Molecular mass can be calculated according 
to: 
Re. S20, W = f[Molecult3r mass] 
where f is a constant. Hence not only is gel 
filtration a useful tool for separation and 
identification of cholinesterase molecular forms 
but it also allows the indirect calculation of 
the true molecular mass of these forms when the data 
is used in conjunction with that gained from sucrose 
density sedimentation. 
Polyacrylamide gradient gel electrophoresis 
Separation of proteins is achieved on the 
basis of molecular size. In addition their apparent 
molecular mass can be determined [Slater, 19693. 
Under the influence of a voltage gradient 
proteins migrate into regions of progressively higher 
gel concentration and thus smaller, average pore 
size. The decreasing pore size increasingly restricts 
the migration ofkthe protein. If electrophoresis is 
continued until the protein migration has virtually 
ceased proteins of low charge density will catch up 
to those of similar size but higher charge density. 
Thus, the final migration position is a Function 
of size and shape. - Migration position is usually 
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referred to in terms of Rf, distance migrated by the 
protein/length of the gel slab. -A plot of Rf Vs 
log [molecular mass] is approximately linear. 
Apparent molecular mass can therefore be determined 
by comparing migration distances with those of 
standard proteins. There are several reports in the 
literature where this technique has been used to 
identify AChE and BChE molecular forms [McIntosh 
and Plummer, 1973; Wright and Plummer, 1973; 
Vidal et al, 1978; McIntosh and Plummer, 1976; 
Rakonczay at al, 1981b; Ortonne et al, 19793. Just 
as in gel filtration, if the molecules under study 
are asymmetric their molecular mass will be 
overestimated. 
Cholinesterase bands can be visualised in the 
gel slabs and adaptation of one of the reactions 
employed for histochemical localisation of the enzyme, 
for instance the Karnovsky and Roots, [1964) reaction 
- Section 1.6. 
Polyacrylamide gel electrophoresis [PAGE and 
Iso-electric focusing 
PAGE using continuous buffer systems [Clarke, 
19643 in rods or gel slabs has been extensively 
used to separate AChE and BChE forms f or more than 
twenty years [Bajgar and Zizovsky, 19713. While 
this technique does not separate on the basis of 
quaternary structure alone but also reflects charge 
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diversity, it is still a powerful technique. 
Charge heterogeneity can occur within a single 
molecular form identified by, for instance, gel 
filtration [Wright and Plummer, 1973] nevertheless, 
in particular locations individual electrophoretic 
forms may have important physiological significance. 
For instance, the AChE released from brain into the 
CSF is of primarily one electrophoretic form [Chubb 
et al, 1974). It may therefore sometimes be helpful 
to adopt electrophoretic techniques in addition to 
other methods. 
In particular PAGE has been widely used 
diagnostically in the detection of neural tube 
defect affected pregnancies by identification 
of an abnormally migrating band in the amniotic 
fluid [Smith, A. Q. et al, 19793. 
Isoelectric focusing first described in 
polyacrylamide gels by Dale and Latner, [1968] 
will separate molecules-on the basis of their 
isoelectric point alone, this therefore reflects 
charge diversity. Molecules of differing charge 
are very efficiently distinguished and consequently 
in human erythrocyte AChE for example thirteen 
distinct bands can be identified [Biagioni 
at all 1982). 
Other, methods of separation 
Any property characteristic of a given molecular 
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form may be used to identify that form in mixed 
solution. 
There is evidence from thermal stability 
studies [Edwards and Brimijoin, 1983) that the G1 
form of the enzyme is the most thermally labile 
species and it has been suggested that this might 
form the basis of a method that could replace 
density gradients as a means of identifying and 
quantitating this particular molecular form [Edwards 
and Brimijoin, 1983J. 
While to a first approximation, the molecular 
forms of. AChE are enzymologically equivalent, one 
study indicates that G1 from rat tissue may have a 
different Km"[Bon and Massoulie, 1976] from other 
forms. Similarly it has been suggested that 
"isoenzymes" of BChE may vary in their response to 
organophosphorus inhibition, however, in that 
particular study it was unclear whether these SChE 
species denoted ChEI and ChEII, corresponded in 
any way to other classification systems [Chemnitius 
et al, 1982]. 
It may be that during assembly of higher molecular 
forms from the basic monomer certain parts of the 
molecule are exposed or obscured. Hence, theoretically 
it may be possible to raise a range of monoclonal 
antibodies which would allow each form to be 
specifically identified. There is as yet little 
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suggestion that this is imminent, however one 
report demonstrates that membrane bound and 
soluble forms of AChE differ immunologically [Zanetta 
et al, 19813. This kind of approach may in the 
long term prove the most rewarding as it would 
permit immunohistochemical study of enzyme 
location as well as quantitative molecular form 
analysis. 
2.7 Stability 
It is acknowledged that under certain 
conditions molecular forms of AChE may inter- 
convert by either association or dissociation. 
However, under neutral aqueous conditions this 
process is slow enough to allow analysis to reflect 
accurately the distinct cellular components present 
at the time of extraction. It has been reported 
that G4 remains unchanged during storage at 4°C for 
up to ten days [Massoulie and Bon, 19823. In the 
same series of experiments G1 was shown to associate 
to produce a 7.5S form, this could be prevented by 
the addition of Triton X-100. It is possible to 
isolate and purify individual molecular forms and 
consequently, these can be thought of as stable 
molecular entities [Massoulie and Bon, 19823. 
Endogenous proteases may act upon the collagen 
containing molecular species such as A12 to produce 
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an increase in the globular fraction. This is 
less of a problem in nervous tissue [Couraud, 
1980] than in muscle extracts. Addition of a 
mixture of protease inhibitors such as that 
suggested by Lai et al, [19833 can prevent this 
autolysis in either-situation. 
2.6 Properties 
Each molecular form has intrinsic properties 
related to its molecular architecture. In 
addition the presence of particular sequences or 
carbohydrate substituent groups confer hydrophobic 
or solubility differences which give rise to 
diversity within a particular molecular form. 
The secreted soluble forms, predominantly Gi 
and G4 do not interact with detergents, however, 
a fraction of cellular G1 and G4 can also be 
solubilised without detergent, these do interact 
with Triton and their S value in the presence of 
this detergent is altered. G4 from a T28 neuro- 
blastoma x sympathetic neuron hybrid has a 
sedimentation coefficient of 10.2S in the absence 
of detergent but 9.7S if detergent is present; 
GI is similarly affected from 4.5S to 3.2S [Lazar 
and Vigny, 19803. This adds to the diversity of 
the simple G,, G2, G4 nomenclature [Fig. '2.53. 
Molecular forms also vary in their thermolability. 
Forms of AChE and BChE are markedly more sensitive 
Fig. 2.5 A diagramatic representation of the 
diversity attributable to hydrophobic 
interactions present within globular 
AChE species. 
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to heat than the larger forms. Ten to fifteen 
minutes at 510C will ensure 95% inactivation of 
G1 without effect on other forms [Edwards and 
8rimijoin, 19833. 
Immunologically it is passible to raise 
monoclonal antibodies with much greater affinity 
for dimeric 5.6S AChE from Torpedo than the 
catalytic subunits of the collagen tail containing 
forms from the same source [Doctor et al, 19833. 
As referred to in Section 2.6 there is 
considerable electrophoretic heterogeneity within 
distinct quaternary structures. 
This diversity of behaviour may simply reflect 
obligatory structural change dictated by the 
quaternary structure. However, it seems likely 
that it also reflects necessary adaptation for 
biological function "in vivo". 
2.9 Function 
It is difficult at present to assign a 
distinct function to individual molecular forms. 
They are catalytically equivalent and therefore 
probably do not directly affect the regulation of 
enzyme activity but may provide a means of adaptation 
to different subcellular and extracellular locations. 
In particular the condensation of multiple catalytic 
units in the A12 is reasonably viewed as a modification 
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to increase packing density and promote the efficient 
termination of acetylcholine mediated signals 
[Brimijoin, 19833. The function of the globular 
species, predominantly G4, located in the presynaptic 
nerve axon remains obscure. Smaller forms such as 
GI may simply be the biosynthetic precursors of 
larger molecules, however, it is unlikely that 
this is their sole "raison d'etre" and there is 
evidence that GI is actively secreted [Massoulie 
et al, 1984. 
It is probable that a fuller understanding of 
the physiological significance of this heterogeneity 
will have to await improved analytical techniques 
such as immunohistochemistry employing specific 
monoclonal antibodies directed against individual 
molecular forms. 
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Section 3: Hirschsprung's Disease 
3.1 History 
Hirschsprungs disease is a congenital disorder 
of the bowel caused by the absence of ganglion cells 
in both Auerbach's intramyenteric and Meissner's 
submucosal plexuses. The disease is named after 
Harald Hirschsprung who in 1886 described a massive 
dilatation and hypertrophy of the colon in two 
infants at autopsy [Weinberg, 1975). 
The remaining history of the disease is 
summarised by Weinberg, [1975] he describes how 
Tittel in 1901, first reported an abnormality of 
the myenteric plexus; this was considered only 
part of the abnormality which he believed also 
included proximal dilatation as a causal feature. 
In 1920 Dala Valle published the first thorough 
histological study of the colon in the disease 
documenting an abnormal distal-plexus in a ten 
month old affected infant. Despite this, reports 
continued to view the proximal dilated bowel as 
the basic abnormality and treat accordingly. 
It was not until 1948 that Whitehouse and 
Kernohan firmly established the cause of the 
disease as due to aganglionosis of the distal bowel 
and in the same year Swenson and Bill reported 
the first successful operative correction of 
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Hirschsprung's disease by removal of the aganglionic 
segment and preservation of the sphincter mechanism. 
3.2 Clinical presentation 
A prominent feature of Hirschsprung's disease 
is failure to pass meconium within the first twenty four 
hours of life. This is followed by the gradual 
development of abdominal distention and subsequently, 
vomiting due to intestinal obstruction. It has 
been described as 'the commonest single cause of 
admission to hospital for obstruction in the 
newborn period'[Jones, 1970]. 
Diagnosis on clinical grounds alone in the 
immediate neonatal period is often confusing with 
a bizarre combination of obstruction or constipation 
followed by explosive diarrhoea-like stools. There 
are periods of abdominal distention and vomiting 
although at times the baby may appear perfectly 
normal [Schnaufer, 1976). If the condition remains 
untreated during childhood, there is a gradual 
increase in the degree of constipation and 
progressive distention of abdomen. The distended 
colon may be palpated and often visualized by its 
impression on the abdominal wall, occasionally 
active peristalsis may also be seen. Anorexia, 
lassitude, poor nutrition and retardation of growth 
are associated features. The child gives the 
appearance of being undernourished with a gross 
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potbelly and wasted extremities [Singleton et al, 
1977). 
The differential diagnosis in the older child 
is often between Hirschsprung's disease and chronic 
or psychogenic causes of constipation. Clinical 
history and physical examination may help differentiate 
these alternatives. In Hirschsprung's disease 
digital examination of the rectum usually reveals 
increased tone in an empty rectum, into which 
faeces. has not been able to enter. Typically there 
will never have been any encoporesis, neither will 
the child have ever passed a normally formed stool. 
There is frequently a history of chronic ill health 
secondary to malnourishment [Schnaufer, 19761.. 
3.3 Occurrence and genetics 
The largest study to date, of 1628 cases of 
Hirschsprung's disease [Ikeda and Goto, 1984) 
over the five year period 1978-1982 in Japan, shows 
an incidence of the disease of I in 4697 live births. 
The length of the aganglionic segment varied from 
very short (confined to the rectum distal to 
peritoneal reflex) to total intestinal aganglionosis 
affecting small bowel and colon. The proportion 
of patients affected by aganglionosis of varying' 
lengths is shown (Fig. 3.1). In approximately 80% 
of cases the aganglionosis region is confined to 
Y 
Fig. 3.1 Adapted from Ikedo and Goto, 1984. 
The number of patients from a total of 
1562 affected by aganglionosis of varying 
lengths. The proportion of the total is 
expressed as a percentage.. 
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rectosigmoid. The length of the affected segment 
appeared to alter the male: f emal ratio; 3.5: 1 in 
lesions confined to the lower rectum falling to 
0.0: 1 in those cases which include small bowel 
and colon. 
Familial involvement in this study was 3%, 
although this increased to 11.3% in cases of 
total colonic aganglionosis. Passarge, (1967] 
showed an overall risk for siblings of a male 
patients to be 2.6% but for siblings of a female 
patient this rose to 7.6%. There is no evidence 
of a simple Mendelian genetic inheritance [Passarge, 
1967). 
Ikeda and Goto, [1984] report that 14% of 
patients have some associated abnormality, the 
most common of these being Down's syndrome, 
occurring in 2.9% of patients, others include 
cardiac anomalies at 2.1% and inguinal hernia. 
A previous large study [1196 patients] 
[Kleinhor at al, 19793 performed in the USA 
showed results similar to the Japanese report. 
The only point of variance was the increased 
overall familial involvement, assessed at 7.0%. 
In long segment disease, where aganglionosis 
extended into the caecum, this increased to-21%. 
A recent UK study of 103 documented cases 
gathered over a 15 year period in South West 
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Scotland, [Orr and Scobie, 19033 showed similar 
results to both of these larger studies. The 
overall incidence quoted was 1: 4,500 live 
births with a male preponderance of 4: 1. The 
overall familial involvement was 6%. The 
distribution of the extent of'aganglionosis 
was also similar, 15% with ultrashort-segment. 
disease, 67% with short segment involvement 
and 18% with a long affected segment. 
3.4 Aetiology 
The cause of the aganglionosis in Hirschsprung's 
disease has not been unequivocally defined. The 
most widely accepted theory remains that of Okamoto 
and Ueda, 01967] who postulate a failure of the 
normal craniocaudal migration of ganglion cells 
during embrylogical development. 
Okamoto demonstrated in normal human embryos 
that by five weeks vagal fibres have already 
reached the upper oesophagus, at six weeks 
neuroblasts can also be seen, by eight weeks all 
but half of the colon has neuroblasts present and by 
twelve weeks the entire myenteric plexus with 
intrinsic ganglia is present along the whole gut. 
The submucosal [Meissner's plexus] [Fig. 3.23 
is formed by migration of neuroblasts across the 
circular muscle layer, again proceeding in a 
Fig. 3.2 Adapted from Ham, 1974 -A transverse 
section of the normal gut wall. The 
major. anatomical features are shown 
including the position of the submucosal 
[Meissner's and Henle's] and the intra- 
myenteric [Auerbach's] nerve plexuses. 
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craniocaudal progression. In Hirschsprung's 
disease, the earlier the termination of these 
migratory processes the longer the segment of 
gut which will finally remain aganglionic. 
In addition to this single vagal hypothesis 
other theories include a dual vagal and pelvic 
origin for ganglia of the myenteric plexus. 
Certainly extrinsic cholinergic nerve fibres 
of sacral origin are demonstrable in the plexus, 
but it seems likely that the dual origin of 
ganglia may only apply in chickens, where the 
anatomy of the terminal digestive tract is 
significantly different (Okamoto et al, 1982). 
Failure of craniocaudal migration of 
ganglia would exclude acquired aganglionosis as. 
a possible cause of Hirschsprung's disease nor 
would it permit segmental aganglionosis [skip 
lesions]. While reliable reports of these 
phenomena are rare they do exist. Acquired 
aganglionosis, a condition where, ganglia are 
clearly visible in specimens taken at birth 
or shortly afterwards and yet cannot be 
identified in biopsies made later in life, has 
been described [Touloukian and Duncan, 1975; 
Towne et all 1979; Dimler, 19813. Similarly, 
reports of segmental aganglionosis keep occurring 
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in the literature; perhaps one of the most 
convincing was a single case where terminal ileum 
and ascending colon were aganglionic, transverse 
colon contained normal ganglia and descending colon 
and rectosigmoid was totally aganglionic [Martin 
at al, 1979]. 
In addition to a failure of craniocaudal 
migration other mechanisms of pathogenesis have 
been suggested for Hirschsprung's disease 
including ischaemia [Earlam, 19723. This patho- 
genesis may underly the atypical pathologies 
such as acquired aganglionosis and skip lesions. 
3.5 Pathophysiology 
In the normal colon motility is regulated 
by the intrinsic automonic nervous system. This 
consists of submucosal [Meisner's and Henle's] 
and the myenteric CAuerbach's plexusesj, [Fig. 3.23. 
These have the appearance of a broad stranded 
network in polygonal array with ganglion cells at 
the junction of neural strands. The meshwork 
consists of Schwann cells supporting various 
nerve cell processes [Weinberg, 19753. The 
neurones of the enteric plexuses are largely 
cholinergic, however sympathetic fibres ending 
in a basket work about the ganglia are also 
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present. - In addition a third component has been 
described, these neurones which depend upon 
purines as their transmitter molecules are 
postulated to act directly upon bowel muscle 
in an inhibitory fashion (Burnstock, 1972]. 
Cholinergic nerve fibres in the normal 
plexus derive largely from . vagal' origin,. however, 
extrinsic nerve bundles also enter through the 
longitudinal-muscle coat. The extrinsic nerve 
trunks are surrounded by a perineurium and have 
a more compact appearance than the plexus itself; 
they immediately ramify and blend with the 
intrinsic plexus structure. 
The way in which differing nerve types 
inter-relate and control muscle contraction is 
poorly understood. In general, cholinergic nerves 
are excitatory whereas adrenergic nerves are 
believed to have both excitatory and inhibitory 
characteristics. Purinergic nerves, as defined 
by Burnstock, [1972] are suggested to have a 
direct inhibitory effect [Fig. 3.33. 
In Hirschsprung's disease ganglion cells 
are absent from all layers of bowel. The delicate 
neural matrix is replaced by hypertrophic nerve 
trunks which stain densely for cholinesterase 
Fig. 3.3 Adapted from Weinberg, 1975 -A 
diagramatic representation of the 
innervation of normal and aganglionic 
bowel. Cholinergic, adrenergic and 
purinergic [as defined by Burnstock, 
1972] nerves are illustrated as 
they are believed to act upon the 
smooth muscle cells of the gut wall,. 
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activity and ramify throughout muscle and mucosal 
layers. These are of extrinsic origin [Okamoto 
et al, 19823 perhaps deriving from the sacral 
region of the spinal chord. There is also an 
increase in adrenergic innervation [Touloukian 
et al, 1973). 
The aganglionic region In Hirschsprung's 
disease is in a constant state of contraction 
and several hypotheses have been devised to 
account for this. The most simple suggests that 
in accord with Cannons Law, "any denervated smooth 
musgle will remain in a constant state of 
contraction", certainly ACh-receptor remains intact 
in Hirschsprung's disease and increased sensitivity 
to acetylcholine may be partly responsible for 
the observed spasm CIkawa at al, 19803. Other 
workers have suggested that the lack of a non- 
adrenergic, possibly purinergic, inhibitory system 
is the major cause of the contraction (Richardson, 
1975). 
An additional factor relating to the altered 
innervation pattern in Hirschsprung's disease and 
contributing to the obstruction is the paradoxical 
distal contraction of the internal anal sphincter 
in response to luminal distension [Lawson and Nixon, 
1967). 
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In the region adjacent to the anal sphincter 
in normal gut there is an absence of ganglia and 
some degree of nerve trunk hypertrophy. The 
resultant muscle response is believed to be partially 
responsible for the normal maintenance of sphincteric 
tone. Consequently, in Hirschsprung's disease we 
may be observing a normal physiological response 
in an abnormal situation. 
In addition to the increased cholinesterase 
activity present in the aganglionic region secondary 
to the nerve trunk hypertrophy there are other 
disturbances of neural activity. Acetylcholine is 
increased almost three fold in the aganglionic 
region [Ikawa at al, 19803. Similarly there is a 
two to three-fold increase in catecholamine 
concentration in the affected segment [Ikawa et al, 
19803. Conversely levels of vasoactive intestinal 
peptide [VIP] are reduced, VIP and substance P 
sensitive nerves are sdimilarly depleted [Bishop et al, 19813. 
The derangement includes not only abnormality 
of the normal direct smooth muscle innervation but 
also disturbances of normal control mechanisms and 
the overall pathophysiology'of the disease is 
clearly complex. 
ri 
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3.6 Diagnosis of Hirschsprung's disease 
The early diagnosis of Hirschsprung's disease 
is important both to improve the long term outlook 
for the affected child, by avoiding the malnourishment 
and chronic ill health with which the disease is 
associated [Section 3.23, and more acutely to avoid 
the life threatening development of enterocolitis. 
Delay in diagnosis can result in increased incidence 
of enterocolitis [Ikeda and Goto, 19843, this 
condition occurs preoperatively in 15-30% of 
children with Hirschsprung's disease [Ikeda and 
Goto, 1984; " Kleinhaus' et al, 19793 and carries a 
mortality rate of 30% [Kleinhaus et al, 1979]. 
While 83% of patients are diagnosed within the 
first year of life [Ikeda and Goto, 19843 a much 
smaller proportion are diagnosed within the first 
month - only 15% in the American Association of 
Pediatrics study [Kleinhaus et al, 19793. Several 
approaches have been used to establish a diagnosis. 
When considering these it is important to remember 
the need for diagnostic accuracy early in life. 
Techniques used include: X-ray, barium enema, 
rectal manometry, histological demonstration of 
ganglia, histochemical demonstration of hypertrophic- 
nerve trunks, measurement of AChE activity in rectal 
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tissue and measurement of AChE activity in both 
erythrocytes and serum. These methods are discussed 
in Sections 3.6Ci]-[vi3. 
Several other disorders resemble Hirschsprung's 
disease and may prove misleading, these include 
neuronal colonic dysplasia [Puri et al, 19773 a 
specific deficiency of argyrophyll neurones [Tanner 
et al, 19763, chronic adynamic bowel [Kapila at al, 
19753, hypoganglionosis [Weinberg, 19753 and Chagas 
disease [Singleton et al, 1977]. 
In addition Hirschsprung's disease may have 
atypical presentations; the long segment form is 
frequently missed [Careskey et al, 19823 and very 
short segment disease is sometimes mistakenly 
labelled as psychogenic constipation [Orr and 
Scobie, 19833. 
Ideally, any satisfactory diagnostic technique 
should be able to differentiate similar. conditions 
and identify unusual presentations of the-disease. 
3.6[i) Radiology 
Radiology, including both plain abdominal X-ray 
and radiopaque enema, is probably the most commonly 
used investigative technique in Hirschspr, ung's 
disease, but alone it is rarely diagnostic [Lavery, 
19833. The aim is to demonstrate a clear funnel- 
shaped transitional zone between a dilated ganglionic 
and narrowed aganglionic bowel. 
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False positive [Lake et al, 1978; Kekomaki 
et al, 1979 and false negative [Lavery, 1983) results 
have both been described. In particular it is often 
difficult to differentiate low rectal aganglionosis 
from functional constipation; consequently very 
short segment disease may be missed [Weinberg, 19753. 
A further limitation to the technique is the 
difficulty of interpretation early in life, 
particularly within the first month [Lavery, 19833. 
Following colostomy the investigation is of little 
value as the typical distention of the ganglionic 
bowel is no longer present. 
An advantage of the technique is the possible 
assessment of the length of-the aganglionic segment. 
3.6Lii] Rectal Manometry 
Schuster first described an abnormal sphinteric 
response to rectal stimulation in Hirschsprung's 
disease in 1965 [Schuster at al, 1965). In normal 
subjects, distension of the rectal ampulla by an 
inflated balloon produces reflex relaxation of the 
internal anal sphincter and contraction of the 
external sphincter. Similar rectal distension in 
patients with Hirschsprung's disease produces a 
reflex contraction of the internal sphincter with 
a normal response of the external sphincter. 
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This phenomenon has been applied diagnostically 
by inflating with air a series of balloons inserted 
into the anal canal [Fig. 3.4] and monitoring the 
pressure response of internal and external 
sphincters. The false positive rate has been 
reported at 5-10% [Kekomaki et al, 1979; Schnaufer, 
1976; Meunier et al., 19783-and the false negative 
rate at 1-2% in children over one month [Meunier 
et al, 1978; Schnaufer, 1976; Kekomaki et al, 19793. 
Equivocal results are also common [Schnaufer, 19763. 
Despite the appreciable error rate this 
technique has gained an undeserved widespread 
acceptance, perhaps. because the test is usually 
performed by the clinician and results obtained 
immediately. 
Major problems occur in the neonatal period, 
during which, in one study 26% were incorrect 
[Meunier et al, 19783. In particular, false 
negative rates of up to 33% have been reported 
[Davies at al, 19813. This may be due in part to 
the low sensitivity of the measuring devices and 
the relative shortness of the functional canals 
[Tamate at al, 19843. Immaturity of the reflex 
has also been suggested to explain these discordant 
results in neonates [Meunier et al, 19783. 
Total colonic aganglionosis also frequently 
Fig. 3.4 Adapted from Weinberg, 1975 -A 
diagramatic representation of the rectal 
manometry procedure. Inflation of the 
rectal balloon induces reflex relaxation 
of the internal sphincter in the normal 
and reflex contraction of the sphincter 
in Hirschsprung's disease. 
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produces false negative results, in one report this 
amounted to five of the six cases studied [Davies et al, 
1981] . Rectal manometry is therefore far from 
reliable, particularly in the very important 
neonatal period, when ideally diagnosis should be 
established. 
3.6[iii] Histology 
The histological demonstration of the absence 
of ganglion cells in a full thickness biopsy taken 
2-3cm above the pectinate line [Fig. 3.5] remains 
the definitive diagnostic procedure for Hirschsprung's 
disease. 
Unfortunately there are several practical 
difficulties with this technique., Firstly, it is 
markedly invasive requiring a general anaesthetic. 
In addition, the development of scar-tissue may 
prejudice subsequent surgery. It is therefore an 
unsuitable procedure for excluding Hirschsprung's 
disease in the otherwise normal, chronically 
constipated child. Secondly, the pathologist may 
have to examine up to 100 sections before there 
is a reasonable certainty that they are entirely 
absent. 
Provided ganglia are not misidentified, false 
negatives are by definition impossible. Given 
adequate tissue false positive results are unlikely, 
however, equivocal results from poor specimens may 
sometimes be reported. 
- 
-r 
Fig. 3.5 Adapted from Weinberg, 1975 -A diagramatic 
representation of the rectal wall. The 
usual site of biopsy employed in the 
diagnosis of Hirschsprung's disease is 
shown in relation to the pectinate line. 
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In order to make the investigation somewhat 
less invasive Bodian, [1960) advocated the use of 
mucosal biopsy for the diagnosis of Hirschsprung's 
disease. Dobbins and Bill, [1965 further reduced 
the amount of tissue required by'using serial 
sections from suction biopsy of rectal mucosa. 
Provided submucosa was present it was usually 
possible to establish a diagnosis, but potential 
problems could arise in regions of hypoganglionosis. 
In addition to the usual paraffin-embedded 
specimens, frozen sections have also been employed. 
These are not adequate for initial diagnosis but 
useful for defining the limit of aganglionosis 
once a diagnosis has been established(Andrassy et al, 
19813 especially peroperatively in order to determine 
the position of colostomy. 
3.6[iv] Histochemistry 
While the introduction of suction biopsy 
techniques made the procedure safer for the patient 
and simpler for the surgeon, the reduced size of 
the specimen presented the pathologist with considerable 
difficulties. In an attempt to overcome these, 
histochemical techniques depending upon the 
demonstration of hypertrophied, cholinesterase 
staining, nerve trunks were introduced [Meier-Ruge et al, 
19721. In addition to the use of this positive 
criterion of nerve trunk hypertrophy, ganglia if 
e- 
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present, are also easily recognizable in cholinesterase 
preperations [Lake et al, 1978]. The staining 
procedure normally used is that of Karnovsky and 
Roots, [1964] [Section 1.6[ii]]. The method 
is simply, reliable and takes under two hours to 
perform. It has been suggested that the biopsy 
specimen should contain at least some muscularis 
mucosae. 
False negative and false positive results do 
occur and the combined mean error rate is 8.4% based 
on those studies shown in Table 3.1. The false negative 
rate is about five times the false positive rate and 
several explanations have been suggested to account 
for the former. These include, the biopsy being 
made proximal to very short segment disease and 
the biopsy being too superficial i. e. mucosae and 
lamina propria only. In some cases of Hirschsprung's 
disease nerve trunk hypertrophy is confined to the 
muscularis mucosae and immediately adjacent lamina 
propria [Chow et al, 19771; in these cases superficial 
biopsy would give a false negative result. However, 
the more exacting the requirement for biopsy sampling, 
the greater the number of samples reported as 
equivocal due to poor biopsy. While many authors 
do not record the number of equivocal results it is 
appreciable, Table 3'. 1. 
False positives with abnormal nerve trunks in 
the presence of ganglia, probably reflect some 
Table 3.1 The summarised results of a number 
of surveys from 1972-1984 reporting the 
use of histochemistry in the diagnosis 
of Hirschsprung's disease. The false 
positive, false negative and equivocal 
result rates are shown, where reported, 
in each case. 
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Table 3.1 The performance of histochemically determined AChE 
... _in_. the . 
detection of... _Hirschsprung's disease ..... 
Number False False Equivocal 
Report of positive negative .. sample "p"atients rate' 'rate " rate 
[%) C%) [%J 
Meier-Ruge at al, 1972 174 0 - 3.4 
Elema at al, 1973 46 0 - - 
Chow at al, 1977 81 28 - - 
Almoyna at al, 1978 60 0 8.3 - 
Lake et al, 1978 168 0 0 - 
Morikawa at al, 1979 25 0 0 0 
Kekomaki at al, 1979 60 2.0 0 - 
Nezlof at al, 1981 123 2.1 7.6 11.0 
Coker-Huntley et al, 58 6.1 0 5.2 
1982 
Hamoudi at al, 1982 [1313" 0 29.0 21.0 
Plenat et al, 1982 115 8.2 17.4 6.0 
Lake and Claireaux, 800 - 0.4 - 
1983 
Ziegler at al, 1984 524 - 0.5 1.5 
Mean 4.2 6.3 ý6.9 
Range 0-8.2 0-29.0 0-21.0 
Combined average 
mean error rate 
= 8.6% 
Refers to number of specimens rather than number of patients 
Based upon Coker-Huntley, [1982) with additions 
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alternative pathology, such as the neuronal colonic 
dysplasia described by Meier-Ruge, 1974. In this 
condition there are structural changes in the 
myenteric plexus with some increase in the number of 
AChE positive nerves. 
Histochemistry then, represents a safe, 
relatively rapid and useful test for the diagnosis 
of Hirschsprung's disease. It can be applied more 
widely than the combination of full thickness biopsy 
and conventional histology but problems do arise 
due largely to sampling difficulties and consequently 
a proportion of Hirschsprung's disease cases are 
missed. 
3.6Cv]Quantitative measurement of tissue 
acetylcholinesterase 
While histochemical assessment of nerve trunk 
hypertrophy is a useful aid in the diagnosis of 
Hirschsprung's disease, it is somewhat subjective 
requiring a high degree of interpretative skill. 
In 1975, Boston at al reported quantitative 
measurement of AChE in homogenised suction biopsy 
specimens as a diagnostic test. This was later 
modified and improved by Dale at al, [1977J and 
gives a reliable, highly significant [p<O. 001] 
separation between Hirschsprung's disease and 
other causes-of chronic constipation. The method 
described by ourselves [Dale et al, 1977) has 
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gained widespread acceptance; the results obtained 
by various authors are shown in Table 3.2. 
The measurement of percentage AChE [% AChE], 
that is the AChE activity expressed as a percentage 
of the total cholinesterase activity, is a useful 
additional parameter avoiding sources of error, 
such as measurement of the weight of small [< 2.0mg) 
biopsy specimens and the effect of dehydration. 
Percentage AChE shows a surprising consistency 
between different reports - Table 3.2. 
The method is safe, using a non-toxic 
inhibitor of BChE; reliable and rapid, taking 
approximately 30 minutes to perform. Table 3.2 shows 
that while results are encouraging the studies 
so far have been small, the largest only including 
13 cases of Hirschsprung's disease (Yangihara at al, 
19833. Therefore, part of this thesis, before 
going on to explore the molecular forms of AChE 
involved in this increase, is devoted to a larger 
study comprising 50 cases of Hirschsprung's disease 
and a larger number of control samples. 
It was reported by Bajger. and Hak, [1979] that not 
only were tissue levels of AChE elevated in the disease 
but that also an electrophoretically distinct band 
of activity could be observed. When the research 
leading to this thesis was commenced the molecular 
A 
Table 3.2 Quantitative acetylcholinesterase 
measurement in rectal tissue biopsy 
specimens in the diagnosis of 
Hirschsprung's disease. The results 
obtained by several authors from 
1975 to 1984 are shown. 
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Table 3.2 Quantitative assessment of AChE in the diacnosis or 
Hirschecrune's disease 
No. or 
AChE Percentage 
Study Patients jLUXiCý1/g p-value AChE'' p-value 
Boston et al, 1975 12 [HO) 10.5 ± 6.9 <0.001 - - 
7 [Cant) 34.3 t 19.1 
Dale et al, 19772 12 [HO) 6.3 ± 3.5 <0.001 50.8 ± 7.7 
< 0.001 
6 [Cant] 23.9 t 5.3 78.5 ± 6.9 
Dale et al, 1979 
a 56 [Cant) 5.0 ± 2.2 <0.001 54.0 t 11.0 < 0.001 
12 [HO) 30.5 t 15.1 81.0 ± 7.0 
Bajgar 6 Hak, ' 19794 6 [Cant) 10.96 - - - 
12 [HO] 25.5 - 
Patrick et al, 19802 101 [Cant) 2.7 t 1.4 - 54.6 t 10.5 - 
9 [HO) 15.2 t 9.0 78.9 ± 6.8 
Yangihara at el, 19632 7 [Cant] 3.0 +_ 1.7 < 0.001 40.7 ± 13.2 
< 0.001 
13 [HO) 7.1 t 3.9 65.9 t 15.8 
Rakonczay 6 Nemeth ,3 7 
[Cant) 3.9 t 0.5 <0.001 45.1 -- 
1964 4 [HO] 25.3 t 5.7 87.8 
No. of 
AChE Percentage 
Study patients LUx10-1/g p-value AChEp-value 
Goto at al, 19902 50 Anterior 92.4 t 54.6 < 0.001 64.7 t 12.8 
< 0.001 
wall 
[aganglionic) 
50 Posterior 28.3 t 14.0 28.5 t 10.2 
wall 
[ganglionic] 
I- Assayed without a specific EChE inhibitor 
2- The method of Dale at al, 1977 
3- As the method of Dale at al, 1977 using iso-CMPA in place of 
lysivane and measuring at 370. C 
4- The method of Ellman at al, 1961 
(Cont) - Control sample, no evidence of Hirschsprung's disease 
[HO) - Confirmed Hirschsprung's disease 
- not stated 
%ý 
- percentage 
AChE = [ACNE/ACNE + SChE) x 100 
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forms of AChE present in rectal tissue had not yet 
been identified, but during the course of the study 
a report was published indicating that the major 
species in aganglionic biopsy tissue was the 108, 
tetrameric form of the enzyme [Rackonczay and Nemeth, 
19843. This substantiated the findings of the present 
study. The work described in this thesis characterises 
more fully the 10S form and how its levels together 
with those of other AChE molecular forms, change in 
the transition from ganglionic to aganglionic bowel. 
Quantitative measurement of AChE is liable 
to the same sampling errors as those described for 
the histochemical technique. It has been suggested 
[Lake et all 19793 that problems with the quantitative 
assay may be encountered because the material in which 
the enzyme is being measured is not microscopically 
assessed and that certain specimens may contain 
lymphoid follicles, etc. The most powerful counter 
argument is that in over 250 samples so far reported 
[Table 3.2), this criticism has not been found to be 
a practical difficulty. 
3.6[vi) Erythrocyte and serum acetylcholinesterase 
The increase in rectal tissue AChE in 
Hirschsprung's disease is well attested [Sections 3.6[ivj, 
3.6[ V3 ]. In order to determine whether or not this is 
reflected in an increased serum level of ACNE, 
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perhaps due to tissue release and whether the disease 
has any effect upon erythrocyte AChE these activities 
were measured by Boston at al, 1978. 
The methods used were adequate for erythrocyte 
AChE, but entirely inappropriate for measurement of 
serum AChE, in'fact in the title to the paper the 
authors refer to serum ACNE, whereas in the results 
they refer to serum pseudocholinesterase, apparently 
without differentiation. The assay method includes 
no selective inhibitor of serum BChE and therefore 
more properly reflects BChE than AChE. They report 
a mean increase in erythrocyte AChE and serum SChE, 
Table 3.3, with p-values of p<0.02 and p<0.05 
respectively. There was considerable overlap between 
groups and the method therefore has little practical 
diagnostic value. 
This work remained unsubstantiated until 1983, 
when conflicting reports began to emerge. Okasara et all 
[1983], using the original assays of Boston at all 
[1978] demonstrated a significant increase in serum 
AChE, p<0.05 in Hirschsprung's disease but failed to 
find any increase in erythrocyte ACNE. Ya-xiong at all 
[1984] on the other hand, found an increase in 
erythrocyte AChE, p<0.001, but no difference in 
serum AChE. 
Yanagihara et al, (1983]again using the original 
assay methods of Boston at all [1978] found a 
Table 3.3 Erythrocyte AChE and serum cholinesterase 
measured in an attempt to investigate, 
their application in diagnosis of 
Hirschsprung's disease. Significant 
differences between Groups, where they 
occur are reported by their p-value. 
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significant increase in both erythrocyte AChE p<0.01 
and serum cholinesterase p<0.01, when Hirschsprung's 
disease patients were compared with normal patients 
but no increase in either when they were compared 
with a control group of patients with idiopathic 
constipation. The most recent report, Bamf orth at al, 
[1985] in seven'children with, and 53 without the 
disease-failed to find any significant increase in 
erythrocyte AChE. 
The increases in erythrocyte AChE if valid are 
difficult to rationalise while measurement of serum 
AChE requires better methodology than has so far 
been applied in order to confirm or deny any 
increase. 
In all of these studies there was considerable 
overlap between groups and therefore it is doubtful 
whether the assays in their present form have any 
diagnostic usefulness in Hirschsprung's disease. 
3.7 Treatment 
In many cases Hirschsprung's disease is diagnosed 
within the first few months of life. The aim of 
treatment is to relieve the obstruction and in 
particular to avoid the risk of enterocolitis. 
A defunctioning temporary colostomy is usually 
performed proximal to the aganglionic segment. The 
child is then usually allowed to grow unitl a weight 
of 10-15 kg is achieved and normal health is restored. 
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In older children a colostomy is not always 
necessary prior to definitive treatment but is 
1 
believed by scme to reduce the subsequent risk of 
infection at cperati6n. 
The treatment of choice is almost invariably 
surgical and three basic operative procedures or' 
variations of these predominate (Fig. 3.6]: - 
[i] Rectosigmoidectomy with end to end 
anastomosis, Swenson and Bill, [1948] 
[ii) Reterorectal transanal pull through with 
side to side anastomosis, Duhamel, [1956) 
[iii)'Endorectal pull through, Soave, [1964) 
Individual procedures are favoured by different 
surgeons. f or their avoidance of post operative 
complications and the maintenance of adequate anal 
sphincter function. 
In some cases of very short segment disease 
sphincterotomy may be corrective, without the need 
for a pull through procedure (Lavery, 1983). 
Total intestinal aganglionosis from duodenum 
to rectum, presents a particularly difficult problem. 
When sufficient length of gut is resected to ensure, 
motility, adequate absorption may be impossible. In 
a recent paper [Potts at al, 1983) referring to eleven 
previously reported cases, all of whom subsequently 
died, a medical approach is suggested involving the 
use of caerulein. This drug is known to produce 
Fig. 3.6 Adapted from Schnaufer, 1976 -A diagramatic 
representation of the major operative- 
procedures currently used in the correction 
of Hirschsprung's disease. 
Swenson- rectosigmoidectomy with end to 
end anastomosis=[Swenson and Bill, 19483. 
Duhamel - reterorectal transanal pull 
through with side to side anastomosis. 
[Duhamel, 19E6). 
Save - Endorectal pull through-[Soave, 
1S63]. 
Regions of aganglionosis are shown-as(S)and 
regions where ganglia are present as 
The position of suture lines in-each case 
are-"represented byxxxX. 
- eg - 
O 
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Soave 
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IIIIIIIIIIII - Anal verge 
Fig. 3.6 Cperative procedures used in the correction 
of Hirschsprung's disease. 
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smooth muscle contraction in denervated muscle. 
In a single case where this type of treatment 
has been attempted the child succumbed due to 
respiratory aspiration caused by vomiting, the 
authors suggest however, that this may represent 
an alternative in an otherwise fatal condition. 
In gene-al, the surgical treatment of 
Hirschsprung's disease is effective and provides 
a relatively trouble free solution to a serious 
and often fatal condition. Early unequivocal 
diagnosis is therefore of the utmost importance. 
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Section 4: Neural Tube DeFects 
4.1 History and anatomy 
Neural tube defects CNTD) have long been 
known to mankind and the pre-historic art of many 
cultures depict forms suggestive of these disorders. 
Certainly, they were recognized by Aristotle and 
Plato CShurtleff and Lamers, 19783 who recommended 
infanticide in such cases. The first recorded 
attempt at corrective surgery is attributed to 
Forestus, who in 1610, operated by ligating the 
cystic sac present in untreated spina bifida. Thus 
began the long and difficult period of medical 
intervention in the management of these harrowing 
and often controversial developmental abnormalities. 
The diversity of disorders which can be 
grouped under the general heading of NTD range from 
simple meningocele without neurological diorder [10% 
of spina bifida cases [Nixon, 19783 to anencephaly 
with absence of much of the forebrain and calvarium. 
Recognizable differentiation of the nervous 
system begins in utero prior to the thirtieth day 
of gestation. The primordial neural plate forms a 
mature brain and spinal chord. It is currently 
believed that incomplete tubular Formation in the 
developing head results in anencephaly, whereas 
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a similar anomaly occuring in the spinal chord 
produces spina bifida [Macri at al, 1981). 
At birth the plaque which covers the region 
of exposed spinal chord in spina bifida is translucent 
and lies flat with the surrounding skin. However, 
without closure this plaque becomes keratinised and 
swells becoming filled with CSF, this gives rise 
to the descriptive classification, "spina bifida 
cystica". 
4.2 Aetiology 
The exact underlying cause of NTO remains 
unclear (Macri et al, 19813. Its occurrence appears 
to contain both genetic and environmental elements. 
Mendelian genetics cannot be demonstrated, however, 
there is a strong familial tendency and the risk 
of an individual with an NTD having offspring 
affected by the disease is around 5% (Siggers, 1978] 
An environmental element, perhaps related to 
dietary intake can also be demonstrated, the recurrence 
rate of NTO in women who have already conceived an 
affected child, approximately 5% in the British 
population [Siggers, 19783, can be reduced to less 
than 1% when a multivitamin supplement containing 
f olate, ascorbic acid and riboflavin is administered 
immediately prior to conception and continued through- 
out pregnancy (Smithells, 19823. 
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It has been suggested by Seller, [1983] that 
the disorder may be attributable to a deficiency in 
DNA synthesis resulting in an overall decreased 
production of nerve cells in the developing 
embryo. The author further suggests that this 
deficient DNA synthesis is caused by an inadequate 
supply of co-factors such as folate, zinc, and 
vitamin 812. Much of the evidence for this hypothesis 
is based upon the observation that inhibitors of 
DNA synthesis given to a strain of NTO producing 
mice at the correct gestational age alter develop- 
ment in such a way that the lesion no longer occurs. 
The argument follows that DNA synthesis being halted 
in the developing fetus allows the build up of 
deficient co-factors so that when synthesis 
recommences fetal growth is synchronised and the 
specific neural lesion does not occur. Clearly, the 
experiments are far from conclusive proof of such 
a theory but nevertheless they do point toward some 
metabolically based abnormality which it may be 
possible to correct. 
The adequate development of a neural tube 
requires more than the growth of neural tissue and 
it has been suggested that the primary failure 
may be mesodermal rather than neurological 
(Nixon, 1978]. 
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The exciting possibility remains that iF 
some co-factor or other metabolic deficiency is 
the primary causative factor, then this disorder 
may be avoidable by suitable replacement therapy. 
4.3 Occurrence and genetics -- 
Neural tube defects appear to be inherited 
in a non-Mendelian multifactorial way. Consequently 
the recurrence risk is linked to the incidence in 
the population. In the USA, where the disease 
is seen in 2 per 1000 live births, the recurrence 
risk is 2%, whereas in Glasgow, where the incidence 
in the whole population is 5 per 1000 the frequency 
with which it recurs is 5% [Haddow and Miller, 
1982). 
The overall frequency is known to vary 
widely between countries, from 9.7 per 1000 in 
Dublin [Coffey and Jessop, 19573 to 0.9 per 1000 
in Japan [Neel, 19583. The occurrence also varies 
between ethnic groups within the same country. 
It is substantially less in the negro [Windham 
and Edmonds, 19823 population in the USA than in 
the while population. In England and Wales there 
is a distinct regional variation in frequency, 
Fig. 4.1, with the highest rates found in Wales. 
Fig. 4.1 Adapted from Alberman, 1976. The 
geographical variation in England 
and Wales of the rates of occurrence 
of NTO. These are expressed per thousand 
live births. 
"f 
t 
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Rate per 1000 total births 
0123 
Wales 
.. 
North West 
North 
East Midlands 
Yorkshire and 
Humberside 
South West 
West Midlands 
South East 
Anencephaly 
Spina bifida 
East Anglia 
Hydrocephalus 
Fig. 4.1 The rate of occurrence of NTO. 
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It has been suggested that environmental factors 
may play a part in this distribution and in the 
higher incidence observed in social groups III, 
IV and V [Smithells, 19821. 
The rate of anencephaly to spina bifida 
varies but in most studies is approximately 1: 1. 
Twenty per cent of cases of spina bifida have 
a closed lesion and are undetectable by most 
antenatal screening programmes [Smith, 19823. 
Other fetal abnormalities are frequently mistaken 
for NTD in detection programmes and chief among 
these are the abdominal wall defects such as 
exompahlos. The frequency of this disorder has 
been reported as 0.3-0.4: 1000 [Wald at al, 19803, 
but individual studies have claimed a higher 
incidence [Read at al, 19823. 
In the UK the recurrence rate for a woman 
with one previous NTD child is approximately 5%; 
if there have been two affected children this is 
increased to 10%. If the parent themselves have 
NTD the risk is 5% or 1% if the familial involvement 
is limited to a second degree relative [Siggers, 19783. 
Several recent reports have shown an overall 
decline in the incidence of NTO in the UK and 
USA [Windham and Edmonds, 1982; Ferguson-Smith, 
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19833. In the UK this might be partially accounted 
for by the antenatal detection and termination of 
affected pregnancies. However, swings in the 
past have been noted; in Dublin in 1900 the rate 
was 1: 1000 and this increased to 9: 1000 by 1960 
[Windham and Edmonds, 19823. Prenatal diagnosis 
is doubtless a partial explanation for the recent 
decline in incidence in the UK, but in the period 
1975 to 1980 there has been a 59% drop and antenatal 
diagnosis is not sufficient to account for all of this 
[Ferguson-Smith, 19833. 
4.4 Prenatal detection of Neural Tube Defects 
Detection of NTD in utero has largely 
depended upon the identification of substances in 
the amniotic fluid whose concentration is increased 
in the presence of the lesion. The difficulties 
and risks associated with amniocentesis restrict 
its use to selected populations at increased risk. 
The actual danger from amniocentesis is hard 
to define because of the problem in obtaining a 
suitably matched reference group. However, the 
best studies available suggest aI to 1.5% risk 
of fetal mortality and some increased risk of 
fetal morbidity including skeletal deformity 
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[Turnbull, 19783. The risk to the mother is slight 
although maternal death attributable to amniocentesis 
has been described [Turnbull and MacKenzie, 19833. 
Identification of groups with increased risk 
of NTO allows amniocentesis to be more effectively 
applied. Two such groups commonly offered prenatal 
diagnosis in the UK are: 
a] Women with a previous NTO affected child. 
b] Women with a raised serum alphaf etoprotein [MSAFP] 
level. 
Once these groups have been successfully identified 
the most appropriate amniotic fluid marker for NTO 
must be decided upon. Several problems must be 
born in mind when choosing such a suitable marker: 
a] The level of many components of amniotic fluid 
change throughout pregnancy, marked change 
with gestational age can make interpretation 
difficult where dates are not accurately 
established. Ideally the marker concentration 
would be idependent of gestational age. 
b] Blood staining of amniotic fluid is common. 
10% of all amniotic fluids [Smith, 19823 
and, most importantly, 40% of those associated 
with anencephaly, and 20% of those with open 
spina bifida are blood stained (Haddow and 
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Miller, 19821. The NTO marker used should 
be insensitive to moderate amounts of blood 
from either fetal or maternal origin. 
c] Other fetal malformations are sometimes 
encountered and some of these, such as 
exomphalos, are surgically correctable. 
Ideally, the concentration of the substance 
measured should not be affected by the 
presence of non-NTD lesions. 
d] Practical considerations dictate that adequate 
methods be available for the substance to 
be measured. Frequently large numbers of 
samples will need to be processed particularly 
if assessment is linked to a whole population 
screening programme, such as maternal serum 
AFP. The method must ideally be cheap, 
reproducible, rapid, suitable for automation, 
use a small amount of amniotic fluid and the 
substance must be stable for a reasonable 
time span to allow measurement and repeat 
as necessary. 
e] In an ideal situation all false positive 
results are unacceptable, in practise the 
false positive rate must be very low compared 
with the true positive rate in the population 
under study. Where amniotic fluids taken for 
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chromosomal studies are assessed the false 
positive rate must be very much less than 0.5%, 
the incidence of NTD in this population. 
f] False negative results are arguably less of 
a problem than false positives, however, if 
the original requirement to detect NTO is 
accepted then a significant false negative 
rate would severely handicap the usefulness 
of the test. 
It is unlikely that any single marker would perfectly 
fulfil all the above requirements. It may be 
necessary to use two assays in conjunction. For 
instance, a test with a low false negative rate 
followed by one with a low false positive rate to 
be performed on all initially positive results. 
The increasing resolution available with 
ultrasonography may make it possible in the future 
to depart from indirect methods of measuring a 
substance in the amniotic Fluid. Recent results 
assessing the usefulness of ultrasound in diagnosis 
of anencephaly and spina bifida without the use of 
amniotic fluid measurement are encouraging [Campbell 
and Pearce, 19833. At present, however, the 
technique is more useful as an adjunct than in the 
definitive detection of NTO. 
In the following pages individual tests used 
in the detection of NTO are discussed in greater 
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detail and a suggested scheme of how they could be 
successfully used in conjunction is outlined. 
4.4Ci] Ultrasonooraphy 
In the 1970's static scanning with its greater 
resolving power was exclusively used for detection 
of fetal abnormalities. However, more recently 
the resolution of real time scanning has improved 
to match static scanning and has several advantages 
[Campbell and Pearce, 1983]: - 
a] Avoidance of movement artefacts. 
b) The study of organs and limbs during movement. 
c) Three-dimensional conceptual images can be built 
up. 
At present ultrasound has two major applications in 
detection of NTO. Firstly, measurement of bi-parietal 
diameter in accurately defining gestational age. 
This can be performed in order to help the 
interpretation of maternal serum AFP [MSAFP] data, 
for which gestational age makes a significant 
difference. Secondly, subsequent to a high MSAFP 
or in cases where there has been a previous NTO 
high resolution ultrasound can be used to detect 
any fetal abnormality and to help in performance of 
amniocentesis. 
The evidence is convincing that ultrasound 
localisation of fetus and placenta is necessary 
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for safe amniocentesis and reduces the number of 
blood stained samples obtained [Kerenyi and Walker, 
1977] . 
The direct use of ultrasound in detecting 
fetal abnormality is valuable; in a recent study 
[Campbell and Pearce, 19833 41 cases of anencephaly 
were detected without any error and 90 cases of 
spina bifida, of which five were closed lesions, 
produced only six false negative and one false 
positive result. 
The future of ultrasound looks promising, at 
present its use in differentiating NTO -lesions 
from other fetal malformations, in accurate dating 
of pregnancy and in guiding amniocentesis makes 
carefully performed ultrasonography a valuable 
contributor to any pre-natal detection programme 
for NTO. 
4.4[ii) Alphaf etoprotein measurement 
Alphafetoprotein CAFP), an oncofetal protein 
with a molecular mass of approximately 70 kDa was 
first described in the serum of human fetuses in 
1956 [Bergstrand and Czar, 19563. In the first 
trimester it is largely produced by the yolk 
sac and after this by the fetal liver. Concentration 
in the fetal serum peaks at the end of the first 
trimester, at 3000 mg/l and declines thereafter 
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until birth when levels are in the range 
10-50 mg/1 [Brack, 19833. 
In the normal fetus, AFP enters amniotic 
fluid by fetal micturation [Weiss et al, 19763, 
however, in the NTD-affected fetus a more direct 
communication may be available and consequently 
amniotic fluid AFP levels are elevated. - The use 
of amniotic fluid AFF in. prenatal detection of 
NTO was first reported by Brock and Sutcliffe 
in 1972. It soon became apparent that in the 
normal fetus change in the concentration of AFP 
in amniotic fluid reflected that of -the fetal 
serum concentration, albeit at a much reduced. , 
level [Brock, 19743. " 
Later it was recognised that transfer across 
amniotic membranes occurred and this allowed the 
measurement of AFP. in maternal serum [MSAFP). 
-Paradoxically levels. of MSAFP rose during the 
second trimester while those in amniotic fluid 
fell [Fig. 4-. 2J. It has been suggested that this 
is due to the rapidly expanding surface-area of 
the amniotic membranes permitting more AFP to 
diffuse across [Haddow and Miller,. 1982). 
Maternal serum AFP is most commonly measured 
by radioimmunoassay and can be used in whole 
population screening to identify patients with a 
Fig. 4.2 The variation in AFP levels in amniotic 
Fluid and maternal serum with gestational 
age is, shown based on data From, Laing, 1985 
and Timothy, 1985 (Personal communications]. 
Overlap is shown between, unaffected, 
open spina bifida and -anencephalic . 
pregnancies both for maternal serum AFP 
and amniotic_flüid AFP results. The 
choice'of intervention-point-between 
two and three multiples of the median 
[MoMs] determines the proportion oF-false- 
positive and-false-negative results. 
Adapted -from -Ferguson-Smith, _'983. - 
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Fig. 4.2 Variation in the level AFP in amniotic fluid and 
maternal serum. 
Gestational age (weeks) Multiples of the median 
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sufficiently high risk NTO to justify subsequent 
amniocentesis. This is usually in the order of 5% 
of patients in whom MSAFP is measured [Macri et all 
1981). False positive results are common and in 
20% of cases this is due to wrongly estimated 
gestational age, a further 25% are attributable to 
threatened or missed abortion [Ferguson-Smith, 
1983) and 5-15% to multiple pregnancy [Leonard, 1981). 
Depending on the "cut-off" used MSAFP will detect 
70-80% of NTO's in the population under study. 
Amniotic fluid AFP measurement has greater 
specificity than MSAFP despite some overlap between 
normal and NTD results [Brock, 19833. The "cut-off" 
limits applied in interpreting amniotic fluid AFP 
results are usually described in terms of multiples 
of the median [MOM] or standard deviations above the 
mean. They vary with gestational age from 2.5MOM 
at 13-15 weeks to 4. OMOM at 22-24 weeks [Brock, 19833. 
False positive results occur at approximately 
0.5% and False negatives at 2% [Collaborative AFP 
Study, 1979]. IF these false positive and negative 
rates are considered to be acceptable three major 
problems remain in using amniotic fluid AFP in 
diagnoses of NTD: - 
a] Uncertin gestational age creates a Fundamental 
difficulty for interpretation. 
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b) Fetal blood contamination invalidates results. 
cl Other fetal malformations are found to be 
associated with elevated AFP levels [Table 4.13. 
To lessen the effects of these interfering factors, 
ultrasound dating of pregnancy has been used to improve 
the precision of the estimation of gestational age. 
The Kleihauer test to identify fetal blood is 
performed on blood stained samples and ultrasound 
may be used to identify other fetal abnormalities. 
With all these precautions the resultant false 
positive rate of 0.5%. is still high, particularly if 
AFP is measured in amniotic fluids from pregnancies 
screened for chromosomal abnormalities arising due 
to advanced maternal age. In this population the 
risk of NTO is approximately 0.5%, equivalent to the 
false positive rate of the test and therefore the 
number of normal fetuses terminated is the same as 
those with the defect. 
AFP estimation has made a very significant 
contribution to the identification of fetal abnormality 
in utero. Its measurement in maternal serum makes 
voluntary whole population screening Feasible, 
indeed it is practised in many regions throughout 
the UK. 
The major problems which remain are the high 
false positive rate, the difficulty in interpretation 
of blood contaminated samples and the uncertainty 
J' 
Table 4.1 Fetal conditions which may give rise to an 
increased amniotic fluid AFP level. 
Exomphalos and congenital nephrosisin 
particular can be confused with NTO in 
antenatal detection. Adapted from Brock, 
1978. 
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Table 4.1 Fetal conditions in which elevations 
of amniotic fluid AFP may be seen 
early in pregnancy 
Probable 
Anencephaly 
Spina bifida [open] 
Intrauterine Death 
Congenital Nephrosis 
Exompahlos 
Fetal Teratoma 
Possible 
Turner's Syndrome 
Duodenal Atresia 
Oesophageal Atresia 
Polycystic Kidneys 
Fallet's Tetralogy 
Annular Pancreas 
Congenital skin defects 
Epidermolysis Sullosa 
Hydrocephalus 
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of determining gestational age - all of which can 
lead to the abortion of normal Fetuses. Recent 
developments have centred upon the analysis of 
other markers in amniotic fluid either as an adjunct 
to AFP measurement or as a more reliable alternative. 
4.4[iii] Cholinesterase measurement 
AChE is secreted by nerve trunks and found 
in soluble forms in the CSF (Section 2.33 and 
therefore it might be expected that in NTO, where 
the lesion exposes nervous tissue and CSF to direct 
contact with amniotic fluid, AChE levels would be 
significantly increased in the presence of the 
abnormality. 
Shortly before our initial report of the 
preliminary work [Dale et al, 1979b), other workers 
[Smith A. O. et. al, 1979; Chubb et al, 19793 independently 
reported similar findings. These three reports 
showed that both AChE and BChE were increased in 
amniotic fluid of NTD affected pregnancies; in our 
awn study (Dale et ei, 1979b) this was without overlap 
in non-bloodstained fluids. 
In addition to this quantitative increase, 
gel electrophoresis revealed a distinct band of 
enzyme activity in the amniotic fluid of NTO affected 
pregnancies [Smith, 19823. This had similar 
characteristics of mobility and inhibitor sensitivity 
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to AChE present in CSF and released by neurones 
in culture. 
Further work with chick embryos with NTD 
suggested that AChE might enter the amniotic fluid 
by direct secretion from nerve axons or by CSF 
leakage (Pilowsky et all 19821. The source of 
AChE activity in normal amniotic fluid is unclear 
but a placental origin has been suggested. 
The application of cholinesterase measurement 
in amniotic fluid has followed two distinct routes: 
a] Quantitative measurement either of total 
cholinesterase activity [ACNE + BChE] or of 
AChE alone. 
b] Qualitative identification of an abnormal band 
of AChE activity on gel electrophoresis'. 
Both approaches offer advantages and suffer from 
drawbacks. The application of quantitative and 
qualitative techniques may ultimately prove distinct 
and complimentary. The methods are discussed below: - 
a] The quantitative approach 
The measurement of total cholinesterase activity 
can be dismissed early in the discussion, its main 
proponent has been Milunsky [Milunsky at al, 1979; 
Milunsky, 19803, although one other group'has 
subsequently reported its use [Simpson, 19833. The 
inherent simplicity and sensitivity of this method 
are greatly outweighed by an inability to distinguish 
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non-NTD lesions and by inordinate sensitivity to 
blood staining of either fetal or maternal origin. 
Quantitative measurement of AChE directly 
either by selective inhibition of BChE, or indirectly 
by inhibition of AChE has been reported by many 
groups, with similar results [Table 4.2]. When 
compared with AFP the advantages of the method 
are numerous. It is very reproducible, simple, 
rapid (taking less than 30 minutes), easily automated 
(Moreau et al, 1982) and cheap [less than 1p per test). 
It is relatively unaffected by gestational age and 
consequently one reference range can be used 
[Hodgson et al, 1981). There are conflicting 
reports of false positive and false negative rates 
- ranging from zero for both (Dale et al, 1981) 
to 8% and 32% respectively [Voigtlander et al, 1981). 
Similar controversy exists over the affect of blood 
staining [Chubb and Pilowsky, 1979; Voigtlander, 
1981) although there is general agreement that it 
is superior to AFP in this respect. 
Several reports suggest that some AFP positive 
non-NTD lesions, such as exomphalos, can be 
identified by high BChE/AChE ratios [Dale at all 
1981; Bonham at all 19813, with AChE levels either 
marginally increased or showing no increase at all 
[Guibaud at all 19823. 
Table 4.2 Quantitative measurement of AChEactivity 
in amniotic fluid in the detection of 
neural tube defects. 
, 
The mean activity 
standard deviation and range is shown 
when reported. 
i I. 
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Table 4.2 Wuentitetive AChE me=surement in smniotic fluid 
Reference Mean =: ý Range 
G nt. Cutacm Method 
Chubb at el, 1979e 
Dale at ei, 1979 b 
Smith A. D., at al, 1979 
Seller at al, 1990 
Dale at al, 1981 
Bonham at  l, 1981 
Webb at al, 1981 
Hodgson at a1,1981 
Voigtlander at al, 1981 
Coombes at al, 1982 
Rorive at ml, 1982 
Guibeud et a1,1982 
Legge 6 Potter, 1983 
Lemedica at al, 1983 
Moreau at al, 1983 
Aitken at al, 1984 
Wyvill at el, 1984 
U/1 U/1 Weeks 
77 2.8 - 0.2 - 8.9 14-23 N ormal 
1 4.5 - - 21 S B Smith A. D., at  1l 1979 
1 23.2 - - 20 A n 
150 3.7 t 1.3 1.4 - 7.8 12-25 N ormal Dale at  ll 1979b 7 -- 8.9 - 15.2 - NTO 
56 2.6 t 1.3 0.9 - 8.6 14-23 Normal 
8 9.9 - 6.2 - 17.0 - An Smith A. D.,. st all 1979 
6 7.2 - 4.8 - 11.7 - SB 
71 2.1 t 1.1 0.5 - 4.8 15-20 Normal 
16 14.9 t10.0 5.9 - 41.3 - An Smith A. D., at a1,1979 
9 8.0 t 4.6 4.0 - 15.8 16-19 SB 
101 2.6 t 1.1 0.4 - 5.8 14-24 Normal 
10 15.0 t 3.3 10.2 - 19.5 - An Dale at all 197S b 26 10.3 t 3.5 5.5 - 23.4 - SB 
5 9.4 t 4.8 2.7 - 15.6 - Ex 
50 2.0 t 0.9 0.6 - 4.2 15-25 Normal 
5 8.0 - 5.1 - 8.6 to An Modified 
9 6.3 - 4.8 - 9.7 to SB Dale at all 1979b 
2 3.9 - 2.6 - 5.1 it Ex 
68 . 3.4 t 1.6 0 - 8.8 14-27 Normal ogle at all 1979b 4 13.2 - 3.3 - 21.0 it An but lower 4 7.7 - 6.2 - 9.7 of 58 centrifugation speed 1 3.6 - of Ex 
204 3.0 t 1.6 - 14-27 Normal 
7 16.9 - 8.4 - 30.0 - An SmLthA. D., at all 1979 
3 38.2 - 4.6 -102.0 - 58 
70 2.9 - 0.9 - 9.0 14-27 Normal 
10 8.1 - 8.2 - 19.3 16-24 An Smlth A. D. at all 1979 3 4.9 - 2.8 - 7.1 18-20 $8 , 
1 6.1 - 17 Ex 
49 3.9 t 1.2 - 16-23 Normal 
46 15.9 - 6.6 -109.0 16-22 NTD Dole at all 1979b 6 15.3 - 2.9 - 48.3 18-22 Ex 
14 1.4 t 0.5 - 3.2 14-24 Normal 6 6.0 - 3.2 - 8.7 - An Smith A. D., at all 1979 
4 3.9 - 2.7 - 6.2 - 58 
127 2.7 t 1.5 0.0 - 7.1 16-24 Normal Dole at  1ý 1979b 17 8.0 f 6.7 1.0 - 28.7 - NTD 
146 1. S t 0.7 - 13-21 Normal 
8 9.3 ± 3.6 - - An Dale at all 1979b 
5.1 t 0.4 - - SB 
412 4.1 ± 1.3 - 15-28 Normal Dela at al on CFA 
4 11.6 - 10.2 - 13.2 - An 1979b 
92 3.4 ± 1.3 1.4 - 7.5 17-20 Normal 
Cal. at al on CFA 
1979b 
210 2.06± 1.06 0.1 - 7.3 14-26 Normal Smith A. D. at all 1979 
159 7.68: 5.24 0.5 - 31.7 - An 
96 5.60t 2.73 0.14- 14.7 - SB 14 1.74t 2.6 0 - 10.7 - Ex 
1410 5.6 - - 14-22 Normal Huilin at  1,1981 
32 18.2 - - An 
28 11.9 - - SB 
An Anencephely SB - Spine Bifid  Ex - Exomphslos CFA - Centrifugal fast 
 n. 1yser 
NTD - Neural tube defect 
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The chief attraction of the quantitative 
method include its objectivity and the speed 
and simplicity of the assay. 
b) Qualitative measurement of AChE 
The original paper reporting a quantitative 
change in AChE activity in amniotic fluid [Smith, A. O. at al, 
19793 also reported an`abnormal band in gel 
electrophoresis when the amniotic fluid of NTO 
pregnancies was examined. This faster migrating 
form, [Fig. 4. J was sensitive to AChE inhibitors such 
as BW 284b51 [Section 1.83. 
This : technique has been thoroughly explored 
in detection. of NTD and is specific in its prediction 
of the disease with low false positive and negative 
rates even in selected cases with anomalous AFP 
results [Table4.3). It is relatively insensitive 
to blood staining with some reports suggesting 
no effect [Buamah at all 1980), later studies however, 
confirm that heavy blood staining does produce 
false positive results and that fetal plasma 
was responsible for this interference [Barlow at all 
1982b ). 
The technique has disadvantages when compared 
with the quantitative method. It is time consuming 
and not amenable to automation. The identification 
of a fast-moving band is somewhat subjective. Cross 
contamination between gels is possible [Smith, 1982). 
Fig. 4.3 Adapted from Smith, 1982 - Polyacrylamide 
gel electrophoresis of-amniotic fluid 
from normal and NTO affected pregnancies - 
stained for cholinesterase activity. The 
effects of selective inhibition of AChE 
[due to BW284c51] and BChE [due. to 
ethopropazine] are. also illustrated. __-.. 
# .. 
ý, . 
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0 
23 
Normal 
1 
Normal 2 
3 
NTD 5 
Iu II G 5 
NTD 
Without inhibitors 
With ethopropazine 
With BW284c51 
Without Inhibitors 
With ethopropazine 
With BW284c51 
Fig. 4.3 Polyacrylamid e gel electrophoresis 
of amniotic fluid from normal and NTO 
affected pregnancy 
i 
Table 4-. 3 A summarised assessment of the results of 
the AChE gel test [polyacrylamide gel 
electrophoresis of amniotic fluid] in the 
detection of NTO from 1979 to 1984. Total 
numbers of false positive and false negative 
results are shown. 
ip 
I 
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Table 4.3 False positive and negative results in the AChE gel test 
used in detection of NTQ 
Study True False True 
False Comments 
Negative Positive Positive Negative 
Smith A. D., at al, 1979 17 0 20 0 
Brock & Hayward, 1980 169 0 30 0 
Suamah at al, 1960 140 0 61 0 
Seller & Cole, 1960 130 7 35 0 Some blood- 
stained samples 
Collaborative AChE Study, 
125 8 8 13 4 
47 blood- 
1981 stained samples 
Haddow et al, 1991 153 1 51 1 
*1 blood- 
stained sample 
Maori et al, 1981 115 0 39 0 
Seller 6 Barry, 1981 1000 1 - - 
Voigtlander et al, 1981 71 0 19 0 
Webb et al, 1981 68 0 7 0 
Barlow at al, 1982a 60 0 17 0 
Coombes at al, 1982 49 0 46 0 
Davidson at al, 1982 40 0 18 2 Both false neg. 
results third 
trimester 
Guibaud et al, 1982 191 0 20 0 
Haddow 6 Miller, 1982 153 1 50 1 
* Fetal blood- 
staining in I FP 
Milunsky S Sapirstein, 1982 106 9 66 0 *6 blood- 
stained samples 
Norgaard-Pederson et al, , 1982 170 0 24 0 
Read et al, 1982 853 2 47 0 
Goldfine at al, 1983b 128 0 - - 
Crandall et al, 1983 333 3 47 0 
*2 blood- 
stained samples 
Simpson, 1983 - 2 37 0 
Van R egemorter et al, 
1963 33 0 10 0 
Aitken et al, 1984 3054 33 170 0 
Wyvill et al, 1984 1408 8 60 0 
. 
8566 
. 
75 
_1687 8 
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The test gives false positive results with 
non-NTD lesions [Table 4.4; in particular, in 75% 
of cases of the surgically correctable condition 
exomphalos an AChE band indicative of NTO is 
visible. This is less of a problem in the quantitative 
assay. Attempts have been made to improve the 
technique by densitometric scanning of the gels. 
This improves the objectivity of the test and 
preliminary results are encouraging [GoldFine et all 
1983a; GoldFine et all 1983b). The interpretation 
of other "extra bands", so far ignored, may be 
of value in identifying non-NTO lesions such as 
exomphalos [Jones and Evans, 19833. 
The major contribution of the AChE gel test 
lies in reducing the false positives generated by 
AFP measurement [Haddow et al, 1981; Milunsky and 
Sapirstein, 198; Collaborative AChE 
Study, 1981). It is estimated that these may be 
reduced by 90% without causing a significant 
number of true positives to be missed 
[Collaborative AChE Study, 1981). 
It is not yet clear whether AChE might 
eventually replace AFP as the primary diagnostic 
test (Brock, 19833. If this were to be the case, 
then the quantitative method would be the method 
of choice (perhaps used in combination with a more 
specific test for secreted AChE activity such as 
the gel test to check positive results]. 
Table 4.4' Fetal abnormalities which give rise to 
false positive AChE gel test results. 
ifs- 
Table 4.4 False cositive cel. test results arisinc due to 
non-NTO malf crmations , 
ar U0. 
Study .. 
L " mL 11 >' a a. .. to 0 
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Y>1 C 0 D0 
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C 3T 
4-W 
to 0 
x16 
oY 
UZ 
0al 
I. 04 
x- 
WU 
0 
º- 
L 
I-W IL U) UZ 
. dN U= 1W . 7 
Brock 6 Hayward, 19E0 4/4 4 /4 1/1 - 0/6 1/1 2/ 0/3 - - - - 
Buamah at al, 1980 4/4 3/3 - - - - - - - - ` 
Seller 6 Cole, 1980 - /4 - - - - - - 
Collaborative AChE Study, 1981 7/63 - 4/4 - 0/11 - - 1/3 1/3 0/1 1/1 
Haddow at  l, 1981 5/5 - 1/1 1/1 - - - - - 
Macri at al, 1981 3/4 - - - 0/2 - - - 
Voigtlander at al, 1981 2/2 2/2 - - 0/1 - - - - 0/1 - - - - 
Barlow at al, 1982a 4/6 - - - - - ` 
Coombso at  1,1982 6/6 - - - 0/2 - - ` 0/1 - - - ` 
Crandall at al, 1982 S/1 V1 - - 0/1 - - 3/8 
Davidson at al, 1982 - - - 1/1 - - - - - - - 
Heddow 6 Miller, 1982 5/5 - - - - - - 
Milunsky 6 Sopirstein, 1982 - - - - 0/1 0/2 1/2 - 
Norgaard Pederson at  l, 1992 4/6 2/2 - - - - 
Read at al, 1982 1/8 - - - 0/1 - - 1/1 - " 
Brock at all 1983 - - - - - - - /1 - " 
Goldfine at al, 1983a - - - - - - ` 1/1 - - - 
Goldfine at al, 1933b fß/10 - - - - - - - 
Holgreve 6 Golbus, 1983 - - - - - - - - 2/2 
Simpson, 1983 - - - - - - 0/ 2 1/ 1 " 
von Regemorter at all 1983 0/3 1/3 - - - ` - - - - - 0/4 
Aitken at al, 1984 6/12 S/13 - - 0/2 0/1 - - - - 
Wyvill at  l, 1984 6/7 3/4 - - - - - - - - 
TOTAL 11? / 27 Ej 2/ 0/ 24 
1/ 
2 
2/ 
2 
2/ 
5 
1/ 
11 
0/ 
2 
2/ 
2 1 
3 
8 
1/ 
2 
2/ 
6 1 4 5 6 2 
False positive results are display ed an fract ion of t he total num ber of comes 
e. g. 1/8,1 positive result from 8 su ch eases 
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The advantages of AChE over AFP are outlined 
in Table 4.5, however at present its widespread use 
is largely confined to samples with elevated AFF 
or where there is known blood staining or uncertainty 
about dates. AFP measurement has been in use for 
some time and AChE is now accepted as an important 
adjunct able to reduce the false positive rate. 
Indeed, in the Lancet editorial on AChE [Editorial, Lancet 
1980] the Editor quotes "The ability of AChE to 
distinguish normal pregnancies from those with 
fetal NTD has been impressive. The physiological 
basis of the new test is also convincing .... sensitivity 
for anencephaly and open spina bifida was least as 
good as and probably better than amniotic fluid AFP 
measurement .... AChE appeared to cope particularly 
well with fetal blood, one of the major problems 
in the use of AFF measurement. .... AChE is the most 
effective complimentary test to AFP in the early 
diagnosis of NTD. It may eventually supplant AFP 
as the primary biochemical test on all second 
trimester amniotic fluids". 
The molecular forms of AChE present in amniotic 
fluid have not been satisfactorily identified in 
accordance with the accepted structural classification 
outlined in Section 2.2. The present work sets out 
to identify and quantitate these. IF an NTO specific 
Table 4.5 AChE and AFP measurement in amniotic fluid 
in the detection of NTO compared on the 
basis of several criteria important in the 
routine use cf_each assay. 
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Table 4.5 Relative merits of amniotic fluid AChE and AFP 
measurement in detection of NTO 
I 
Possible source of difficulty AFP AChE 
Change with gestational age : Marked Slight if at all 
Effect of fetal bloodstaining : Marked 
Little effect unless 
marked bloodstaining 
Discrimination of non-NTD Discriminates 
lesions e. 
does not g. exomphalos, : discriminate exomphalos and 
congenital nephrosis congenital nephrosis 
Takes 24 hrs 
Simplicity, speed and complicated S Rapid C30 min] simple 
cheapness of assay moderately less than Ip per test 
expensive 
False positive rate 0.5% 
Table to reduce AFP false 
positive rate by 90% 
False negative rate : 2.0% 0.5% % 
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AChE form could be identified then perhaps a 
suitable quantitative assay could be devised which 
would combine the virtues of both the quantitative 
and qualitative tests presently employed and 
consequently replace amniotic fluid AFP estimation 
in detection of NTD. 
4.4[iv] Other tests which have been used 
The shortcomings of AFP measurement in 
detection of NTO have long been recognized. In 
particular False positive results and fetal 
blood staining have created problems. Prior to 
AChE measurement, several other markers were 
examined, with varying degrees of success, these 
included concanavalin A reactive AFP and "rapidly 
adhering cells". These together with several other 
less well publicised parameters are outlined below: 
Concanavalin A reactive AFP 
Initially this test appeared to be promising. 
AFP exists in concanavalin A[ on A) -reactive. and 
unreactive forms. In the presence of NTO there 
is an increase in Can A reactive AFP in amniotic 
Fluid. It was suggested that this could be applied 
diagnostically [Smith, C'. J., at all 19793. Unfortunately 
a lack of independence from AFP measurement itself, 
together with marked changes in response to 
gestational age have meant that this test provides 
little additional information [Brock, 19833. 
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Consequently, the technique which is both time 
consuming and difficult has not gained widespread 
acceptance. 
Rapidly adhering cells 
When amniotic fluid cells are plated out 
for in-vitro culture they normally adhere slowly 
to glass or plastic. In the presence of NTO, the 
number of cells which adhere rapidly [less than 
24 hours] is increased [Sutherland et al, 1975). 
The application of this technique in diagnosis 
of NTO has been difficult to verify and the technique 
has not gained widespread acceptance, perhaps due 
to its subjective element in classifying cell 
types. 
Several other parameters such as amniotic 
fluid IgM, 0-trace protein, fibrinogen degradation 
products, «2 macroglobulin, ß-lipoprotein, f erritin 
and transferrin have been measured; despite 
occasional claims to the contrary they appear to 
have little to offer over AFP measurement (Seller 
et all 1981; Legge and Potter, 1983). Multifactorial 
approaches have been made such as amniotic fluid 
amino acid profiles with similarly disappointing 
results (Pettit and Allen, 1981). 
More recently, monoclonal antibodies have been 
applied in the detection of neuroFilaments. It has 
been proposed that this may be of value in the 
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detection of NTO and reagents are available 
[Labsystems Ltd]. Their usefulness remains to 
be evaluated. 
4.4[v] Overall diagnostic plan 
The overall success of prenatal detection 
for NTO depends not only upon the efficiency of 
individual tests used, such as amniotic fluid 
AFP, but also upon the way in which these are set 
into an overall' plan CFi"g. 4.4] and the care with 
which they are interpreted. 
Both amniotic fluid AFP and AChE measurement 
are usually performed on high risk groups or 
those patients from which amniotic fluid has 
already been collected for other reasons. These 
groups include women with a previous NTD-affected 
pregnancy, those with an elevated maternal serum 
AFP and those in whom amniocentesis has been 
performed to detect chromosomal abnormalities 
e. g. Downs Syndrome. 
Ultrasonography is routinely performed prior 
to amniocentesis and is used to accurately date 
the pregnancy and to exclude multiple pregnancies. 
Following amniocentesis, if AFP or AChE results 
are positive, ultrasonography may be able to define 
the fetal abnormality present. 
., 
Fig. 4.4 Adapted from Leonard, 1901 -A suggested 
diagnostic plan for detection of NTD. 
Three initial groups are considered: 
Those screened for elevated maternal. - 
serum AFP. 
Those with a previous NTO affected 
pregnancy. 
Those on whom amniocentesis-was 
desirable because of an increased 
risk of chromosomal abnormality 
due to advanced maternal age. 
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Maternal serum AFP 
16-18 weeks 
Normal 
Positive 
No further tests 
Repeat 
Normal 
Positive 
No further tests 
Sonography -ý Twins, wrong gestation 
Encephalocele, fetal 
demise 
Risk of chromoscmal 
abnormality Previous NTO affected pregnancy 
Amniocentesis 
Normal Elevated AFP or quantitative 
AChE 
Follow as high risk 
pregnancy 
Sonography 
Other confirmatory tests 
including AChE gel test 
to reduce false +ve rate 
Normal 
Abnormal 
Follow as high 
risk pregnancy 
Possible termination 
Adapted from Leonard, 1981 
Follow as high risk 
pregnancy 
Fig. 4.4 A diagnostic plan for the prenatal detection 
OExomphalos or other 
correctable fetal 
abnormality 
of NTO 
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As each test is found to be positive the 
risk of NTD increases [Smith, 1S82): - 
Chance 
of NTO 
Positive maternal serum AFP only 1: 13 
Positive maternal serum AFP + positive amniotic 18 :1 fluid AFP 
Positive maternal serum AFP + positive amniotic 288 :1 Fluid AFP + positive AChE gel test 
The classification of individual results, 
e. g. amniotic fluid AFP, depends upon continual 
updating of reference ranges on the basis of pregnancy 
outcome and the analysis of this data. It is possible 
[Strike and Smith, 19823 to calculate the individual 
risk for each pregnancy based on the actual level 
of maternal serum AFP, amniotic fluid AFP and the 
result of the AChE gel test; this is greater if the 
levels are higher and less if lower, even when 
beyond the accepted positive cut-off value. 
When dealing with population screening procedures 
strict adherence to a programmed investigation is 
vital together with careful interpretation of test 
results on the basis of continually updated data. 
4.5 Ethical difficulties of prenatal diaonosis 
The operation of a prenatal programme raises 
difficult questions. These can be classified as: - 
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a] The purely pragmatic 
Is such a programme cost effective? The 
consensus opinion is that this is clearly a cost 
effective procedure when long term care of the 
affected individuals is considered [Leonard, 19813. 
b) The mixed pragmatic/moral 
When the incidence of the disorder in the group 
under study is low,. as in thos undergoing amnio- 
centesis for detection of chromosomal abnormalities, 
[where the rate of NTO is about 0.5%] it may be 
uncomfortably near or even exceeded by the false 
positive rate of the test (also about 0.5% for 
amniotic fluid AFP). This effectively means 
terminating one perfectly normal pregnancy for every 
NTD affected fetus detected. 
c] The purely moral 
It is reported [Leonard, 1981) that with better 
means of treatment 'many individuals lead happy 
productive l'ives'. This must obviously raise doubts 
about whether anyone has the right to terminate 
this life. Even when the defect is severe, life may 
prove just as valuable to the individual concerned 
and their family, if society implicitly or explicitly 
counsels otherwise this may set a dangerous precedent. 
In practice, the moral justification for 
prenatal detection, rests upon "properly informed 
discussion" with the family involved. Alas, it is 
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probably naive to imagine that this is achieved 
in all cases, even if attempted. Indeed, the 
relativistic morality of the present society may 
not provide a sufficiently strong framework [Schaeffer 
and Koop, 19823 on which'to-base the eventual 
decision which has irrevocable consequences not 
only for the family, but also for the newborn child. 
These questions are far too often mutually hedged 
by all concerned. 
4.6 Prevention and treatment 
The suggestion of a link between NTO and 
vitamin deficiency was first suggested by Smithells 
in 1976 (Smithells at al, 1976). Further studies 
in this are summarised by Smithells, [1982] and show 
that the recurrence rate in 493 mothers not receiving 
a multivitamin supplement including folic acid, 
ascorbic acid and riboflavin during pregnancy was 
23 of 493 studied. A similar group of 397 who were 
given this supplement showed only two recurrences. 
The difference is highly significant p< 0.0003. 
The Fuller investigation of this phenomena 
has been hampered by the ethical 
witholding, what would appear to 
preventative measure, from women 
1982]. It would appear however, 
low income groups, vitamin suppl 
preventing NTO. 
difficulties of 
be an effective 
at risk [Editorial; Lancet 
that particularly in 
ement is useful in 
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When an NTO affected child is carried to 
term the decision to treat may be difficult [Nixon, 
1978). Pure meningocele without neurological 
disorder is obviously treatable but association 
with the Arnold Chiari malformation and gross 
spinal kyphosis gives a poor prognosis. Corrective 
surgery includes removal of prominant bifid spines 
and closure, using adjacent skin. During the 
post-operative period particular attention should 
be given to the urinary system and longer term 
management too must be carefully arranged. In 
particular impairment of skin sensation below the 
lesion may produce wounds which are difficult to 
heal [Macri et al, 19813. 
The decision whether or not to treat the NTO 
affected child must be made promptly, it is 
unfortunate that such a difficult decision must often 
be made in relative haste, however evidence shows 
that the best results are obtained by operation 
within 48 hours of birth [Nixon, 19783. 
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Section 5: Aims of-the Thesis 
It is intended to: - 
5.1 Further investigate AChE assays currently in use 
In particular for: - 
a] Diagnosis of Hirschsprung's disease 
Studies have been performed on a limited number 
of cases [Section 3]. A larger retrospective 
analysis is necessary, comparing biopsy AChE levels 
with the final diagnosis established. 
b] Detection of neural tube defects 
The present method in use is performed manually. 
An automated method would improve precision and 
allow samples to be processed more rapidly. This 
is to be investigated. 
5.2 Examine AChE and BChE molecular forms in 
Hirschsprung's disease and in amniotic fluid 
from NTO affected pregnancies 
a] Hirschsprungts disease 
It is intended to investigate both AChE and 
BChE molecular forms in normal and aganglionic 
rectal tissue. To quantitate the changing levels 
of these forms and to compare these changes with 
those seen histochemically and histologically in 
the transition from normal to aganglionic gut. 
b] Neural tube defects 
Molecular forms of AChE and BChE are to be 
examined in amniotic fluid from normal pregnancy and 
those affected by anencephaly, spina bifida and 
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excmphalos. The forms are to be quantitated and 
the increase in the level of each form compared 
with the increase in overall activity. The aim 
if possible, is to identify a form of AChE, present 
in NTO pregnancies alone, which would form the 
basis of a much improved diagnostic test. 
Quantitation of the activity of molecular 
species in both rectal tissue and amniotic fluid 
must include information about their stability 
and the possible effects of native proteases on 
the molecular form profile. In addition their 
release from rectal tissue is also to be investigated, 
this will provide information about their possible 
cellular location. 
5.3 Characterise the molecular forms 
Present in amniotic fluid and rectal tissue 
Particular attention will be paid to any form 
or forms specifically increased in either Hirschsprung's 
disease or NTO. Further characterisation of these 
forms will include: 
a] Approximate molecular mass-determination 
by comparison of gel filtration and 
sucrose density data. 
b] In the case of amniotic fluid their behaviour 
on polyacrylamide gel electrophoresis. 
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c] Thermal stability studies. 
d) Response to substrate inhibition. 
e) Relative sensitivity to commonly used inhibitors. 
f] Interaction with detergents - suggesting 
possible cellular localisation. 
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MATERIALSAN0 --M E-T-H DDS 
Section 6: Assays in current use 
Section 7: Molecular forms - analytical techniques 
Section 8: Materials studied and patients 
investigated 
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Section S: Assays in current use 
6.1 Measurement of AChE and BChE in amniotic 
Fluid 
The measurement of AChE activity in amniotic 
fluid has been previously described [Dale at al, 
1S813: - 
Each amniotic fluid sample was centrifuged 
at 1.5,000g for 3 min in an EppendorF Model 5414S 
microcentrifuge [Anderman Ltd] to remove cellular 
debris and contaminating erythrocytes. 
The following reagents were added to a 10mm 
light path cuvette: 
A. 2.55m1 of 0.1M - disodium hydrogen/potassium 
dihydrogen phosphate buffer; pHB. O 
B. 0.05m1 of 9.52 x 10-4M ethopropazine 
hydrochloride [May and Baker; Sigma Chemical Co. ] 
C. 0. lml of 0.01M DTNB in o. IM disodium hydrogen/ 
potassium dihydrogen phosphate buffer; pH7.0 
To this mixture was added 0.2m1 of centrifuged 
amniotic fluid which was then mixed by inversion 
three times and incubated for 5 min at 30°C. The 
reaction was initiated by the addition of 0.1m1 of 
0.015M acetylthiocholine iodide. The initial rate 
of change in absorbance at 412nm was then followed 
for 5 to 10 min at 30°C. Amniotic fluid was omitted 
from blank cuvettes set up to correct for non- 
enzymic hydrolysis. Results are calculated in 
- 132 - 
International Units per litre [U/1]: - 
U/1 = abs. /min TV x 
106 = abs/min x 1103 
Em SV 
abs. /min: change in absorbance [optical density units] 
per minute 
Em - molar extinction cofficient of the 
: nitrobenzoate ion i'. e .. -1 . 36 "x . 104 
TV "-- total volume -in the cuvette.. 
Sv- sample volume 
Acetylthiocholine [AThChJ iodide may be replaced 
in the assay by acetyl-ß-methylthiocholine iodide 
[A/MThCh) [0.015MJ, this improved the specificity of 
the assay by reducing cross reaction with BChE 
[Bonham at al, 19813. 
It is possible without change in final 
concentration to adapt these assay procedures for 
use on a centrifugal fast analyser [CFA] such as 
the Cobas Bic [Roche Ltd]. 
The sample volume is reduced to 0.02m1 and 
28 samples can be analysed simultaneously in an 
assay time of less than 15 min. The transfer and 
pipetting of reagents and samples is automated 
[Fig. 6.1J which would be expected to improve 
overall precision. Other analytical parameters are 
listed in Table 6.1. 
9 
Fig. 6.1 A schematic guide to the operation of a 
centrifugal fast analyser [Cobas Bic, Roche 
LtdJ". A cross section. of a single cuvette 
is shown with the. position of reagent and 
sample pockets and the reaction cuvette 
illustrated. 
,-ý-ý. 
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Sample 
A vials 
Cuvettes 
000 O O 
O0 
Q0 Pipette 
OO transfer 
O0 
OO p 
Op p0 
Sample disc 
Cuvette rotor 
Reagent 
00 
0 Start reagent 
Reagent 
reservoir 
Cuvette 
Photodector -t- ht source 
Sample well 
Reagent well 
Fig. 6.1 A schematic guide to the operation of the 
centrifugal fast analyser 
Table 6.1 Parameter listing together, -with reagent 
concentration used for assay of AChE 
and BChE in amniotic fluid specimens 
with the Cobas Bio centrifugal fast 
analyser. 
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Table 6.1 Parameter listing and reagent composition 
used for AChE and EChE assay or amniotic 
fluid samples on the CFA 
Parameter listing 
1 Units U/1 
2 Calculation Factor 920 
3 STD 1 Conc 0 
4 STD 2 Conc 0 
5 STD 3 Conc 0 
6 Limit 1 
7 Temperature [Deg C) 30.0 
8 Type of analysis 2 
9 Wavelength [nm) 412 
10 Sample volume [/I1) 20 
11 Dilutent volume (µl) 60 
12 Reagent volume [/L1) 300 
13 Incubation time [Sec) 0 
14 Start reagent volume [141) 0 
IS Time of First reading 40 
16 Time interval [Sec) 30 
17 Number of readings 20 
18 Blanking made I 
19 Printout mode I 
Reagent Composition: - 
OTNB: 4.3 x 10-4M 
ATCH: 6.4 x 10-4M 
Ethopropazine: 1.8 x 10-BM 
Contained in pH8.0,0-IM 
disodium hydrogen/dihydrogen 
potassium phosphate buffer 
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The results of this automated technique are 
compared with those of the manual method in 
S ect icn 9.1. 
The normal reference values for the manual 
technique were: 
Mean = 2.6 ± 1.1 (SDI; 
et al, 1981]. 
Range 0.4 - 5.6 U/1 [Oale 
6.2 Measurement of rectal suction biopsy AChE 
Rectal suction biopsies were made as described 
in Section 3. The biopsy specimens without added 
liquid or preservative were placed in tightly 
capped tubes and transported to the laboratory as 
quickly as possible. The tubes were then refrigerated 
at -20°C for at least 30 min in order to allow the 
samples to freeze. This was carried out on all 
samples to standardise the technique for those which 
it was not possible to analyse the same day. 
Samples were thawed, dried by contact with 
filter paper and weighed on a microbalance Microforce Mk 
2C [C. I. Electronics]. If the weight was greater 
than 10mg the sample was divided to produce a 
specimen of less than 10mg. This was then transferred 
to a glass homogeniser body [2ml, Potter Elvehjem type - 
Jencons Ltd] and Iml of 0. IM, pHB. 0 phosphate buffer 
added. The sample was then homogenised using a 
motor driven PTFE pestle at 3,000 rpm and the result- 
ing suspension centrifuged at 15,000g in an Eppendorf 
microcentrifuge [Anderman Ltd]. 
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The method of assay was described by Dale at all 
1977. The following reagents were added to 10 mm 
light path cuvettes: - 
Cuvette I Cuvette 2 
[ml] [ml) Reagents 
2.35 2.4 O. IM, disodium hydrogen/potassium 
dihydrogen phosphate buffer, pH8.0 
0.05 - 6.52 x 10-4M ethopropopazine 
hydrochloride 
0.10 0.10 0.01M DNTB in 0.1M disodium 
hydrogen/potassium dihydrogen 
phosphate buffer pH7.0 
Ethopropazine hydrochloride was dissolved in 
30m1 of 2M HC1 and made up to 100m1 with O. IM 
pH7.0 phosphate buffer. 0.4m1 of the centrifuged 
homogenate was then added to each cuvette, mixed 
by inversion and incubated for 5 min at 25°C. The 
reaction was initiated by the addition of 0.1ml of 
0.015M AThCh made up in 0.01M HC1. The rate of change 
of absorbance at 412nm was followed for 10 min at 
25°C in a Pye Unicam SP8100 spectrophotometer [Pye 
Unicam Ltd]. 0.4m1 of 0.1M, pH8.0 phosphate buffer 
was substituted for centrifuged homogenate in blank 
cuvettes set up to correct for non-enzymic hydrolysis. 
A suitable control material was prepared from 
bovine erythrocyte AChE (Sigma Chemical Co Ltd] and 
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human plasma (as a source of BChEJ, made up in pHB. 0 
phosphate buffer to produce a chance in absorbance 
of approximately 0.006/min due to AChE and 0.006/min 
attributable to BChE. The aliquoted material was 
stored in liquid nitrogen and removed as required. 
Results were calculated in terms of International 
Units x 10-1 per gram of wet weight tissue [U x 10-1/g]: - 
Ux 10-1/g = abs. /min x 
TV 
x 
106 
x 10 
Em SV Sample Wt [mg/ml] 
Ux 10-. 
I /g = 5515 / Sample Wt [mg/ml] 
abs/min, TV , SV and E are described 
in Section 6.1. 
m 
Cuvette 1: In the presence of ethopropazine, 
measured only AChE 
Cuvette 2: Without ethopropazine, measured AChE + 
EChE 
The ratio: - 
Cuvette 1x 100 = AChE x 100, 
Cuvette 2 AChE + SChE 
is the percentage of total cholinesterase activity 
attributable to AChE, [%AChE]. This parameter was found 
to be particularly useful as it was unaffected by 
weighing errors or indeed other possible experimental 
variations common to both cuvettes, such as temperature 
fluctuation. This was especially important for small 
biopsy specimens as described in Section 3. 
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The results obtained over a seven year period 
using this technique are shown in Section 11 and 
reference values for AChE and %AChE are described. 
6.3 Histological and Histochemical assessment 
Suction biopsies were frozen and 8 ILM cryostat 
sections were cut and stained for acetylcholinesterase 
activity by the method of Karnovsky and Roots, [1964). 
Positive and negative control sections were processed 
simultaneously for each section. 
The remaining previously frozen tissue was then 
fixed in 10% Formalin and processed routinely for 
paraffin embedding and sections were stained with 
haemotoxylin and eosin. The criterion of normality 
was taken to be the presence of ganglion cells. 
The rectal mucosal sleeve obtained during the 
surgical procedure for correction of the disorder 
was similarly treated. - Adjacent sections were 
assessed histochemically and histologically and in 
addition the profile of AChE molecular forms 
determined (Section 12.2). 
The histochemical and histological studies 
were performed by Or D. J. Scott [Department of 
Histopathology, Newcastle General Hospital] to whom 
I would accordingly like to record my thanks. 
6.4 AFP estimation 
AFP was determined in amniotic fluid samples 
by radial immunodiFFusion [Behring AFP-RID plates, 
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Hoescht Ltd]. Patient samples were compared with 
serially diluted standards which allowed results 
to be calculated in jig/ml. These estimations were 
performed by Mr K Creene, Department of Human 
Genetics, University of Newcastle upon Tyne. 
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Section 7: Molecular forms - Analytical 
techniques 
7.1 Sucrose density sedimentation 
The theoretical basis of this technique is 
outlined in Section 2.6. Ultracentrifugation was 
performed in the Neurochemistry and Neuropathology 
Departments, Newcastle General Hospital, where the 
staff offered technical assistance for which I 
would like to record my appreciation. 
[i] Gradient characteristics 
While several materials are available for 
performing density gradient centrifugation including: 
glycerol, metrizamide, Ficoll and Percoll, the 
majority of reports of the separation of AChE 
molecular forms utilize sucrose. In accordance 
with the work of Hall, [1973] and many other authors 
it was decided to begin by using 5-20% w/v sucrose 
gradients resting on a 50% w/v sucrose cushion. In 
common with other workers using this type of gradient, 
difficulty was encountered in separating monomeric 
[G1] and dimeric [G2] AChE Forms. Subsequently the 
gradients were changed to 10-40% w/w sucrose and 
run at higher speeds. As expected [Griffiths, 19793 
this had the effect of sharpening the peaks and 
improving the resolution between G1 and G2. 
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In each case gradients were formed in 5. Oml 
polyallomer Beckman centrifuge tubes. They were 
constructed as follows: - 
5-20% w/v Equal volumes [1.025m1) of 20%, 15%, 
10% and 5% w/v sucrose [Sigma Chemical Co, Grade 1) 
made up in 0.01M phosphate buffer [pH7.2 containing 
0.5% v/v Triton X-100 [BOH Ltd) and IM NaCl 
[80H Analar], were successively overlayed. The 
layers were allowed to diffuse for approximately 
three hours at room temperature. O. Sml of 50% w/v 
sucrose was then slowly introduced at the bottom 
of the tube. 
10-40% w/w : Equal volumes [1.15mlJ of 40%, 30%, 
20% and 10% w/w sucrose solution were successively 
overlayered. The gradients were left to diffuse as 
for the 5-20% w/v gradients. 
In each case the gradients were then chilled 
for 15 min on ice prior to sample application. 
[ii] Centrifugation conditions 
As referred to in Section 2.6, Young, [19783 
has designed a computer program to allow the 
sedimentation characteristics of various gradients 
under different run conditions to be calculated. The 
program required some modification to be compatible 
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with FET. (Commodore) Basic. This modified program 
is included in Appendix 1. 
It is possible to use the program to: 
a) Simulatecradient separation characteristics. 
Hence with a given gradient the optimum 
centrifugation conditions including: rotor type, 
temperature, length and speed of run can be 
calculated. This was carried out to define suitable 
conditions for separation of the species with the 
S-values under study, the results compared well 
with experimentally obtained data. 
: b] Calculate S-value. Reversing the above 
procedure by defining the run conditions, gradient 
characteristics and the position on the gradient 
of the substance under study allowed calculation of 
the S-value. It was found that this was a less 
accurate method of determination than comparison with 
markers of known S-value [Fig. 7.63. The program 
was therefore used mainly for determination 
of run conditions. These were then checked 
experimentally, final run conditions were: 
5-20% w/v gradients 37,500 rpm in a Spinco L 
or L275B Beckman centrifuge [Beckman Ltd] with an 
SW6S swing out rotor for 17 hours [140,000 g max]. 
10-40% w/w gradients : 40,000 rpm in a Spinco L 
with an SW50.1 rotor for 24 hours g max or 55,000 rpm 
in an L275B with an SW65 rotor for 17 hours [300,000 g 
max]. 
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[iii) Sample and marker application 
5 µl of each of the regularly used marker 
enzymes were mixed with 200-400 /L1 of sample and 
carefully layered on top of the gradients. The 
exact amount of sample applied depended upon the 
activity present. Marker enzymes used included, 
equine liver alcohol dehydrogenase, 4. GS, [Sigma 
Chemical Co Ltd; Cal Biochem Ltd) adjusted to 
12 x 103 U /l; E. Coli 1j-galactosidase, 16. OS, 
[Sigma Chemical Co) 105 U /l; bovine liver catalase, 
11.35, [Sigma Chemical Co) 2.5 x 107 U/1 and E. Coli 
alkaline phosphate, 6.3S, 6000 U/1. Enzyme assays 
are described in Section 7.1[vi). 
tiv] Fractionation 
Following centrifugation the open end of the 
gradient tube was covered with "parafilm" and. the 
bottom punctured with a 21 gauge hypodermic needle 
to allow fractions to be collected drop wise. 
Between 30 and 40 fractions were collected for each 
gradient into pre-weighed fraction tubes suitable 
for direct use on the Cobas Sic centrifugal fast 
analyser. After fractionation the collecting tubes 
were reweighed allowing the volume of each fraction 
to be calculated from the density determined by 
refractive index. The gradient tubes were washed 
with 0.5m1 of gradient buffer to remove any sedimented 
activity adhering to the tube walls (this was 
undetectable or negligible in all cases]. 
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CvJ Measurement of cholinesterase activity 
The average fraction volume recovered was 
approximately 140 /., L1. Using the centrifugal fast 
analyser [CFA], [Cobas Sic; Roche Diagnostics Ltd] 
it was possible to measure, AChE, BChE and three 
marker enzymes on each sample, leaving sufficient 
for the sucrose concentration to be-calculated 
from refractive index measurement [Pocket 
refractometer, Bellingham and Stanley Ltd]. 
Sucrose concentrations were calculated using 
conversion tables published by Griffiths, [1979]. 
AChE activity was measured using A1MThCh 
as substrate in the presence of ethopropazine by 
a method adapted from Bonham et al, [1981].. BChE 
was measured using butyrylthiocholine CBThCh] as 
substrate. In both assays the CFA parameter 
listing is identical and is shown in Table 7.1. 
Linearity and reproducibility were checked 
using an erythrocyte lysate or tissue homogenate 
as a source of AChE) and plasma as a source of 
BChE. The assay was found to be linear up to 
430 U/1 For AChE and 250 U/1 For BChE [Fig. 7.1a]. 
using a sample volume of 20 /Li [as above] and a 
reduced reagent volume. Reproducibility even at 
low levels of activity was excellent [Fig. 7.1b]. 
The fractions obtained from the gradients 
contained 0.01M phosphate buffer pH7.3, IM NaC1, 
Fig. 7.1a The extent of the linearity of AChE and 
BChE assays is shown for an increasing 
concentration of each enzyme. Erythrocyte 
haemolysate and human plasma was used as 
a source of AChE and BChE respectively. 
Fig. 7.1b The reproducibility of AChE and BChE 
automated assays [CFA] are shown at two 
different levels of enzyme activity. 
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Dilution 
Fig. 7.1a The linearity of AChE and 
BChE assays 
Mean activity CV 
U/1 % 
AChE 58.0 0.9 
1.9 4.7 
BChE 64.0 0.9 
2.2 2.2 
Fi2.7.1b The reproducibility of AChE 
and BChE assays 
Table 7.1 Parameter listing together with reacent 
concentration used for assay of AChE and 
EChE in gradient fractions obtained from 
sedimentation analysis. 
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Table 7.1 Parameter listing end reagent composition used 
Fcr ACNE and EChE assay cF Gradient fractions 
cn the CFA 
Parameter listinc 
I Units U/1 
2 Calculation Factor 919.12 
3 STD 1 Conc 0 
4 STD 2 Conc 0 
5 STD 3 Conc 0 
6 Limit 0 
7 Temperature CaC] 37 
8 Type of analysis 2 
9 Wavelength [nm] 412 
10 Sample volume [A1] 20 
11 Diluent volume [1413 20 
12 Reagent volume [µl] 300 
13 Incubation time [Sec) 0 
14 Start reagent volume C1413 0 
15 Time of first reading [Sec] 40 
16 Time interval [Sec] 10 
17 Number of readings 20 
18 Blanking mode I 
19 Printout mode I 
Reagent Composition: - 
DTNB: 3.8 x 10-4M 
APMThCh or BThCh - 5.7 x 10-4M 
Ethopropazine: 1.6 x 10-5M 
Contained in pH8.0,0.1M, disodium 
hydrogen/dihydrogen potassium 
phosphate buffer. 
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0.5% v/v Triton X-100 and sucrose of either 5-20% 
w/v or 10-40% w/w. Each of NaCl, Triton X-100 and 
sucrose were assessed for their effect upon the 
assay reagents and upon AChE and BChE activity. 
[a] Effect of Triton X-100 
0.5% w/v Triton produced a 25% increase in 
the activity of a red blood cell haemolysate 
AChE, and'a 29%. inhibition of plasma BChE. 
Otherwise Triton was without direct effect upon the 
assay reagents. 
[ b) Effect of NaCl 
NaCl up to IM did not effect either the 
assay reagents nor AChE activity. However, IM NaCl 
was found to inhibit BChE by 10%. 
Cc] Effect of Sucrose 
Sucrose from different sources [BOH AR grade 
and Sigma Chemical Co, Grade 13, while not 
affecting AChE or BChE activity directly, did however 
react with the assay reagents. Although OTNB was 
stable in the presence of sucrose and alone produced 
no increase in absorbance in the presence of substrate 
It did appear to react with substrate [A ß MThCh, 
AThCh or BThCh) in the presence of DTNB to produce 
a measurable rate. In this way it possessed esterase- 
like activity. This was more marked at higher pH 
and sucrose concentrations [Fig. 7.263, consequently 
Fig. 7.2a The effect of changing the pH of the_ assay 
buffer, from pH8.0 to 7.0 upon-the artef. actual 
activity-attributable to interference in the 
assay by sucrose. . 
Fig. 7.2b The sensitivity of the AChE assay at different 
buffer pH. 
- 14E - 
10 
U 
N 
U 
N 
U 
. 
°c 
U 
a 
a, U 
pH 
ao 
7.9 
7.6 
7.3 
-- . 7.0 
10 20 ju 4u 
Percent Sucrose (w/w) 
Fig. 7.2a The effect of buffer change on 
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assay interference by sucrose 
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Fig. 7.2b The effect of pH chance on 
assay sensitivity 
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the pH of the assay was reduced from pHB. 0 
[Bonham at al, 1°81) to pH7.3, this in turn 
reduced the "artefactual" esterase activity of 
40% w/w sucrose by more than 60% but produced only 
a moderate decrease in the sensitivity of the assay 
(Fig. 7.2b). The slight remaining artefactual 
activity was corrected For by the computer program 
used to calculate the results, this was effectively 
a blank correction (Section 7.1(vii). 
['vi) Measurement of marker enzymes 
Four enzymes of known sedimentation coefficient 
and molecular weight were regularly used as S-value 
markers. 
Ca) j3 - Galactosidase (Sigma Chemical Co Ltd)16. OS 
A kinetic assay procedure described in Data 
Sheet with Product No 0-5635 Sigma Chemical Co 
and based upon the hydrolysis of a -nitrophenyl- ß- 
0-galactopyranoside [ONPG] (Craven at al, 19653 was 
adapted for use on the CFA and required only 10/1l 
of sample. The reaction was linear up to 1000 U/1 
and had a CV of 3.5% at 48 U/i. 
[. 'b) Alcohol dehydrogenase [Sigma Chemical Co 
and Cal-Biochem] 4.8S 
The original preparation obtained from Sigma 
Chemical Co contained some interfering esterase 
activity; a second preperation obtained from Cal-Biochem 
contained only negligible amounts and this was 
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subsequently used. The assay based upon the linked 
oxidation of ethanol to NAD [Valee and Hoch, 1°55] 
was adapted for use on the CFA. The rate of reduction 
of NAD to NADH was followed at 340nm. A 10141 sample 
was used and the reaction was linear up to 400 U/1 
the. 
-CV at 
36 U/1 was 2.4%. 
[c] Alkaline phosphatase [Sigma Chemical Co] 6.33 
The assay based upon that of Gaven and Levinthal, 
(1960] using p-nitrophenylphosphate as substrate and 
following its conversion to p-nitrophenol with a 
consequent increase in absorbance at 405nm was 
adopted for use on the CFA. The sample volume 
required was 10 111. 
[d] Catalase (Sigma Chemical Co) 11.35 
It was necessary to measure this enzyme manually 
in silica cuvettes since the plastic cuvettes of 
the CFA do not permit measurement at UV wavelengths below 340nm. 
The method [Beers and Sizer, 1952] followed the 
catalytic degradation of 0.2% v/v hydrogen peroxide 
CBDH, AR grade] in phosphate buffer at pH 7.0 by 
observing the decrease in absorbance at 240nm. 
[e] Additional markers 
In addition to these regularly used markers, 
the sedimentation characteristics of the gradients 
were more closely defined by using additional markers 
[Fig. 7.76], these included: - Cytochrome C, ovalbumin, 
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yeast alcohol dehydrogenase, rabbit muscle aldolase 
and thyroglobulin [all obtained from Sigma Chemical 
Col. 
Cytochrcme C was measured by its absorbance at 
405nm, [the absorption maximum] ovalbumin and 
thyroglobulin by Lowry assay [Lowry at al, 1951), 
yeast alcohol dehydrogenase by a modification of the 
previously described assay for equine liver alcohol 
dehydrogenase in which the concentration of ethanol 
was increased ten fold. This increase was necessary 
because of the higher Km of the yeast enzyme. 
Aldolase was measured manually by a colorimetric 
method described in Sigma Technical'Bulletin 
No. 752 (Sigma Chemical Co] using reagents obtained 
from the same company. 
[vii] Calculation and presentation of results 
The number of fractions obtained from each 
gradient varied from 30 to 40 making simple 
graphical plots of Enzyme activity Vs Fraction number 
difficult to compare. In order to permit direct 
comparison between subsequent gradients and accurate 
calculation of the amounts of each molecular form 
present it was necessary to calculate the volume of 
each fraction. The fraction weight and sucrose 
concentration were measured and used to calculate 
the volume, so that enzyme activity could be plotted 
nr 
152 
against increasing volume. In addition, as 
previously described in Section 7.1[, v], there was 
an artefactual increase in AChE and EChE activity 
due to interference from sucrose; this could be 
compensated for by applying a mathematical 
correction based on the sucrose concentration in 
that fraction. 
The calculations. involved were tedious and 
time-consuming and a computer program was 
constructed which, given fraction number, weight, 
AChE activity, BChE activity and sucrose 
concentration, would correct for sucrose interference 
and calculate the fraction volume and-the enzyme 
activity [i. e. volume x activity U/13. By 
culmulative addition of these data the gradient 
volume could be calculated and a running culmulative 
total of enzyme activity and volume produced. The 
results were then presented in both graphic and 
tabular form, an example of tabulated results for 
a theoretical four fraction gradient are shown 
below: - 
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Total AChE activity:. 2.09 mU 
Total volume: 0.644 ml 
Total EChE activity: 3.20 mU 
Fraction Wt Vol %Vol 
No [g] [m13 [%J 
1 0.1E0 0.131 20.23 
2 0.200 0.180 48.12 
3 0.174 0.162 73.23 
4 0.179 0.173 99.99 
Recovery [ACNE]= 84% 
AChE EChE % suc %AChE %EChE 
[u/13 -[u/17Cd/lOOgJ 1%] Ci] 
3.4 2.8 40 21.2 11.5 
2.0 2.4 30 38.4 25.1 
6.0 13.4 20 91.8 92.6 
1.0 1.4 10 99.9 99.9 
Recovery CBChEJ = 80% 
Given the activity and volume of the sample 
originally applied, the program will also calculate 
the recovery of activity as shown above. Results are 
displayed in both tabular and graphic form including 
plots of AChE, BChE and sucrose concentration Vs 
culmulatively increasing volume. It is therefore 
possible to calculate the amount of each form present 
from the areas under the peaks, this is simplified by 
comparison with the culmulatively increasing % AChE 
and % BChE at each point on the graph. The actual 
calculation from these data of the amount of each 
form present can be done in one of two ways. 
METHOD A: Directly by comparing the percentage of 
activity under each given peak with the total AChE 
or BChE activity printed at the top of the tabular 
listing. 
METHOD B: Indirectly by comparing the percentage of 
activity under each peak with the activity of AChE 
or BChE in the sample originally applied. 
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Method "A" was suitable for the high activities 
encountered using biopsy specimen homogenates, whereas 
method "6" was more suitable for the very low 
activity found in amniotic fluid, where minor 
baseline variations could significantly affect 
the calculated total activities. 
The program [Appendix 23, therefore offers 
several advantages: 
13 Saves several hours for each sample in 
tabulating results and plotting data points. 
23 Performs a" mathematical correction of 
interference due to sucrose. 
33 Calculates the volume of each fraction from 
fraction weight and sucrose concentration. 
43 Permits direct comparison between subsequent 
gradients from graphically produced data. 
53 Enables the rapid quantitation of each of the 
molecular forms present. 
63 Provides the necessary data, i. e. the position 
on the gradient for subsequent calculation of 
S-value. 
73 Calculates the recovery of activity for each 
gradient. 
A schematic representation of the whole procedure of 
density gradient centrifugation and processing of 
results is shown in Fig. 7.3. 
[viii] Analytical separation 
The separation of molecular forms produced by 
the gradients are shown in Fig. 7.4. As anticipated 
Fig. 7.3 A., schematic guide to the procedure used 
for density gradient sedimentation is 
shown. The sample described illustrates 
the procedure for 10-40% w/w gradients 
centrifuged for 17 'hr in an SW65 rotor 
at 55,000 rpm. 
__ ýýý _ 
Sample 
addition 
3 hr at Cool 
room at 40C 
temp. 
Centrifuge for 
17 hr at 55,000 rpm 
. 2 
Puncture the 
oil base of tube 
SW65 
rotor 
Re-weigh vials Measurement of: 
AChE, BChE, ADH 
Pre-weighed catalase, ß-galactosidase 
vials refractive 
index 
WIN 
PET minicomputer 
Tabulated results 
Fig. 7.3 A schematic guide to the procedure used for density 
gradient sedimentation 
Fic. 7.4- Examples of ACNE, BChE activity and 
sucrose concentration are shown as they 
vary in 5ml gradients of 5-20% w/v 
sucrose and 10-407 w/w sucrose. The 
results are plotted in this form by the 
program [listed in Appendix 2) with the 
only exception that the points are not 
joined as they appear opposite. 
ký 
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Fig. 7.4 Graphs of AChE, ECKE and sucrose concentration 
versus percentage gradient volume as produced 
by the computer program 
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in Section 7.1[i]the separation of monomeric, G1 , 
and dimeric G2 enzyme is improved by employing 
10-40% w/w rather than 5-20'w/v gradients. The 
sucrose concentration plotted against culmulative 
gradient volume is also shown, there is some 
distortion of the 5-20% w/v gradients introduced 
by the 50% w/v cushion. The graphs are shown in 
eight fold reduction, as they appear from the 
computer printer except that the points are linked 
and the molecular forms labelled for ease of 
interpretation. 
fix] Reproducibility of guantitation 
To test the reproducibility with which the 
molecular forms can be quantitated three samples 
were analysed each in triplicate. Two were homogenised 
rectal tissue and the third amniotic fluid. The 
forms were quantitated as described in Section 7.1Cvii3 
and the results shown in Table 7.2. At levels above 
2 U/1 the reproducibility was good; below 2U/1, the 
variation became more marked and consequently too 
much importance should not be attached to minor 
quantitative changes in forms which are present at 
or below this level. 
CK] The effect of different inhibitors 
The selective BChE inhibitor ethopropazine 
was used in the assay of the gradient fractions 
described in Section 7.1 C .V") to enable specific 
measurement of AChE activity. In addition to this 
direct method, an indirect method is often reported 
Table 7.2-, The reproducibility of quantitating 
individual AChE molecular forms was assessed 
by analysing three samples in triplicate. 
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Table 7.2 Assessment of the reorcducibility of 
molecular form guantitation 
ý1 G2 G4 A12 
U/i 
Sample I. 3.6 
. 
3.81 4.55 1.02 
in triplicate [3.38-3.82) [3.39-4.23) [4.28-4.82) [0.92-1.12) 
Homogenised 
tissue 
Sample 2 3.43 3.3 2.89 0.7 
in triplicate [3.36-3.50) [3.23-3.37) [2.9 -3.08) [0.59-0.81) 
Sample 3 1.15 1.65 13. E3 Amniotic 
in triplicate [0.80-1.50) [1.20-2.1) C8.1 -9.5) - fluid 
Results are shown as: 
Mean in each case [Range) 
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[Chubb and Smith, 19753. In this approach the 
compound BW284c51 is used to selectively inhibit` 
AChE; AChE being measured as the difference between 
the total and remaining activity after BW284c51 
inhibition. To compare these two methods the 
same gradient was assayed for: 
a] total cholinesterase activity 
63 ethopropazine-resistant activity 
c) BW284c51 sensitive activity 
Fig. 7.5 shows that the profiles of ethopropazine- 
resistant and BW284c51 sensitive activity compare 
well. It is reassuring that different inhibitors 
produce such similar results. Quantitative results 
for the molecular forms are shown: 
A12 A8 G4 G2 G1 
U/1 
2.3 
2.6 
1.1 
1.2 
4.8 
4.9 
1.6 
1.8 
2.2 
1.9 
7.1[xij Recovery of activity 
lysivane 
resistant 
8W284c51 
sensitive 
In order to check the recovery of enzyme 
activity, a Triton X-100 extract of rectal tissue 
was layered onto the prepared gradients. The use 
of Triton X-100 containing extracts rules out any 
Fig. 7.5 The effect of using two different methods of 
selective inhibition an finally calculated 
AChE activity. BW284c51 sensitive and 
ethopropazine resistant activity is 
,. 
equivalent in each molecular form illustrated. 
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Fig. 7.5 AChE activity measured using two different 
selective inhibition methods 
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variability due to the effect of this detergent 
in the gradient buffer. Following fractionation 
each gradient tube was sealed and washed out to 
detect any cholinesterase activity which may have 
sedimented onto the bottom of the tube, in all 
cases. this was negligible. 
Recoveries obtained were: 
AChE : Mean 97.4%; SEM = 1.3 Range: [93.3 - 102.0) 
BChE Mean 94.0%; SEM = 3.6 Range: [80.0 - 106.9] 
The recoveries were close to 100%, the slight loss in 
activity of BChE is probably attributable to inhibition 
by NaCl contained in the gradient buffer system 
[Section 7. ICV ]]. 
7.1(xii) Calculation of S-value 
To calculate the S -value of the AChE and 
BChE forms, two methods were compared. The actual 
S-value gradient was determined by a calibration 
with nine markers between 1.7 and 19.25. The two 
methods were: 
11 Calculation from curvilinear interpolation 
using a computer program [Appendix 3], based 
upon three markers of established S-value; 
AOH, 4. SS, catalase, 11.3S and 0-galactosidase, 
16.0S. 
23 Direct calculation of S-value from the relevant 
parameters i. e. spin-speed, dimensions of the 
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rotor, duration of the run, temperature, 
gradient sucrose concentration. The program 
was referred to in Section 7.1[ii). 
Fig. 7.6 shows the actual gradient as constructed 
on the basis of the nine known markers. The gradients 
predicted by curvilinear interpolation of the three 
markers [AOH, catalase and ß-galactosidase) and by 
prediction based on centrifugation parameters were 
compared. 
The curvilinear prediction is close to the 
experimentally determined gradient based on the use 
of nine markers, this method was therefore adopted 
for all S-value calculations. The' calculation based 
on centrifugation parameters, *while being parallel 
[Fig. 7.6) to the true gradient, consistently 
underestimated the S-value. However, as referred to 
in Section 7.1CJJit was found to be useful in simulating 
changes in gradient and run conditions, saving many 
hours of experimental work. 
7.2 Preparative-scale density centrifugation 
The analytical sucrose gradients described in 
Section 7.1 did not provide sufficient material to 
allow further studies following the assay of ACNE, 
EChE, sucrose and marker enzymes. To prepare adequate 
quantities of these molecular forms a larger scale 
preparation was necessary. 
Accordingly, centrifugation was performed in 
a Beckman L-B centrifuge with an SW-41, six place 
Fig. 7.6 Comparison of different methods of predicting 
S-value. These include: 
A- Calculation by computer program from 
basic run parameters (Appendix 1] 
e- Calculation by curvilinear interpolation 
(Appendix 31 of three markers of known 
S-value: ß -galactosidase, 16. OS; catalase, 
11.3S; alcohol dehydrogenase, 4.6S. 
The experimentally determined curve produced 
by nine markers of known S-value is. shown 
for comparison, C. 
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rotor. The gradients, 5-15% w/w sucrose were 
designed by the computer program outlined in 
Section 7.1[ii]to give separation of the forms G1, 
G2, G4 and A1Z'[Fig. 7.7]. They were formed by 
successive overlayering of 3.8m1 aliquots of 15, 
10 and 5% w/w sucrose buff erred as described in 
Section 7.1[i). 
The sample volume was limited to 600 µl to 
include the marker enzymes: ß-galactosidase, catalase 
and alcohol dehydrogenase as . referred 
to in 
Section 7. fCiii). 
The gradients were run at 36,000 rpm for 
23'/o hr at 4°C and then fractionated immediately 
by puncturing the tube as outlined in Section 7.1 [iv]. 
20-30 fractions of approximately 450141 were 
collected into pre-weighed tubes which were 
subsequently re-weighed to calculate the fraction 
volume. Fractions in the immediate region [usually 
one either side] of the peak activity for each 
molecular form were speedily pooled and placed in 
liquid nitrogen for storage, or used in further 
studies on the same day. When necessary the pools 
were concentrated by vacuum ultrafiltration employing 
the "Collodion bag" system (Sartorius Instruments Ltd) 
by this method molecules of greater than 12 kDa are 
retained and concentrated. 
Fig. 7.7 The separation of AChE forms achieved 
using 13m1 5-15% w/w sucrose gradients. 
The change in S-value at each point in 
the gradient is also shown. 
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Fig. 7.7 The separation achieved using preparative 
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7.3 Gel filtration 
AChE and EChE molecular forms can be separated 
by gel filtration using suitable media. This 
technique was used to determine the Stokes radius 
of individual molecular forms as described in 
Section 2.6 and hence calculate the approximate, 
"true" rather than "apparent" molecular mass of 
these forms using the sedimentation data. 
In addition the technique provided a check on 
the homogeneity of molecular forms separated by 
sucrose density sedimentation. 
The equipment used included: 
LKB gel filtration column 95cm long, 1.6cm internal 
diameter together with a water jacket, and fittings, 
valves and flow adaptors [LKB Instruments Ltd). 
LKB Multitemp Flow Cooler [LKB Instruments Ltd] 
P-1 Peristaltic pump [Pharmacia Ltd] 
FRAC-100 Fraction collector [Pharmacia Ltd) 
The molecular mass of G1, G2 and G4 AChE forms are 
approximately 80,160 and 320 k0a respectively. 
Consequently, Ultrogel AcA34 ELKS Instruments Ltd] 
a 3% acrylamide, 4% agarose mixed gel with a quoted 
linear fractionation range of 20-350 k0a [Product 
Information Sheet No 200908, LKB Instruments Ltd] 
appeared a suitable medium for their separation. 
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Unfortunately, because the molecular forms are 
asymmetric their apparent molecular mass proved 
to be considerably greater than expected, [Section 
15.13 and therefore the use of this gel was 
abandoned in favour of the larger pore size Ultrogel 
AcA22 with a linear fractionation range of 100- 
1,200 kDa [Product Information Sheet No 200908, 
LKB Instruments Ltd]. 
The column was packed following the gel 
manufacturers instructions and equilibrated at 
6°C with 0. OIM phosphate buffer, pH7.2 containing 
0.5% v/v Triton X-100,1. OM NaCl and 0.02% sodium 
azide [BOH Chemicals Ltd]. With the exception of 
the azide, this buffer system was identical to that 
described in Section 7.1[i] for use in sucrose density 
sedimentation analysis. The whole procedure is 
shown schematically in Fig-7.8. The samples 
including molecular mass markers of known Stokes 
Radius were applied in gel buffer in a total volume 
of up to 2. Oml [approximately 1% of the bed volume] 
using a three way valve system. The flow rate was 
set at 3.5m1/hr using the peristaltic pump and 1.0ml 
fractions were collected. The total bed volume Vt, 
was calculated from the dimensions of the column. 
The void volume Vo, from calibration with Blue 
Fig. 7.8 A schematic guide to the procedure for 
separation and identification of AChE 
forms by gel filtration. 
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Dextran 2000 [Pharmacia Ltd] and the volume not 
accessible to solvent, Vg from the equation: 
Vg = Vt 
a. d 
Where 
Vg - the volume not accessible to the solvent 
Vt - total volume of the gel bed 
6- bed volume'reconsituted per gram of dry gel 
d- density of the dry gel 
Values of 6 and d for Ultragel AcA22 were supplied 
by LKB Instruments [personal communication] and 
were 132m1/g and 1.007g/ml respectively. 
From these data the volume of the stationary 
phase, Vs can be calculated: 
Vs = Vt - Vg - Vo 
and kd values calculated as described in Section 2.6 
kd = Ve - Vo 
Vs 
where Vs is the elution volume of the molecule studied. 
The protein markers of known molecular mass 
and Stokes radius were all obtained from Sigma Chemical 
Co and are listed in Table 7.3. 
Cytochrome C, haemoglobin, ferritin and Blue 
Dextran were measured by the absorbance at their 
absorption maxima, 415,408,400 and 615nm respectively. 
Lactate dehydrogenase was measured according to the 
Table 7.3 Molecular mass and Stokes radius of the 
protein markers used in calibrating the 
gel filtration column containing 
Ultrogel AcA22. 
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Table 7.3 Molecular mass and Stakes radius of the nine protein 
markers used in cel filtraticn 
Protein marker 
Molecular mass Stokes radius 
[KOa] [nm] 
Horse heart cytochrome C1 12.4 1.741 
Bovine blood haemoglobin r1 321 2.401 
Chick egg ovalbumin 433 3.043 
E. Cali Alkaline phosphatase 905 - 
Rabbit muscle lactate dehydrogenase 1404 3.742 
Beef heat catalase 2321 5.222 
Horse spleen ferritin 4404 8.02 
E. Coliß-galactosidase 5403 8.23 
Procine thyroglobulin SBS 8.53 
flats taken from Siegel and Monty, [1966]1; Ackers, [1964)2; 
Rakonczay at al, [1981x]3; Pharmacia Fine Chemicals, [1980)4 
Taylor and Coleman, [1972)5. 
* Andrews, [1962) has shown that at the concentrations used, haemoglobin 
is highly dissociated upon gel filtration so that the subunits exist 
as dimers rather than tetramers [a2ß2)" The molecular parameters 
reported here reflect this dissociation. 
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recommendation of the Scandanavian and Dutch 
Committee on Enzymes [Scandanavian Society for 
Clinical Chemistry and Clinical Physiology, 19743 
based upon the reduction of pyruvate to lactate 
linked with production of NAD. The method was 
performed on the Cobas Bic centrifugal fast 
analyser [Roche Diagnostics Ltd] using reagents 
supplied by J. T. Baker Chemicals. Ovalbumin and 
thryoglobulin were measured by their protein 
concentration as determined by the Lowry assay 
[Lowry et al, 19513, centrifugation of the 
fractions cleared the samples of the gelatenous 
precipitate produced by Triton. Alkaline 
phosphatase, catalase and ß-galactosidase 
activities were measured as described in 
Section 7.1[vi). 
Cholinesterase activity was measured with 
AThCh or BThCh as substrate on the Cobas Bio CFA 
at 370C'using a pHS. 0,0. IM phosphate buffer 
system. The method was as described in 
Section 7.1&/] except that the sample volume was 
increased to 40 N, 1 and the time interval between 
readings to 20 sec. These changes produced a 
fourfold increase in sensitivity, this was 
important as the enzyme activities being 
measured were particularly low. The reproducibility 
of the assay at these low activities was also 
improved reflected in a CV of only 3.6% at an AChE 
level of 0.91 U/l. 
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Calculation of gel pore size 
The averace Kd values for the molecular mass 
markers is shown for 12 runs with the same column 
conditions plotted against log [Molecular mass] 
in Fig. 7.9. 
The combination of experimentally determined 
Kd with literature values for. Stokes Radius, 
Re, allowed the gel pore size, r, to be-calculated 
according to the equation [Ackers, 19643: 
Kd = 
(i_e)2 
1-2.104. Re + 2.09 Re 
3-0.95 Re 5 
rrrr 
When averaged for the seven markers, haemoglobin, 
ovalbumin, LOH, catalase, ferritin, ß-galactosidase 
and thyroglobulin, the mean was 46.36 t 5.62 [S03nm. 
Cytochrome C was disregarded because of its reported 
- anomalous behaviour, Siegel and Monty, C1966). 
True molecular weight calculation 
Kd values for the molecular forms of AChE 
from rectal tissue homogenates and amniotic fluid 
were determined as described for the marker proteins. 
Having already determined the effective gel pore 
size, r, to be 46.36nm, the equation of Ackers, [1964] 
shown above could then be applied in reverse to 
determine the Stokes Radius, Re, of these forms. 
These data were used in combination with the 
sedimentation data to give an approximate measurement 
Fig. 7.9 Average Kd values of marker proteins 
obtained by gel filtration using Ultrogel 
AcA22 plotted against log10 [molecular 
mass). 
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of the true molecular mass, according to the 
equation: 
Re. Scg, W = F. [Molecular mass) 
(Rakonczay et al, 1S81), 
Where f is a constant. 
A plot of Re. S201W versus molecular mass is shown 
in Fig. 7.10 for markers of-known Re and S20, W value. 
This is remarkably linear and consequently the 
value of f could -be determined and used in the 
subsequent . caldulation -of" molecular mass, given Re 
and S20, W values. Based upon the markers shown in 
Fig. 7.10, f= 3958 ± 124 [SD]. 
The separation of AChE molecular forms achieved 
by the column as well as the determination of 
"apparent" and approximate "true" molecular mass 
are described in Sections 15.1 and 2. 
7.4 Polyacrylamide gel electrophoresis [PAGE) 
Electrophoresis in continuous buffer systems 
using constant concentration slab or tube gels has 
been used to separate AChE and 6ChE molecular forms, 
Section 2.6. The separation obtained is dependent 
on charge as well as molecular mass and differs 
from those obtained by mass-only dependent methods 
such as, sucrose density sedimentation and gel 
filtration. Nevertheless, the technique has been 
Fig. 7.10 A plot of Stokes radius [nm] x Sedimentation 
coefficient versus molecular mass for 
protein markers. The slope of the graph 
is 3958 t 124 nm. S-value. log molecular 
-1 mass 
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widely applied, particularly in the diagnosis 
of NTD [Section 4.43. Consequently, it was decided 
to investigate the results of this technique with 
amniotic fluid samples. Recent reports have 
suggested that densitometric scanning of the gels 
improved the usefulness of the method [Goldfine 
et al, 1983a, b] and this was investigated. The 
equipment used consisted of: 
Flow cooled gel electrophoresis tank suitable for 
gel slabs, GE-2/4 LS [Pharmacia Ltd] 
LKB Multitemp flow cooler ELKS Instruments Ltd] 
LKB 2103 high voltage power supply ELKS Instruments 
Ltd] 
LKB scanning laser densitometer CLKB Instruments Ltd] 
The 5% gels were prepared with 5% cross 
linking by mixing equal quantities of: 
I., Acrylamide 19g + N, N-methylene-bis-acrylamide 
Ig [Electran grade, BOH Chemicals Ltd] dissolved 
in 100m1 water. 
2. N, N, N1N1, tetramethylethylenediamine [TEMED] 
[Sigma Chemical Co] 100 µl in 100m1 THIS/ 
glycine buffer, pH8.1,6 g TRIS +29g glycine 
per litre [Sigma Chemical Col 
3. Water [distilled] 
4. Ammonium persulphate CAR grade, BOH Chemicals 
Ltd] 1.2g/100m1 water. 
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The solutions were decassed with helium and 
mixed in the order 1,2,3, +4 and quickly, but 
evenly poured, between two 6x Scm clean glass 
plates separated by 3mm plastic or glass spacers 
and sealed at the bottom and sides. Sample wells 
were formed by the insertion of a plastic toothed 
former before the gel had set. The gels were left 
to harden at 4°C overnight. 
They were then placed in the electrophoresis 
tanks containing TRIS/glycine buffer, pH8.1 [1.5g 
TRIS/7.25g glycine per litre] and initially 
electrophoresed for one hour at 100V. Samples Cup 
to 30 [U] containing 13% w/w sucrose and 114l of 
0.5 w/v bromophenol blue were then pipetted into 
the sample wells. The electrophoresis buffer was 
maintained at 10°C by the flow cooler throughout. 
The gels were then run at 100V for 20 min followed 
by 12 hr at 200V until the bromophenol blue ran 
from the bottom of the gel. 
The gels were removed and carefully stained 
by a method based on that adopted by Suamah, [1980]: - 
To harden gel and partially fix proteins: 
Incubation for 30 min in 0.07M sodium 
maelate buffer pH6.5 [BOH Chemicals Ltd] 
saturated with sodium sulphate [BOH 
Chemicals Ltd] and containing 10-4M 
ethopropazine. 
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To stain for cholinesterase activity: 
Overnight incubation at room temperature 
in 0.07M sodium maelate buffer, pH6.5 
saturated with sodium sulphate 
containing 4mM copper sulphate, 20mM 
glycine,, 3mM magnesium chloride, [all 
obtainable from BOH Chemical CoJ 
and 4mM acetylthiocholine iodide 
together with Sx 10-5M ethopropazine. 
The white bands of copper thiocholine precipitated 
as a result of the reaction were then counterstained 
by immersion for a few minutes in a saturated 
solution of dithioxamide; this copper-complexing 
reagent produces a green colour with copper thiocholine 
and helps visualisation. The gels were then scanned 
using a laser densitometer. 
The results of the traces produced by this 
high resolution scanning densitometer are shown 
in Section 10.2. The whole procedure is represented 
schematically in Fig. 7.11. 
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for polyacrylamide gel electrophoresis 
of amniotic fluid samples and the 
subsequent identification of AChE 
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Section 8: Materials studied and patients 
investigated 
6.1 Amniotic fluids 
This study group included 39 patients in whom 
transabdominal amniocentesis was considered 
desirable on clinical grounds [increased risk of 
NTO or advancing maternal age enhancing the 
likelihood of Downs Syndrome 3. 
The gestational age of the pregnancies concerned 
ranged from 15 - 25 weeks and included 17 with normal 
outcome, nine with an anencephalic fetus, seven with 
spina bifida, five with exomphalos and one pregnancy 
with subsequently confirmed intra-uterine death. 
AFP levels were measured as described in 
Section 6.4 and aliquots were then stored at -20°C. 
The average length of time of storage was six months, 
sufficient to allow the outcome to be established. 
The effect of this type of storage on the activity of 
individual molecular forms of AChE is reported in 
Section 10.1. 
Prior to measurement of AChE or analysis by 
other techniques including sucrose density 
sedimentation, the specimens were thawed and spun 
at 15,000g for 3 min in an Eppendcrf centrifuge. 
Frequently the amount of specimen available 
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was limited and the techniques for separation of the 
molecular forms were designed in a way to accommodate 
this, e. g. for sucrose density sedimentation only 
200-300 141 of amniotic fluid was required. Gel 
filtration, because of the high dilution of the 
original sample required that amniotic fluids were 
concentrated before use. This was performed as 
described for the pooled fractions from preparative 
density sedimentation [Section 7.21. 
Amniotic fluids could be used for PAGE studies 
without prior concentration. Pooled fractions 
obtained from sucrose density sedimentation runs 
were used for various studies and are outlined in 
the experiments concerned [Section 15.1-4]. 
8.2 Biopsy specimens 
Over a seven year period 213 children were 
investigated for chronic constipation or failure 
to pass meconium. Suction rectal biopsies were 
made in each of these cases both for histological/ 
histochemical assessment [Section 6.33 and for 
quantitative measurement of AChE activity [Section 
6.2]. 
On receipt, the specimens were dealt with as 
outlined in Section 6.2. On the basis of histological 
classification 45 of these 213 were subsequently 
confirmed to have Hirschsprung's disease. 
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The-results of quantitative AChE measurement 
are reported in Section 11. 
8.3 Rectal "pull-thrcuch" specimens 
During corrective surgery using the Soave 
operative technique, tissue was removed and sent 
to the Pathology Department for histological 
confirmation of the disease. 
The tissue included rectal sleeve [dissected 
out during operation and consisting of mucosa 
only) , frequently together with more proximal 
upper rectum and sigmoid colon [including both 
muscle and mucosal layers]. The tubular specimen 
was opened using dissecting scissors and pinned 
out onto a cork board. Three strips were then cut 
longitudinally; one was used for histological 
investigation, one for histochemical assessment and 
one for biochemical measurement of AChE and 
EChE molecular forms. The laterally adjacent 
strips were then divided transversely into 
between five and nine sections of 2-3cm length 
dependent upon the overall length of the specimen. 
In this way histochemistry, histology and 
biochemistry could all be directly compared in 
transversely adjacent segments. The samples for 
histology were fixed in Formalin and embedded in 
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paraffin wax; those for histochemistry were 
immediately frozen and 8/m sections cut for 
cholinesterase staining and those for biochemical 
investigation individually placed in screw capped 
tubes for storage in liquid nitrogen. The whole 
procedure from surgical removal to liquid nitrogen 
storage took less than three hours. 
Material was obtained and processed in this 
way from seven patients: 
Case A: Rectal sleeve measuring 10cm consisting of 
mucosal layer only From a male infant aged 
ten months. 
Case B: A 15cm length off bowel including upper 
rectum and sigmoid colon involving both 
muscle and mucosal layers obtained from a 
male infant aged eleven months. 
Case C: A 24cm length of bowel including distal 
colon and rectum comprising both muscle 
and mucosal layers from a male infant 
aged eleven months. 
Case 0: A 20cm length of descending colon containing 
both muscle and mucosal layers from a 
male infant aged eleven months. 
Case E: Rectal sleeve measuring 14cm consisting 
of mucosal layer only from a male infant 
aged one year. 
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Case F: Control tissue; a 30cm segment of bowel 
extending from upper rectum into sicmcid 
colon and containing both muscle and 
mucosal layers, excised from a 14 year 
old girl on clinical grounds other than 
Hirschsprung's disease. 
Case G: Rectal sleeve and upper rectum measuring 
20cm and including both muscle and mucosal 
layers taken from a female infant aged 
one year. Used for gel filtration studies 
only. 
Case A- E and G had histologically confirmed 
Hirschsprung's disease. 
When both muscle and mucos a were present 
these were separated under a binocular microscope 
after removal from liquid nitrogen storage and 
" immediately before molecular form analysis. When 
only one layer was analysed the remaining dissected 
tissue was replaced into liquid nitrogen storage. 
These samples were homogenised in O. IM 
phosphate buffer, pH8.0 as outlined in Section 
6.2, unlike the biopsy specimens however, the amount 
of buffer used was adjusted to give a final homogenate 
of 5% w/v. In one case, E, the initial homogenisation 
was performed by only 20 passes of the homogeniser 
using 0.1M phosphate buffer, pH7.3, this was followed 
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by resuspension of the pellet in 0.01M phosphate 
buffer, pH7.2 containing IM NaCl, 1mM EOTA and 
0.5% w/v Triton X-100 all obtainable from EOH 
Chemicals Ltd. These two methods differentiated 
Triton releasable [possibly membrane-bound] forms 
from easily solubilised species. In all cases sucrose 
density sedimentation was carried out on the same 
day that the homogenates were made. 200-300fL1 
of 5% w/v homogenate was used for each gradient, 
in total 65 samples-were processed for sedimentation 
analysis and the results are shown in Section 12.2-6. 
The preparation of tissue samples as explained- 
above is shown schematically in Fig. G. I. 
Gel filtration studies were performed on 
homogenates made from Cases C and G. The 
extraction buffer was O. IM phosphate, pH8.0. 
Tissue from cases C and G was used in the 
preparative scale sucrose density sedimentation 
described in Section 7.2. 
Where tissue from other sources is used in 
various experiments this is detailed within the 
description of these experiments. 
Fig. 8.1 A schematic guide to the tissue preparation 
procedure employed in "rectal pull, through" 
specimens. The procedure includes storage 
in liquid nitrogen prior to further 
microscopic dissection of 'the samples and 
the measurement of AChE and EChE molecular 
forms by sedimentation or gel filtration. 
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Fig. 8.1 A schematic guide to the tissue preparation 
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Section 9: AChE measurement in amniotic Fluid 
9.1 Comparison of results 'by "manual" and'CFA" assay 
Dale et al, [1961] reported the ranee of AChE 
in amniotic fluid for 101 pregnancies with a normal 
outcome as 0.4-5. e U/1 [Mean 2. E6 t 1.1 [SO] U/1], 
these values compare well with others reported in the 
literature, they go-on to report a coefficient of 
variation from ten replicate samples of 3.7%. 
Automation of this assay would be expected to 
have several advantages including: increased speed 
of assay when large numbers are being analysed, 
improved reproducibility and smaller sample volume, 
[Section 6.13. However, good comparison with the manual 
assay would be important if the automated technique 
were to replace it without affecting interpretation. 
An assay was designed to comply with the require- 
ments of the laboratory centrifugal fast analyser 
[CFA] [Cobas Bic, Rodle Ltd, UKW without any change 
in the final reagent concentration. The assay 
parameters and reagent composition are described 
in Section 6.1. 
Twenty four amniotic fluid samples including 
15 with normal outcome and nine affected by NTO 
were assayed by both methods and the results compared, 
Fig. 9.1. The correlation was excellent with a 
coefficient, r=0.99, a linear regression of 
y, [CFA assay] Vs x, [manual assay) gave a straight 
e 
Fig. 9.1 The correlation between results derived using: 
automated [centrifugal fast analyser] and, 
manual methods for, measuring AChE activity in 
amniotic fluid. 
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Fig. 9.1 Automated and manual assays for measurement 
of AChE in amniotic Fluid compared 
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line of the equation y=1.01x + 0.23. The 
coefficient of variation was 2.1% for 13 replicates 
at a mean activity of 2.9 U/l. 
The rood correlation between "manual" and 
"CFA" assays meant that these could be used 
interchangeably, using the manual assay for single 
samples and the faster automated assay when larger 
batches were being analysed. This flexibility was 
useful when considering a routine service for 
diagnosis of NTO. 
4 
9.2 AChE and AFP results from the amniotic fluid 
samples for molecular form analysis _ 
The AChE and AFP results from the 39 amniotic 
fluid samples subsequently studied by density gradient 
sedimentation analysis are shown in Table 9.1. 
All normal pregnancies gave results within the 
normal reference range 0.4 - 5.8 U/1 quoted by 
Dale et al, [1981], and while some of the NTD 
pregnancies were close to the upper limit of this 
this range [N 4; AChE = 5.1 U/13, all were correctly 
classified by the test. Two of the NTD-affected 
cases CSB1 and SB6] were reported to have "border- 
line" AFP levels of 54 and 48 µg/ml respectively. 
This is important when comparing the sensitivity 
with which lesions may be detected, large lesions 
with markedly elevated AFP results are relatively 
easy to classify correctly by most techniques. 
Table 9.1 Gestational age, AFP level and AChE activity 
in the amniotic fluid samples under study., 
The results are grouped on the basis of 
pregnancy outcome. 
i 
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Cases with borderline AFP levels allow some 
assessment of the practical additional value and' 
sensitivity of a new assay. 
The five cases of excmphalos all cave AChE 
results within the normal range whereas the single 
case of intrauterine death had a distinctly 
elevated AChE activity. 
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Section 10: Molecular forms of cholinesterases 
in 2mnictic fluid 
10.1 Sucrose density sedimentation results 
[i] Quantitaticn of AChE molecular forms 
Samples of amniotic fluid from the 39 cases 
listed in Table 9.1 were carefully layered onto 
preformed sucrose gradients and the centrifugation, 
fractionation, measurement and calculation of results 
carried out as outlined in Section 7. lCvii3. 
The results from these gradients are shown 
in Figs-10.1-5. In all cases of NTD and the 
single case of intrauterine death there was a 
prominent peak migrating in the region of the 
catalase marker. This peak had sedimentation 
coefficient of 10.3 t 0.5S , the position 
characteristic of G4 AChE [Section 2.23. This form 
of the enzyme was either entirely absent or present 
only in trace amounts in pregnancies with normal 
outcome. In exomphalos cases where there is leakage 
of fetal plasma, with exposure of neural tissue, 
G4 was present at a low activity [Fig. 10.53 
The actual amounts of the three forms Gý, 
02 and G4 were quantitated as described in Section 7.1. 
and the results are shown in Table 10.1. It can be 
seen from these results that the increase in AChE 
activity in amniotic fluids from NTO affected 
pregnancies is due largely to the presence of G4 
AChE. 
,, 
_ß 
°1 ý 
v +ý t 
Figs. 10.1-5 The heterogeneity of AChE in amniotic fluid 
demonstrated by sucrose density gradient, 
sedimentation. Samples include those from: 
pregnancies with normal outcome [NI- N17) 
and those affected by anencephaly [An1-9] 
spina bifida (SB 1-73 exomphalos [Ex 1-53 
and intrauterine death [IU0]. Markers,,,,,, 
with known sedimentation are shown: 
ß galactosidase [gal, SE0, W = 16. CS3; catalas e 
[cat, S20, W = 11.3S3 and alcohol dehydrogenas e 
Cadh, S20, W - 4.85]. The molecular forms 
of AChE identified on the basis of their 
sedimentation coefficient are labelled 
0 1,62 and 64. 
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Table 10.1 Quantitive measurement of AChE molecular. 
forms [G1, G2 and G4]. The activity of each 
form present was calculated from the area of 
the corresponding peak of the sedimentation 
profile. The mean and standard deviation 
[SO] of each form is shown for amniotic . fluid 
from normal pregnancies and those affected by 
neural tube defects [NTO]. 
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In Fic. 10.6 the levels of each form are 
compared. The increase in total AChE activity_reflected 
the increase in G4 [p. < 0.0005], whereas increases in 
GI and GE were less significant [p <0.05, p C0.02 
respectively]. Measurement of G4 offers the 
advantage that in normals the activity of this form 
is clustered around zero. Consequently assessment 
of G4 AChE provides the potential for a simple 
"yes or no" test for detection of NTO. 
Iii] Determination of sedimentation coefficient 
of AChE forms 
The sedimentation coefficient for each of the 
AChE species was, determined by curvilinear inter- 
polation between protein markers as outlined in 
Section 7.1. 
The results are shown below: - 
Species Mean SO n 
G4 10.3 0.5 26 
G2 5.5 0.7 32 
G1 4.0 0.6 32 
Ciiij Stability of molecular forms on storage 
Under certain conditions AChE molecular may 
interconvert [Section 2.23. In particular, larger 
forms, such as G4 may dissociate to the monomeric 
t 
Fig. 10.6 A graphic representation of the activities 
of AChE molecular forms GG2 and G4 in 
amniotic fluid obtained. from pregnancies 
with various outcomes including: 
Intrauterine death 
Anencephaly 
Spina bifida 0 
Exomphalos 
Normal " "t ý` 
c f 
k 
.ý 
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20r 
Mean ± SO 
0.9 ±0.7 (normal) 
1.5 ±0.9 (NTD) 
P<0-05 
a 
a v 
. 
ii 
U 
Q 
W 
0"" 
d 
9 
G, 
o Spina bifida 
Anencephaly 
Mean ±SD 
0.9 ±0.7 (normal) 
2.1 ± 1.9 (NTD) 
P<0; 02 
Mean t SD 
0.1 ±0.2 (normal) 
6.0 ±3.2 (NTD) 
p<0110005 
g 
D 
g 
00 
A 
O 
0 
®ý 
DI 
i 
oi 
OtOA0 
o4iýöý 
G2 
" Exomphalos 
" Normal . 
G4 
o Intrauterine death 
Fig. 10.6 The activity eF G1, G2 and G4 AChE 
compared in amniotic Fluid samples 
From pregnancies with varying outcome 
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species G1. To measure the extent of these storage- 
induced changes freshly obtained amniotic fluid 
[Case A53 was divided into three aliquots: - one was 
analysed immediately, one was stored at -20°C for 
four months and one stored at 4°C for six weeks. 
Analysed 
Immediately 
Stored at 
-20°C for 
four months- 
Stored at 
4°C for 
six weeks 
AChE Activity of % 
each 
Activity 
° of 
each 
Activity % of 
each 
species CU/1) form 
[U/1] 
-f crni 
[U/1] 
form 
G4 10.9 77% 9.2 83% 2.2 8% 
G2 2.1 15% 1.3 12% 1.2 5% 
G1 1.1 6% 0.6 5% 10.2 75% 
Prolonged storage at -20°C produced little change 
in the molecular form profile whereas following 
six weeks storage at 4°C much of the G4 had 
dissociated with a resultant increase in GI activity. 
Patient specimens were all stored at -20°C. 
10.2 Polyacrylamide gel electrophoresis (PAGE] 
The identification of a prominent AChE band 
on PAGE of amniotic fluid specimens from NTO affected 
pregnancies has been widely reported [see Section 4.43. 
- 203 - 
More recently densitometric scanning of gels has 
been applied to improve both the objectivity and 
sensitivity of the technique [Section 4.43. 
To verify these findings and compare the 
migration of G4 AChE recovered from sedimentation 
gradients with the abnormal peak observed on 
electrophoresis, several samples including: two 
fromanencephalic, two from spina bifida, two 
from exomphalos and three from normal pregnancies 
were subjected to electrophoresis in 5% PAG slab 
gels by the method of Buamah, 019803 as-described 
in Section 7.4. In addition-, fractions 
from sedimentation analyses of amniotic fluid 
from pregnancies complicated by-anencephaly 
were pooled to provide a source of G4 and 
concentrated by vacumn ultrafiltration. 
These samples were electrophoresed and the 
gels stained and scanned as outlined in Section 7.4. 
The results are shown in Fig. 10.7. A prominent 
peak was observed in all cases of NTO but not in 
normal or exomphalos affected cases. G4 AChE 
recovered from the gradient migrated in a manner 
identical with the peak seen in the NTD pregnancies. 
These findings confirm that, not only is 64 
largely responsible for the increase in AChE 
activity measured quantitatively, but also gives 
Fig. 10.7 Densitometric scans of amniotic fluid samples 
subjected to polyacrylamide gel electrophoresis 
and stained for AChE activity. G4 obtained. by 
density sedimentation co-migrates with the 
peak characteristic of neural tube defect 
affected pregnancies. Pregnancies with normal 
outcome or affected by exomphalos show no 
corresponding peak. 
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Fig. 10.7 Polyacrylamide gel electrophoresis of 
AChE in amniotic fluid from pregnancies 
with varying outcome. 
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rise to the abnormal peak seen electrophoretically 
in NTO cases. It therefore appears that this form 
of AChE is a very useful marker for exposed nervous 
tissue in utero and for practical purposes may be 
considered "NTO-specific". 
10.3 BChE molecular forms in amniotic fluid 
BChE'exists in a series of molecular forms 
similar "to ' those described for AChE i. e. G1, G2, 
G4, Ag and A12'[Section 2.1]. The predominant BChE 
species in serum is the tetrameric G4 Form sedimenting 
at approximately 11i. OS [Section 2.33. 
The 39 'amniotic fluid samples in which AChE 
forms were determined were also analysed to determine 
the profile of. BChE species present. As in serum, 
the predominant form in all cases was G4 sedimenting 
at 11.6 ± 0.4$. - In addition less rapidly 
sedimenting species in the region of 4.5 + 0.55 and 
6.3--1 0.7S were identified. These were believed to 
correspond to G1 and G2 forms respectively. 
In pregnancies affected by NTO there was a 
significant increase in 64 BChE activity Cp < 0.001; 
Fig. 10.83. The actual levels are shown below: - 
Pregnancy outcome G4-BChE activity Number in 
(U/1) group 
Normal 4.1 t 3.3 (n = 17) 
NTO group 19.2 t 10.6 [n = 163 
Exomphalos group 19.5 ± 12.6 (n = 53 
Intrauterine death 47.7 (n = 1) 
Fig. 10.6 The heterogeneity of., BChE in amniotic fluid, 
demonstrated by sucrose density-gradient 
sedimentation. Samples. include those from. 
pregnancies with normal outcome [N1-4) and 
those affected by anencephaly [An1], spina 
bifida [SBI), exomphalcs (EX1] and 
intrauterine. death [IUD). Markers of known 
sedimentation coefficients are-shown: 
ß galactosidase Cgal, S20, W = 16. OS3; catalase 
(cat, S20, W = 11.3S3, and alcohol dehydrogenase 
[adh, S20, W = 4. BS). , The molecular forms of: 
AChE identified on the basis of their 
sedimentation coefficient are labelled G1, 
G2 and G4. - 
H 
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Unlike the situation with respect to G4 AChE, 
the EChE G4 form is present even in normals and 
is simply increased in pregnancies affected by 
NTD. In non-NTD fetal malformations, including 
exomphalos and intrauterine death, there was also 
a distinct elevation in G4 BChE. 
It would appear that the most likely 
explanation is that the increased activity of G4 
BChE in fetal malformation reflects fetal serum 
leakage and is therefore not as "NTO-specific" 
as the increase in G4 AChE. 
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Section-11: Measurement of total AChE activity 
in rectal biopsy specimens 
11.1 Results of seven year study 
It is well established that Hirschsprung's 
disease is accompanied by a local increase in AChE 
activity in the aganglionic zone [Section 3.6[v]]. 
The largest series so far described includes a total 
of 110 cases, of which only nine had proven 
Hirschsprung's disease [Patrick et al, 19803. 
Over the period of preparation of this thesis 
further data were collected from routine biopsy 
samples in which AChE was measured for diagnosis 
of Hirschsprung's disease. The results were compared 
with the eventual outcome in each case as verified 
by histology. 
The study group included 213 children aged 
between 2 days and 14 years in whom failure to pass 
meconium or chronic constipation suggested a 
diagnosis of Hirschsprung's disease. Duplicate 
unfixed biopsy samples were obtained as described 
in Section 3.6Ciii). . One sample was examined 
histochemically and histologically and in the other 
AChE activity was measured as outlined in Section 3.6[v). 
The non-Hirschsprung's group consisted of 164 
children in whom ganglia were clearly identified. 
The disease was confirmed by histological and 
clinical criteria in 45 cases and corrective surgery 
- 209 - 
undertaken by the Soave operative procedure; these 
patients showed a significant increase [p < 0.001) 
in AChE activity [Table 11.13. In four cases 
unexplained discordant results were obtained, two 
of these proved to be very short segment disease, 
and sampling. beyond the affected region was the 
probable cause of the inappropriately low results. 
In one case, it is believed that sampling was too 
superficial. The remaining case showed an unusual 
histochemical appearance with only a marginal 
increase in the number of nerve fibres in the 
aganglionic zone, AChE activity was similarly 
borderline, this may reflect an atypical pathology. 
While AChE is markedly increased in the 
disease, EChE activity is only marginally affected. 
Thus the percentage of cholinesterase activity 
attributable to AChE (%AChE] is also increased. 
This parameter was diagnostically useful as it 
was free from variations introduced as a result 
of dehydration, weighing or pipetting errors. 
AChE and %AChE results for both groups are shown 
in Table 11.1. 
When AChE is plotted against %AChE [Fig. 11.13, 
four categories can be defined on the basis of the 
2 SD "cut-off" limits for each parameter [ACNE, 
14.2 U/1; %AChE, 72.7%): AChE and %AChE, increased; 
Table 11.1 AChE and % AChE activity in rectal suction'' 
biopsy specimens in cases with Hirschsprung 
disease and patients with evidence of 
constipation but who are histologically 
normal . 
- 210 - 
Table 11.1 Acetylcholinesterase activity and percentace 
original activity in rectal suction biopsy 
samples 
AChE 
e% 
AChE b 
Group Number of Cases " "'mean ± SO mean t SO 
Hirschsprung's 45 
disease 
Non-Hirschsprung'S 164 
disease cases 
34.2 t 22.7 77.5 + 6.3 
6.6 t 3.8 57.5 + 10.6 
p-value < 0.001 <0.001 
a Enzyme activity expressed as µmales x 10-1 acetylthiocholine 
hydrolysed per minute per gram of wet weight tissue, 
measured at 25°C. 
b The proportion of enzyme activity attributable to AChE 
expressed as a percentage of the total cholinesterase 
activity i. e. [ACNE/AChE + BChE] x 100. 
Fig. 4-1.1 %AChE Versus AChE activity in patients with 
Hirschsprungs disease and those with no 
histological evidence of the disease. Four 
groups are created on the basis of AChE 
and %AChE activity: 
AChE and %AChE increased 
AChE increased, %AChE normal 
%AChE increased, AChE normal 
AChE normal, %AChE normal 
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- 212 - 
AChE and %AChE, normal; AChE increased, %AChE normal; 
AChE normal, %AChE, increased. IF it is assumed 
that both AChE and %AChE must be increased before 
a diagnosis of Hirschsprung=s disease is considered 
likely then the false positive rate is zero. Eight 
per cent of results were regarded as equivocal with 
one parameter raised and one normal. 
The sensitivity of the test in the diagnosis 
of the disease is 73% and the specificity is 100%. 
Where: - 
True-positives 
Sensitivity = True positives + False negatives 
x 100 
and Specificity = 
True negatives 
False positives + true negatives 
x 100 
In practice this means that measurement of. AChE is 
a simple and effective way of excluding Hirschsprung's 
disease in chronically constipated children. 
The increase in AChE activity in Hirschsprung's 
disease was confirmed to be diagnostically useful. 
It was decided to investigate the change in molecular 
forms which gave rise to this increase. Since the 
biopsy samples were too small C< S. Omg] For adequate 
assessment of individual molecular forms, material 
resected as a result of surgical correction of the 
disorder was used. These "pull-through" specimens 
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of bowel included. the aganglionic zone and the 
transition into normal ganclionic bowel. Direct 
comparison could be made by sampling along the 
length of these specimens and performing molecular 
form analysis and histology on transversely 
adjacent samples. The results are described in 
the following section. 
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Section 12: Molecular forms of AChE in canclionic 
aid acanclicnic bowel 
12.1 Patients included in the Study 
In five cases of Hirschsprung's disease, segments 
of bowel were resected during corrective surgery. 
Details of these specimens and the patients from which 
they were obtained are described in Section 8.3. 
In four of these cases, specimens contained both 
aganglionic and ganglionic [normal] tissue. In one 
case of long segment disease while the tissue was 
entirely aganglionic, nerve trunk hypertrophy 
present in the distal region of resected bowel was 
not evident in the proximal region. This is in 
accordance with the view that sacral innervation gives 
rise to the nerve trunk hypertrophy characteristic 
of the disease and that such innervation is confined 
to the distal region of the gut [Garret at al, 19693. 
A single patient whose sigmoid colon was resected 
for a cause other than Hirschsprung's disease was 
also sampled as a control specimen. Further controls 
were considered unnecessary as each specimen included 
its own control, that is the normal (ganglionic) 
region with which changes in molecular forms could 
be compared. 
In all cases the specimens were sampled For 
histological and histochemical investigation. In 
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three instances the routine biopsy total AChE assay was 
also performed on samples taken along the length 
of the specimen. 
As described in Section'B. 3, some segments 
of bowel contained both muscle and mucosal layers; 
where this occurred the layers were separated by 
microscopic dissection and the molecular'f orms of 
AChE examined independantly in each layer. 
After sampling, individual specimens were 
stored in liquid nitrogen until required. They 
were then removed, thawed and homogenised in pH8.0, 
O. IM phosphate buffer; this is described in greater 
detail in Section 8.3. In one case the samples 
were homogenised in two different buffers: 
Firstly in a mild aqueous medium of O. IM phosphate 
buffer at pH7.3. The pellet from this was then 
resuspended in a`second phosphate buffer containing 
IM NaCl and 0.5% w/v Triton X-100. 'These buffers 
would be expected to release. soluble and membrane 
bound forms respectively. 
12.2 Variation in activity of AChE molecular forms 
in relation to the changing histological and 
histochemical appearance 
The changes in molecular forms of AChE shown 
in Figs. 12.1-6 are compared with the changing 
histological and histochemical appearance. Each 
Fig. 12.1-6 The changing level of activity of AChE 
molecular forms [G1,62, G4 and A12) as 
they vary along the length of resected 
bowel -segments. Cases A, B, C and"E show 
a clear transition from a region of 
aganglionosis to a normal (gangl"ionic) 
region. Case D is an example of long 
segment disease in which the segment of .N 
bowel analysed was entirely aganglionic.., 
Case F, a child with no evidence of 
Hirschsprung's disease. acts as an 
independent control. In each case the 
changing histological and histochemical 
appearance is shown for comparison. The,,, 
actual AChE molecular form profile from ;-., 
extreme ends, proximal and distal, is 
illustrated. Inclusion of the profile at, 
each point would have made the Figure 
unnecessarily complex. 
In Cases B, C and E the total AChE activity 
was measured at intervals by the biopsy 
assay outlined in Section 11. The changing 
total AChE activity reFlects the increase 
in G4-AChE and the changing histochemical 
appearance. 
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figure also shows the actual AChE sedimentation 
profile from the extreme ends of the resected bowel 
specimen. The inclusion of the actual AChE 
sedimentation profile results at each point would 
make the figure unnecessarily complicated, these 
are therefore summarised in the display of the 
changing level of each form. 
In all cases an increase in the activity of 
G4 AChE accompanied the transition into the region 
where nerve trunk hypertrophy was demonstrable 
histochemically. This increase in G4 ranged from 
4-to 14-Fold. Where both muscle and mucosal layers 
were present, Cases B and 0, the changes in G4 were 
more prominent in the muscle than mucosal layers. 
The actual level of these forms are shown in Table 12.1. 
Forms G2 and A12 showed no consistent variation 
when compared with the histological and histochemical 
appearance. However, the activity of GI was higher 
in the aganglionic and histochemically positive 
region of cases 6,0 and E than in the normal 
ganglionic zone. In the muscle layers of cases B 
and 0 this increase in GI was particularly well 
defined [Figs. 12.2 and 12.43. 
In the control case F, Fig. 12.6, there was no 
discernable pattern of change in any of the AChE 
molecular forms from either muscle or mucosal layers. 
ýi 
Table 12.1 Quantitative activity of AChE molecular 
Forms at intervals along resected bowel 
segments from cases A-F. The presence or 
absence of ganglia at each point is also 
shown for comparison. `'` 
iý 
J: 
i 
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This. suppcrts the view that the variation is linked 
to the transition from normal to aganglionic bowel. 
Assay of total AChE perf crmed at intervals 
along the segments of Cases B, C and E showed 
changes which paralleled those of G4 and compared 
well with the histochemical and histological findings. 
12.3 AChE activity in a single case of long segment 
Hirschsprung's disease 
In a patient with total colonic aganglionosis 
a segment of descending colon measuring 24 cm was 
removed, Case 0. The specimen was entirely 
aganglionic, however, nerve trunk hypertrophy was 
observed only in the distal 8 cm. This case provided 
a useful model for independent study of the effects 
of nerve trunk hypertrophy and agariglionosis on 
molecular forms of AChE. The increase in G4-AChE 
was linked [Fig. 12.43 to the transition to the region 
of nerve trunk hypertrophy and aganglionosis. The 
significance of these findings are discussed in 
Section 19.4. 
12.4 Variation in membrane bound and soluble AChE 
in Hirschsprung's disease 
In Case E, Fig. 12.5, different extraction 
techniques allowed membrane bound and soluble forms 
to be studied separately. The change in G4 activity 
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was more pronounced in the membrane bound fraction 
than in the soluble component. The activity of the 
other AChE forms were similar in both instances. 
12.5 Summery of AChE molecular form changes in 
Hirschsprung's disease 
In summary, the changes in AChE molecular 
forms in resected bowel segments, cases A-F, suggest 
that variation in ACNE activity largely reflect 
changes in the G4 form. The most prominent changes 
in G4 occur in the membrane bound fraction and 
this is directly associated with the nerve trunk 
hypertrophy seen in the disease. 
Fig. 12.7, summarises these Findings by 
superimposing results from the musocal layers of 
Cases A, 6, C and E. The transition from normal 
to aganglionic bowel was used as a marker point 
from which direct comparison could be made. Case 0 
which was entirely aganglionic and the control 
Case F were ommitted from this figure as neither 
included the transition from ganglionic to 
aganglionic bowel. 
12.6 Determination of sedimentation coefficient 
The sedimentation coefficient of each molecular 
Form was determined by curvilinear interpolation 
between protein markers as outlined in Section 7.1. 
Fig. 12.7 A summarised representation of the variation 
in the activities of Gil G2, G4 and A12 
molecular forms in resected bowel segments 
from Oases A, B, C and E. The transition 
from the aganglionic [distal) region to the, 
ganglionic [proximal) zone is indicated, "-"-"-" 
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Results were collected from all the profiles 
obtained from Cases A-F and the Mean and SQ 
calculated for each fcrm. 
Sedimentation Values 
Species Mean so n 
G 3.50 0.51 57 
G2 4.99 0.53 58. 
G4 9.22 0.75 63 
A12 16.78 1.01 52 
12.7 Differential extraction of AChE molecular 
forms from rectal tissue 
Three different extraction media were used 
successively in the homogenisation of a 5% w/v 
suspension of rectal tissue using a Potter Elevehjem 
type homogeniser. The molecular forms released by 
each media in turn were determined by velocity 
sedimentation analysis. The experimental details 
are shown schematically in Fig. 12.8. The three 
different buffer systems included: 
Buffer A: A physiological buffer; pH7.4 
based on Hank's medium. 
Fig. 12.6 A schematic representation of the experimental 
assessment of the effect of different 
extraction media on AChE release from rectal 
tissue. 
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Buffer 8: The buffer used in the routine 
biopsy AChE assay; pH8.0, O. IM 
Na/K phosphate. - 
Buffer C: A buffer containing the detergent 
Triton X-100 capable of releasing 
membrane bound components; pH7.3, 
O. IM Na/K phosphate containing 1% 
w/v Triton X-100. 
The tissue was homogenised twice in each buffer system 
to ensure complete release of those molecular forms 
involved at each stage. The profile of AChE species 
was determined for the first of the two extractions 
in each case. Supernatants A,, B, and C1 were 
assumed to contain the same distribution of forms 
as their parent supernatants A, B and C respectively. 
The results obtained using tissue from Case B 
were as follows: 
Supernatant 
G1 G2 
U/1 
G4 A12 
Buffer AA J 9.0 7.8 11.7 - 
A1 2.8 2.4 3.6 - 
Buffer BB 2.6 1.4 3.0 1.5 
81 0.4 0.2 0.4 0.2 
Buffer CC I 1.3 1.8 5.9 0.6 
c1 0.2 0.3 0.9 0.1 
Total activity16.3 13.9 2S. 5 2.4 
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From these results it can be seen that a substantial 
proportion of the globular forms G1, G2 and G4 
were released by a single homogenisation in 
physiological buffer, 550 of G1,56% of G2 and 
46% of G4 respectively. Further amounts of each 
form were released by buffer B used in the routine 
biopsy assay including the majority of the A12 
activity. Buffer C containing Triton, released 
the remaining membrane bound activity of which G4 
was the major component. 
These experiments suggest that the majority 
of AChE activity, 80%, is released by buffer B 
used in the routine biopsy AChE assay, however, a 
proportion of AChE remains on the membrane and can 
only be released by Triton. G4 in particular has 
almost one third of its activity in this bound 
form. 
12.8 The effect of native proteases on AChE 
molecular forms in rectal tissue 
Some reports in the literature suggest that 
native proteases present in muscle may enhance the 
release of, or even interconvert AChE molecular 
forms [Section 2.43. 
In order to test the effect of native proteases 
on AChE in rectal tissue, mucosa from the aganglionic 
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region of resected bowel wes finely minced using 
a scalpel and then allocated to three separate 
aliquots: A, 6 and C. 
A- was immediately homogenised at a concentration 
of 5% w/v on ice in 0. IM, pH8.0 phosphate 
buffer containing a mixture of protease 
inhibitors: Aprotinin, 0.2mg/ml, Benzamidine 
2mM, EGTA SmM, Leupeptin 0.02mg/ml, Ovomucoid 
0.02mg/ml, Pepstatin 0.02mg/ml, Soya bean trypsin 
inhibitor 0.1mg/ml and Lima bean trypsin 
inhibitor 0.2mg/ml [Barnard et al, 19843. All 
were obtained from Sigma Chemical Co Ltd. 
B. - was immediately homogenised-at a concentration 
of w/v in pHB. O, O. IM phosphate buffer 
without protease inhibitors. 
C- was stored at room temperature for four hours 
in a moist environment and then homogenised at 
a concentration of 5% w/v in pH8.0,0.2M 
phosphate buffer without protease inhibitors. 
The resulting homogenates were then centrifuged 
at 15,000g for 3 minutes and the molecular form 
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profile assessed by velocity sedimentation analysis. 
The results are shown below: 
Aliquot G G2 G4 
U/1 
A [homogenised on ice 22.0 12.0 32.0 
with protease inhibitors] 
6 [homogenised without 23.5 13.5 37.5 
protease inhibitors] 
C [Four hours at room 
temperature followed by 13.0 11.5 35.5 homogenisation without 
protease inhibitors] 
Homogenisation in the presence or absence of protease 
inhibitors did not substantially affect the activity 
of any of the molecular forms. 
The molecular forms also appeared quite stable 
to incubation for four hours at room temperature 
although some decrease in Gi activity was noticeable. 
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Section 13: Molecular forms cf BCht in canolicnic 
and acanclicnic bowel 
13.1 Variation in the level of BChE molecular forms 
EChE exists in molecular forms similar to 
those of AChE [Section 2.3]. In rectal tissue three 
major forms are identifiable, Fig. 13.1, these include 
G, G2 and -G4 . 
Molecular form profiles of BChE were determined 
at intervals along the length of the resected bowel 
segments of Cases A-F as previously described. for 
AChE forms (Section 12.1). 
The results for those cases showing a clear 
transition from ganglionic to aganglionic bowel are 
summarised in Fig. 13.2. ECKE activity does not 
appear to vary in a consistent way in any of its forms 
between ganglionic and aganglionic tissue. This is 
in direct contrast to AChE which shows a distinct 
increase in G4 in aganglionic tissue [Fig. 12.73. 
13.2 Determination of sedimentation coefficient 
The sedimentation coefficient of each molecular 
form was determined by curvilinear interpolation 
between protein markers as outlined in Section 7.1. 
L 
Fig. 13.1 A density gradient sedimentation profile 
of BChE molecular forms present in rectal 
tissue homogenates. 
tý 
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The results were collected-for all of the 
profiles obtained from Cases A-F and the Mean and 
SO calculated for each form. 
Sedimentation Values 
Species Mean SO n 
G1 4.1 0.33 57 
G2 5.2 0.57 56 
64 11.4 0.65 61 
The sedimentation coefficients of these BChE species 
are slightly higher than their AChE counterparts, 
[Section 12.6]. These values are in accord with the 
reported values for mammalian cholinesterases, 
[Section 2.2) and suggests a somewhat higher molecular 
mass for EChE forms. 
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Section 14: Summary of the results from amniotic 
fluid and resected bowel secments 
14.1 Molecular fcrms of AChE and EChE in amniotic 
fluid 
Three forms of both AChE and BChE were 
identifiable in amniotic fluid by sucrose density 
sedimentation analysis. The sedimentation coefficients 
of these forms are shown in Table 14.1. Both AChE 
and BChE activity was increased in amniotic fluid 
from NTO affected pregnancies when compared with 
those with a normal outcome. This increase was 
particularly marked in a form sedimenting at approx- 
imately 10S and believed to correspond to the tetrameric, 
G4 form of the enzyme. 
G4 BChE, while increased in the presence of 
NTD and other fetal malformations, was also present 
in normal pregnancies. It is probable that the 
increase in G4 EChE is due to fetal serum leakage. 
G4 AChE was virtually absent in amniotic fluid 
From pregnancies with normal outcome and appears to 
be NTO-speciFic. It is probable that this marker 
is released from the nervous tissue exposed as a 
result of the lesion. 
14.2 Molecular forms of AChE and BChE in rectal tissue 
Four forms of AChE and three of BChE were 
identifiable in tissue homogenates made from resected 
Table 14.1 The sedimentation coefficients of AChE ands 
BChE molecular forms present in amniotic 
fluid and rectal tissue. 
_. ý ý: 
_. _ 
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Table 14.1 Sedimentaticn ccefficients cf AChE and 
EChE molecular forms from amniotic fluid 
and rectal tissue 
Source G G2 G4 A 12 
Amnictic Fluid: 
AChE 4.0 t 0.6 5.5 :t C3.7 10.3 + 0.5 
EChE 4.5 t 0.5 6.3 t 0.7 11.6 + 0.4 
Rectal tissue: 
AChE 3.5 t 0.5 5.0 t 0.5 9.2 t 0.8 16. e + 1.0 
EChE 4.1 + 0.3 5.2 t O. S 11.4 + 0.7 
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bowel secments taken from five cases of Hirschsprung's 
disease and one control case. 
There was an increase in overall ACNE activity 
in the aganglionic region of bowel in each case. 
One particular form of AChE sedimenting at 
approximately IOS and believed to represent the 
tetrameric form, G 41 of the enzyme, comprised the 
major component of this increase. 
The increase in G4-AChE followed the nerve 
trunk hypertrophy seen in the disease and was not 
directly related to aganglionosis. It would seem 
probable that this G4-AChE is a product of the 
nerve trunk hyperplasia. 
BChE molecular forms showed no consistent 
changes when aganglionic and ganglionic regions 
were compared. 
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Section 15: Cherecterisation of AChE and 
EC, -, E molecular forms 
In the previous Sections, 10-13, the variation 
in molecular forms of AChE and SChE was described 
in amniotic fluid and rectal tissue. These 
findings are summarised in Section 14 and in 
particular an increase in G4-AChE is described in 
amniotic fluid in the presence of NTQ and in rectal 
tissue in regions of aganglionosis. 
In this section the individual characteristics 
of ACNE and BChE molecular forms are studied and 
compared with particular reference given to 
G4-AChE. 
15.1 Gel Filtration 
It is possible to separate AChE molecular 
forms by gal filtration using media with a suitable 
fractionation range, (Section 2.63. * The experimental 
details are outlined in Section 7.3. This technique 
not only provides independent evidence confirming 
the existence and homogeneity of molecular forms 
identified by sucrose density sedimentation, but also, 
when combined with sedimentation data, allows the true 
molecular mass to be calculated. 
Ultrogel AcA 22 proved to be a suitable medium 
for separation. The void volume, Vo, of the column 
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was estimated from the elution volume of Blue 
Dextran. The total bed volume, Vt, by the 
dimensions or the column and the volume not 
accessible to s 
Vg 
Where B is the 
132 ml/g and d 
1.007 g/ml. 
From this data 
phase could be 
solvent, Vg, from the equation: 
Vt / B. d 
bed volume per gram of dry gel, 
is the density of the dry gel, 
Vs, the volume of the stationary 
calculated: . 
Vs = Vt - Vg - Vo 
Hence, Kd values were calculated: 
Kd = Ve - Va 
Vs 
Employing this methodKd values of the nine protein 
markers were estimated and averaged from the results 
of 12 runs. These average values are shown in 
Fig. 7.9 plotted against log [molecular mass3. 
In the same way samples including markers 
were applied tothe top oF the column in a volume oF 
less than 2 ml and I- ml Fractions collected. From 
these data Kd values of AChE molecular forms were 
calculated. 
The elution profiles obtained using rectal 
tissue homogenates are shown in Fig. 15.1. These 
included samples obtained by homogenisation in O. IM, 
Fig. 15.1 AChE molecular forms from rectal tissue 
separated by gel filtration an Ultrogel AcA22. 
The void volume is shown as Vo and individual 
molecular forms are labelled: 0 r'34 and A, 2, 
3 
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Fig. IS; i Separation of molecular forms of AChE 
from rectal tissue by gel filtration 
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pHS. 0 phosphate buffer and also by further extraction 
of the tissue with buffer containing IM NaCl and 
0. E% w/v Triton. In both cases the results show 
the presence of GV G4 and A 12 AChE molecular fcrms. 
Fractions containing distinct molecular forms 
G1, G and obtained by preparative sucrose density 2 G4 
gradient sedimentation (Section 7.23, were pooled, 
concentrated and chromatographed as for. rectal 
tissue homogenates. The results are shown in 
Fig. 15.2. 
Average Kd values obtained for each AChE 
molecular form present in rectal tissue were 
calculated and when ccmpared with the prctein 
marker calibration curve, Fig. 15.3, apparent 
molecular mass could be estimated. The results 
are shown below: 
Molecu-lar. -mass 
Apparent molecular mass 
CKOE3 I 
A12 0.28 >670 
13 4 0.47 550 
G2 0.52 470 
0.60 285 
The results are in excess oF the true molecular 
weight and reflect the asymmetry present in the 
molecules. Compensation can be made an the basis 
I 
Fig. 15.2 Gel f iltraticn uslng Ultrogel AcA22 cF 
individual AChE molecular forms EG V C32 
and G 43 obtained by density sedimentation, 
the elution volume in each case is shown 
as Va. 
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Fig. 15.2 Gal filtration of individual AChE 
molecular forms 
Fig. 15.3 The distribution coefficient, Kd versus 
loglo molecular mass for'nine proteins oF 
known molecular mass. The Kd values of 
AChE molecular forms from rectal tissue 
and amniotic fluid are also indicated. 
The apparent molecular mass oF these AChE 
species can be calculated by comparison 
with the protein marker curve. 
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Fig. 15.3 Kd values of rectal tissue and amnictic fluid 
AChE species compared with nine marker proteins 
- 246 - 
of S value to give true molecular weights and this 
is described in the following section. The Kd 
values for A 12 
AChE are less than the largest 
protein marker and consequently apparent molecular 
mass for this form cannot be estimated accurately and 
is reported as >67,0. K[3a. 
Pooled and--concentrated amniotic fluid from 
pregnancies affected by anencephaly end spina 
bifida were also chromatographed; results are shown 
in Fig. 15.4. Kd values were calculated and the 
apparent molecular mass of these amniotic fluid 
forms estimated from comparison with Fig. 15.3. 
These are shown below: 
Molecular-fcrm Kd 
Apparent molecular mass 
CKDa3 
G40.54 405 
G20.57 335 
G10.62 230 
Forms present in amnictic Fluid have a greater 
Kd value and correspondingly lower apparent molecular 
mass than their counterparts obtained From rectal 
tissue. This difference in hydrodynamic behaviour 
is also reflected in the difference in S-value of . 
the forms from different sources as shown in Table 14.1. 
Taken together these results suggest that the 
1' 
Fig. 15.4 Gal f iltraticn of AChE molecular Forms present 
in amniotic fluid from pregnancies affected by 
anencephaly and spina bifida. The AChE species 
A 
are labelled and the void volume, Vo, is 
indicated. 
f 
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Fig. 15.4 Gel filtration of AChE molecular forms 
from amniotic fluid 
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species present in rectal tissue are more expanded 
in stiuc"Cure, with an increased molecular asymmetry, 
2ivin-c rise to lower Kd and S values. The. incressed 
asymmetry slows down sedimentation and artefactually 
increases the apparent molecular mass toward gel 
filtration. This effect can be circumvented 
by combining S-value and gel filtration data to 
give an estimate of true molecular mass for each 
form as outlined in the following section. 
15.2 Estimation of molecular mass oF AChE forms 
The combination oF experimentally determined 
Kd for the protein markers with literature values 
for Stokes radius, Re, allowed the effective gel 
pore size, r, to be calculated according to the 
equation (1] (Ackers, IS64): 
Kd _Re)2 1-2.104-Re + 2.09 
(Re)3- 
O. SS ae 5, 
rrr(r)- 
When this was averaged for all the markers 
as described in Section 7.3, the pore radius, r, 
could be calculated: - 
Mean effective pore radius = 46.36 t 5.62 (SO]. nm 
By applying equation [I] with known pore size, r 
and known Kd value for AChE molecular forms, the 
Stakes radius, Re for each form could be calculated. 
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These are shown below: 
Mdlecul-ar'f crm Kd'Value Stckes radius [nm3 
Rectal tissue 
A 12 0.26 
12. IS 
G4 0.47 7.54 
G2 0.52 6.60 
G1 0.60 5.33 
Amnictic fluid 
G4 0.55 6.27 
G2 0.57 5.75 
G1 0.62 4.92 
Because, Re. S20'w ýf Cmolecular mass3 
CSection 7.33. When f is determined from protein 
markers with known Re, S 2,, w and molecular mass, 
this can be applied to determine the molecular 
mass of any substance of known Re and S 20'w value, 
The value of f determined, as described in 
Section 7.3, was 
f= 3958 t 124 
The estimation of molecular mass using this method, 
- 250 - 
for each AChE form in turn is shown below: 
Molecular form Re S20, w f 
Calculated molecular 
mass 
Cnm) CS-units3 CKDal 
Rectal tissue 
A 12 12. IS 16.8 3sss all 
G4 7.54 S. 2 3sse 275 
G2 6.60 5.0 3S58 131 
G1 5.33 3.5, 3958 74 
Amnictic fluid 
G46.27 10.3 3ssa 256 
G25.75 5.5 39SE3 126 
GI4. S2 4.0 395a 7E3 
Due to the experimental variability in determining 
components Re and S 201w upon which Further calculation 
is based, the molecular mass is only approximate. 
However, the results are sufficiently accurate to 
support the identiFication oF the AChE Forms as 
monomer, dimer, tetramer and in the case oF A 12' three 
linked tetramers. 
Assuming the tatramer, G4 to have an arbitrary 
molecular mass oF Four, the other molecular Forms 
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then have molecular masses in the ratics shown below: 
A12 G4 G2 , GI 
Rectal tissue 11.81 4.00 1.90 1. CIS 
Amnictic fluid 4.00 1.96 1.22 
These ratios confirm the subscript ratios by 
which the molecular forms are denoted i. e. G 11 G21 
G4 and A 12' 
The results oF gel Filtration thereFore 
provides further evidence for the existence of 
AChE forms as distinct molecular entities. These 
are identifiable by density gradient sedimentaticn 
as well as filtration chromotography. 
The estimation of molecular mass of these 
Forms supports the assumption that they exist as 
a series: monomer, dimer, tetramers i. e. G1, G 21 
and G4 respectively. 
15.3 Thermal Stability 
There is evidence (Section 2.83 that molecular 
forms of AChE differ in their sensitivity towards 
inactivation by heat. Edwards and Brimijoin, (19833, 
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describe how G, -AChE. is inactivated by heatkin2 
for 10-15 min at SI C C, whereas G4 is relatively 
resistant to t1his treatment. 
In order to investicate this, molecular forms 
of AChE from rectal tissue were prepared by 
sucrose density centrifugation. The appropriate 
Fractions corresponding to distinct species were 
pooled and made up to a volume of 1ml in each 
case. Both the separation of these Forms by density 
centrifugation and the experiments determining 
their temperature sensitivity were performed on the 
same day to avoid possible interconversion an 
storage. 
Iml pools of each form G 11 62 and G4 
obtained in this way were incubated in thin walled 
pre-heated glass tubes in a 49 0C water bath. 60/11 
aliquots were removed into pre-cooled tubes in an ice 
bath at the times indicated. Finally, after 30 min 
at 49 0 C, the temperature of the water bath was 
increased to 60 CC and the remaining samples incubated 
for a further period of 60 min at SOOC. The 
activity of the samples heated in this way- provided 
a "blank" result which was then substracted from 
the other measured activities. 
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Time interval Enzyme activity 
Percentage remaining 
activity 
Cmin3 CU/13 C%l 
G4G4 
0 10.3 S. 4 26.4 100.0 100.0 100.0 
1 10.5 9.9 27.7 102.0 105.3 104.9 
2 10.1 9.9 27.5 Se. 1 105.3 104.2 
3 9.6 9.3 
_27.8 
93.2 Se-9 105.3 
4 9.6 9.3 27.6 93.2 se. s 104. S 
5 e. 9 9.3 27.3 E36.4 Se. 9 103.4 
6 E3.5 9.2 27.3 62.5 97.9 103.4 
7 7.9 S. 1 25.9 76.7 96.8 Se. 1 
10 7.1 8.5 26.6 68.9 90.4 100.8 
15 6.2 - 25.5 60.2 - S6.5 
20 5.7 8.0 24.9 55.3 E35.1 94.3 
25 5.8 7.0 24.6 56.3 74.5 93.2 
30 4.7 6.7 23.6 45.6 71.3 SO. 2 
The results, Fig. 15.5, expressed both in terms 
of activity and percentage change, show that in 
accordance with the findings of Edwards and Brimijoin, 
is the most thermally labile species and 
G4 is relatively resistant to inactivation. 
In all cases GV 02 and G4' increase in activity 
is observed Following brieF incubation at 4S 0 C, this 
is limited to 6% oF the original activity at time 
zero. 
These Findings are important to two ways. 
Firstly, they substantiate the results oF another 
group, Edwards and Brimijoin, [19833 and also 
0 Fig. 1S. S The effect of incubation at 49 C on individual 
AChE molecular forms recovered from density 
71 
gradient sedimentation of rectal tissue 
hcmogenates. .. 
The activity_oF each form CG,, -c3 2 
and G43 is shown as'both: , the actual measured 
activity and as the change'relative to the 
initial activty, taken as 100%. 
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Fig. 15.5 Temperature lability oF individual AChE 
molecular Forms 
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indicate the similarity between AChE forms from 
different sources, human rectal tissue and rat 
heart muscle respectively. 'Secondly, they confirm 
that distinct molecular entities are being studied 
and that the peaks obtained by density centrifugation 
represent behaviourally and structurally differing 
forms of the same enzyme. Lastly, the relative . 
resistance of G4 -AChE toward heat inactivation may 
prove valuable in the design of a specific assay 
directed toward this form. 
15.4 Substrate inhibition 
It is well attested that AChE is subject to 
substrate inhibition at concentrationsin excess of 
2-3 mM CFiG. 1.23. 
In order to assess the effect of varying 
substrate concentration an individual molecular forms, 
these were prepared by sucrose density sedimentation 
of rectal tissue homogenates. Appropriate fractions 
were pooled representing G,, G2 and G4 respectively. 
The activity of these pools was measured, on the 
same day to avoid storage effects, using a final 
concentration of acetylthiocholine ranging from 
0.07 to 35 mM. The measurements were performed on 
a centrifugal fast analyser (Cobas Sic] immediately 
after addition of the substrate to reagent containing 
pH7.3 phosphate buffer, OTNB and the selective 
inhibitor ethopropazine. The analyses, an duplicate 
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samples for each of the three forms we complete 
within four minutes. It was important to perf crm 
the assays quickly due to the rate of increase of 
optical density caused by the ncn-enzymic break- 
down of AThCh at high concentration. A reagent 
blank containing substrate, of equivalent concentration 
to that in the test was Used in every case. ' 
The results are listed below: - 
Substrate concentration 1 C mm) , 
AChE 
1 
activity 
CU/13 
24 
0.07 5.6 8.1 29.7 
0.18 6.8 11.3 46.8 
0.35 7.6 13.6 S9.0 
0.44 7 .9 14.7 so .5 
O. Gs S. 6 16.0 67.3 
1.20 9.3 18.6 72. S 
1.77 10. S I E3.4 73.3 
3.54 S. 0 I E3.0 7 1. E3 
8.84 6.4 16.3 63.8 
17.70 6.0 14.2 56.5 
35.40 - 54.1 
The results, Fig. 15.6, are similar For each 
molecular form with peak activity in the region of 
2.0 . 
04. This confirms the widely held view, 
expressed Brimijoin, (19833, that the molecular 
Forms are catalytically similar. 
  
Fig. 15.6 The effect oF increasing substrate 
Cacetylthiocholinel concentration on the 
activity of individual AChE molecular forms 
recovered frcm_density gradient sedimentation 
of rectal tissue homogenates. The'cptimum 
activity in each case is approximately 2. OmM, 
at higher concentrations there is inhibition 
due to excess substrate. 
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Fig. 15.6 Substrate inhibition oF individual AChE 
molecular Forms 
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15.5 Triton reactivity 
Each of the globular series of AChEj Gil G2 
and G4 occur in two forms: 
Cil Soluble species, which may be secreted or" 
cytoplasmic, and are easily released by 
aqueous buffers at physiological pH 
CU3 Membrane bound species, which are attached 
either internally or externally to cell 
membrane components. 
The soluble forms may or may not react with 
detergents such as Triton X-100, [Section 2.63 
whereas membrane bound forms will react with Triton 
in such a way that their sedimentation coefficient 
is altered, [Lazar and Vigny, 19603. Therefore, 
Lazar and Vigny reported that when sucrose density 
sedimentation analysis of AChE derived from aT 28 
neuroblastoma x sympathetic neuron hybrid is 
performed in media with and without Triton, the 
measured S-value was altered. G4 gave an S-value of 
10.2S in the absence of Triton and 9.7S in its 
presencelwhile G1 gave S-values of 4. SS and 3.2 in 
the absence and presence of Triton respectively. 
To test the reactivity toward Triton of 
AChE molecular forms from rectal tissue and amniotic 
fluid, sucrose density sedimentation was performed 
I 
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with and without 0.5% v/v Triton X-100 in the 
centrifygaticn media cF O; OIM phosphate buffer, 
pH7.2 containing IM NaCl. 
Two different hcmcgenisation media were used 
in turn with the rectal tissue: a] without Triton, 
b) with 1% v/v Triton. The detergent was subsequently 
removed From homogenate by dialysis against three 
changes of 600 volumes of O. IM phosphate buffer 
pHS. O. 
In all, three types OF sample were analysed , 
to compare the results of density centrifugation in 
the presence and absence of Triton. Namely, 
amniotic fluid, rectal tissue homogenised in the 
presence of 17. y/v Triton, and rectal tissue 
homogenised in a phosphate buffer that contained no 
detergent. 
The S-values obtained by curvilinear inter- 
polation between protein markers in each case are 
shown below and the proFiles obtained illustrated 
in Fig. 15.7. 
Rectal tissue 
AChE Rectal tissue CPhosphate buffer Amniotic 
species (Triton Extract] extract3 fluid 
G49.4 11.3 9.8 10. S 10.9 10.7 
G2 5.3 7.1 4c 
G 3. S 4.4 3. S 5.1 4.6 4.6 
+T -T +T -T +T -T 
+T, with Triton (O. S% v/v]; -T, without Triton 
present only in trace amounts, S Value not accurately 
measurable. 
Fig. 15.7 Sucrose density sedimentation performed in 
the absence, -T and presence, +T of 0.5% v/v 
Tritcý *X-100 on: 
a] A phosphate buffer [pH8.010. IMI extract 
of rectal tissue 
b) A Triton extract of rectal tissue 
C] Amnictic fluid 
Individual AChE molecular Forms are identified 
and the AChE profile obtained in the absence 
of Triton X-100, -T is shaded. 
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Fig. 15.7 The effect oF Triton X-100 on the 
sedimentation oF AChE molecular Forms 
From rectal tissue and amniotic Fluid 
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Frcm these results can be seen that the 
- marked differences occur in the Triton extract most 
of rectal tissue, suggesting that -these f crms derive 
From cell membranes. Changes in S-value are also 
seen in the samples produced by homcgenisation in 
phosphate buffer, this suggests that at least some 
membrane-bound enzyme is released by this buffer 
system. The chances in S value of rectal tissue forms 
are of the same order as those reported by Lazar 
and Vigny, CISBOI and point to a behavioural 
similarity between AChE species from different sources. 
In addition to the changes in S-value, a loss 
of activity is also noticeable in the absence of 
Triton, [Fig. 15.73 particularly in the Triton 
extractable species. 
Removal of Triton from the centrifugation 
media does not affect the sedimentation of amnictic 
fluid AChE forms indicating that these are soluble 
species which may derive from exposed nerve trunks 
by secretion into the amniotic Fluid. 
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Section IE: Acety1cholinesterase measurement 
detec. ticn of neural tube defects 
16.1 The value of acety1cholinesterase 
measurement. 
A recent review article (Turnbull and MacKenzie, 
19633 describes how, following the legalisation of 
pregnancy termination less than 20 years ago, 
amniocentesis has become increasingly important as 
a means of investigating the unborn Fetus. This 
technique has gained particularly widespread 
application in the prenatal detection of NTD. 
Prior to ISSO the identification of NTO affected 
pregnancies rested almost exclusively an the 
demonstration of an increased level of AFP (Editorial, Lancet 
ISEOI in the amnictic fluid from such individuals 
(first described by Brock and Sutcliffe, 19723. 
However, in Brock's own words: "The effectiveness 
of AFP assay is not as complete as might be 
desired in a form of diagnosis on which critical 
decisions about termination-of pregnancy must be 
made", (Brock and Hayward, 19803. Therefore despite 
the additional contribution made bY ultrasound the 
need for a further biochemical test to complement or 
replace AFP was apparent (Editorial, Lancet, 1960]. 
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It was acainst this background that in 
1S79 Smith, A. D. et al, Chubb et, al and Dale at al, b3 
First described the close association between 
raised amnictic fluid AChE and NTO. Initial studies 
suggested that AChE was more specific and possibly 
more sensitive than AFP in the detection oF NTO 
(Smith, 1SE32]. In the same review (Smith, 19623 
the author asserts, the now commonly held view, 
that this improvement in, specificity derives from 
a neural origin-for AChE in the presence of NTOI 
probably due to leakage of CSF (the species 
identified in amniotic fluid showed the same 
electrophoretic mobility as the CSF enzyme]. 
Research using experimental animals with an NTO 
lesion have since confirmed this hypothesis 
(Pilcwsky et al, 19823 and have provided Further 
support for the use of AChE in the detection of 
NTO in man. 
16.2 Comparison of qualitative and quantitative 
techniques 
Following these initial findings there was 
an increase in the number of reports confirming 
and at times qualifying these results. Only 
recently has this begun to "tail-off" (Fig. 16.13. 
The later reports are fewer but tend to be on larger 
populations, with two oF the more recent: Aitken et all 
C19841 and Wyvill et al, CISE341 including 3785 
Fig. 16.1 The culmulative total of reports from IS79 
to ISSS concerning the use of cholinesterase 
measurement in the detecti'on of neural tube 
defects. Data forige5 is still incomplete. ' 
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Fig. 16.1 The culmulative total of reports describing 
cholinesterase measurement in amnictic flufd 
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and 14SS samples respectively. 
In their original article, Smith ,A . 0. et-all ClS7S] 
described two distinct approaches to amnictic fluid 
AChE measurement: 
(i] Quantitative assayq in which the rate of 
hydrolysis of acetylthiccholine and the 
subsequent detection of the evolved thiol 
is determined in the presence and absence 
of the selective AChE inhibitor, BW264cSi. 
(ii3 Qualitative AChE assay, demonstrating a fast 
migrating band of AChE activity on 
electrophoresis in polyacrylamide gels in 
the presence of NTO, which was absent in 
pregnancies with normal-outcome. This is 
often. simply referred to as the "gel-test". 
Since then there has remained controversy 
over the relative merits of these two approaches to the 
detection of NTO. The points are detailed in 
Section 4.4 Ciii]. 
In favour of the qualitative assay are several 
reports which suggest that it is less affected by 
contamination with blood than the quantitative 
test (Buamah et al, ISSO; Voigtlander et al, ISGI; 
Brock and Hayward, ISSOI. This is important as it 
has been demonstrated that approximately 10% oF all 
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samples contain blood [Smith, 10-623. In addition 
to its beneFits with respect to blood staining, 
several reports suggest that the gel test shows 
better discrimination between NTO affected and 
normal pregnancies than the quantitative assay 
CSeller and Cole, ISSO; Aitken et al, 1984; Wyvill, 
19643. At least some of this improvement in 
specificity may result from the assertion that 
this test measures one specific secretory form of 
AChE [Hodgson et al, 19613. It is certainly true 
that the "gel-test" has gained more widespread 
acceptance than the quantitative assay [Brack et al, 
19653 and its usefulness has been clearly 
demonstrated in practice [Collaborative AChE 
Study, ISS13. 
Despite these advantages, even advocates 
of the qualitative approach allow that it has 
certain drawbacks. Gels can be prone to cross 
contamination via the cathode buffer. There are 
occasional problems in the interpretation of faint 
bands (Barlow et al , 1982a3 and, despite the Fact 
that densitometry has been used to make the test 
more objective (Milunsky and Sapirstein, ISS23, it 
remains at best semi-quantitative, requiring a 
considerable degree oF operator time and experience 
to produce reliable results. 
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In ccntrast, the quantitative measurement 
of AChE is rapid, simple to perform and easy to 
interpret (Smith, 1962) it is entirely objective 
and not operatcr-dependent. In addition, several 
reports support the view that it discriminates 
well between NTO and normal pregnancies COale at al, 
ISBI; Bonham et al, ISSI; Legge and Potter, 1983) 
and consequently its proponents have described 
this approach as "the method of choice" (Legge 
and Potter, 19633. 
It would appear a sensible view not to 
consider these techniques as competing alternatives 
but as complementary [Buamah at al, 1980). The 
objectivity, speed and simplicity oF the quantitative 
assay coupled with the ease oF automation allow 
this method to be used in ways in which the gel 
test could not be. For instance, it has been 
suggested that quantitative amniotic fluid AChE 
measurement could be completed and reported during 
an out patient visit, consequently allaying 
anxiety in cases where a favourable outcome could 
be assured CHullin at al, 19613. It has also been 
anticipated that AChE might in the future altogether 
replace AFP in the detection of NTO (Milunsky and 
Sapirstein, IS823. - In this situation the quantitative 
assay with its ease of automation would be a more 
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suitable procedure for large numbers of samples 
than gel electrcphcresis. 
Cn the other hand, the qualitative test has 
certain advantages in specificity, particularly in 
the Face of blood contamination. It would appear 
a reasonable approach to measure all samples 
quantitatively and then proceed to electrophoresis 
only in cases where the results were borderline 
or there was visible evidence of blood contamination. 
It has been one oF the aims oF this thesis 
to examine the diagnostic potential of the molecular 
heterogeneity of both AChE and BChE in amnictic 
fluid demonstrated by sucrose density sedimentation, 
which prior to this work had not been used in this 
context. It was anticipated that this would create 
a better understanding of both the "gel-test" and 
the quantitative assay by identifying the molecular 
species present in each case. If one particular 
form of the enzyme were demonstrated to be responsible 
for the increased activity of the quantitative 
assay and the additional band seen an the "gel-test1v 
this would form the basis for a new assay i. e. 
quantitative measurement ofthqt partilcular species. 
This would combine the advantages of both approaches. 
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16.3 AChE results from the samples under study 
The study Group consisted of 39 samples from 
subjects with known pregnancy outcome: 17 were 
normal, nine were affected by affected by anencephaly, 
seven by spina biFida, five by exomphalos and there 
was a single case of intrauterine death. The 
samples were chosen to include some with borderline 
AFP results: SSI AFP = 54/tg/ml and SSS AFP = 
48/tg/ml. It was in these cases that the identification 
of any new marker would be most rigorously tested. 
The results obtained in this group are 
shown in Table 9.1. ' It can be seen that 
there is a clear separation between groups with no 
overlap. These results are consistent with those 
of Dale et all CISS13; Bonham et all CISSil and 
Legge and Potterl CIS83] but are at variance with 
the recent reports of Aitken et all CISS43 and 
Wyvill, CISS43 and other workers CSeller et all 
ISSO]. It has been suggested that these differences 
may be attributable to "subtle method changes from 
operator to operator" (Legge and Potter, IS633. 
Alternatively, they may simply reflect a larger 
collection of samples with small lesions producing 
more borderline results. 
The AChE activity detErmined in normal, spina 
bifida and anencephalic groups are shown in Table S. I. 
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The means in each case are 3.5,6.7 and 15.2U/1 
respectively. The activity was significantly 
higher in the NTO cases, p<O. CCIC35. Taking into 
account minor methodological variations, these 
results compare well with the corresponding 
overall means obtained by averaging results from 
the literature shown in Table 4.2, these are 
2.9,6.1 and 11.6 U/1 respectively for the 
corresponding groups. The 3S samples in which 
molecular forms of AChE and SChE are to be 
identified can therefore be assumed to be 
representative of the population of samples 
normally encountered in routine detection of NTO. 
16.4 Automation of AChE assay in amnictic 
fluid 
It was stated in Section 16.2 that one 
advantage of the quantitative assay was its 
suitability for automation. This has been 
capitalised on by several groups (Lamedica at all 
1983; Moreau at all IS82; Wyvill at all 1964; Hay at all 
19S33 who have designed assays based upon dýfferent 
types -of CFA , an instrument widely used, as a means 
of routine enzyme analysis in clinical chemistry 
laboratories. 
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In addition to the saving in time when larce 
numbers of specimens are to be analysed, automation 
will also improve the precision of an assay. This 
is particularly important as early reports suggested 
that poor precision, possibly attributable to 
lack of Familiarity with the assay CSeller et al, 
1S803, was a problem. The results outlined in 
Section S. 1 obtained by the automated procedure 
and described in Section 6.1 showed excellent 
precision. The CV = 2.1% at 2. S U/1, was close to 
the CV of I. S% at 3.1 U/1 reported by Hay at al, 
CISS33, using a very similar procedure and better 
than the CV of S. 6% at 4.7 U/1 quoted by Wyvill at al, 
(19843 using a Multistat III CFA CIL Instruments 
Ltd]. The correlation between the manual and 
automated techniques was also excellent Cr = O. SS3. 
The flexibility of this type of procedure 
enables large and small batches of samples to be 
coped with. Up to 28 samples can be processed in 
less than 30 min and once reagents have been 
prepared, the analyser is capable of measuring up 
to 150 samples per hour. This type of adaptability 
would permit even the highest workloads from 
regionally based prenatal detection programmes to 
be accommodated. 
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Ccmpariscn between AFP and AChE in the 
detection cf NTO 
The availability of a simple, reproducible, 
automated procedure 
AChE brings with it 
amnictic fluid AFP 
Consequently, it is 
merits of these two 
each be applied. 
for measuring amnictic fluid 
the possibility of abandoning 
=omplately in favour of AChE. 
worth considering the relative 
approaches and how they might 
Intýarpretbtion of amniotýic fluid AFP 
msýasurement has ýhrý-ee main problem areas, CErock 
and Hayward, ISS03: Samples contaminated with 
fetal blood which give spuriously elevated AFP 
levels; pregnancies in which gestational dating is 
uncartain making interpretation of AFP [itself 
related to gestational age3 dubious; the 
observation that other fetal malformations, some 
of which are surgically correctable, are also 
associated with a clearly raised AFP concentration 
(Table 4.1, Section 4.4]. Despite these difficulties 
AFP has been extensively used for the past 13 years 
and several large studies testify to its effective- 
ness in practice, notably the Collaborative AFP 
Study (19793 where 13,940 Fluids were analysed and 
that of Milunsky, (19803 who described experience 
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with samples from 20,000 pregnancies. The detection 
rates quoted were SE*/'* and -05% respectively and the 
false positive rate for each corresponded to 0.5% 
and 1% . While these data appear acceptable, 
nevertheless, as the incidence of NTO in the 
population is low (0.2-0.3%; Alberman, IS76] this 
false positive rate could lead to as many incorrect 
as correct diagnosis (Editorial, Lancet, 19803. 
It is in this area of reducing the false 
positive rate of the AFP assay that the measurement 
of AChE has found considerable support. The report 
of the Collaborative AChE Study, CISS13 confirmed 
that AChE is capable of reducing the number of false 
positives by 94% while only decreasing the detection 
rate by 1%. It is true that ultrasound too, may 
have a contribution in this respect, however, it 
reduces the true positive rate to a greater extent 
than is the case for AChE (Collaborative AChE 
Study, 19813. As a result, and despite the range 
of alternative secondary tests to AFP which have 
been proposed, Read at al, [19e23 was led to conclude 
that, "the gel-test is the only suitable adjunct 
to AFP11 and Haddow and Miller, CISS23 arrived at 
similar conclusions. 
Quantitative measurement of AChE is simple, 
cheap, rapid, reproducible (Dale at al, IS79b3and 
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easily automated. The possibility was raised by 
Smith, A. D. at al Cla-7S] that it may eventually 
supplant AFF altogether, over which it displays 
several potential advantages: - 
Unlike AFP, AChE is derived predominantly 
from the nervous system and is likely to be a 
better marker for a fetal CNS abnormality. In 
this respect the actual results are somewhat 
disappointing CBrock, 19633, nevertheless, it is 
capable of differentiating abdominal wall defects 
such as exompahlos from NTO (Bonham at al, 19811 
which AFP is not. This is an important group of 
disorders in which the incidence is 12% of that 
shown by NTO itself (Collaborative AChE Study, 
19813, if left to term they are amenable to 
surgical correction, but if AFP alone is used as a 
guide these case's are prematurely aborted. 
Cholinesterase measurement is less affected 
by contamination with blood than AFP (Milunsky 
at all 19793, the "gel-test" is particularly 
resistant to interference from this source [Brock 
and Hayward, 1980]. 
The major advantage of quantitative AChE 
measurement compared with AFP is its independence 
of change with gestational age during the second 
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trimester [Bonham at all ISSI; Hodgson et all 1SGII. 
This enables one reference range to be used and 
avoids a major cause of interpretative difficulty 
with the AFF assay. 
The large amount of experience amassed with 
AFP measurement has sustained its position so far, 
as the primary marker for NTO. In addition, the 
use of maternal serum AFF screening programmes 
first suggested by Brock -at al, C 19733 also maintained 
the inertia of continuing with AFP measurement. 
There are no equivalently large studies using 
AChE and the most comprehensive reports that do exist 
concentrate an the "gel-test" [Aitken at al, IS84; 
Wyvill at al, ISS43. Such studies establish the 
use of the 11cel-test" as an adjunct to AFP. The 
eventual replacement of AFP by quantitative AChE, 
probably awaits the development of an assay directed 
toward that fraction of AChE activity derives from 
nerve tissue exposed as a result of the lesion. 
Before such an assay can be designed an 'INTO- 
specific" Form of AChE must be identified. 
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Section 17: Molecular forms of AChE and EChE 
in ammictic fluicl 
17.1 The importance of understanding the AChE 
forms present in amniotic fluid 
In order to gain a clear understanding of the 
interpretation of AChE results it is important 
to answer some basic questions relating to the 
nature and origin of the increased levels of the 
enzyme in the presence of NTO. It has been known 
for sometime that both AChE and BChE exist in a 
number of electrophoretically distinct Forms 
(Section 2.13. More recently, polymorphism 
based upon molecular size and distinguishable by 
sedimentation coefficient has been described, firstly 
in electric fish [Massoulig and Rieger, ISSSI and 
subsequently in mammals [Hall, IS731. Distinct 
quaternary structures have been proposed for each 
of these differently sedimenting forms., 
(Section 2.23. 
AChE is found to exist in at least six 
molecular forms including three globular species; 
GV G2 and 04 and three asymmetric species; A49 Ae 
and A 12' In man, CSF is found to contain soluble 
AChE corresponding mainly to the G4 Form [Massoulie' 
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and Son, ISE23, which is probably derived by 
direct secretion from me rve tissue (Scarsella 
at al, 
- 
IS793. By identifying the forms of AChE 
present in amnictic fluid in NTO affected pregnancy 
and comparing these with those known to occur in 
fetal serum and CSF, it may be possible to 
indicate the likely origin of the increased AChE 
activity . The potential effects of other 
interpretative difficulties could also be more 
accurately assessed, for example contamination 
by fetal or maternal blood. In addition a modified 
specific assay may be able to be designed leading 
to an eventual definitive test For NTO. 
17.2 Molecular forms of AChE identified by 
sucrose density sedimentation 
The results of the sucrose density sedimentation 
analysis performed on 39 
are described in Section 
17 from pregnancies with 
affected by anencephaly, 
five cases of exomphalas 
intrauterine death. 
samples of amnictic fluid 
10.1. The samples included 
normal outcome, nine 
seven by spina biFida, 
and a single case of 
In all samples from cases of NTD, but not 
normals, there was a prominent peak of AChE activity 
migrating with a sedimentation coefficient oF 10.3S. 
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Comparing this 
G4 -AChE in the 
it was assumed 
tetrameric, 04 
peak, there wei 
sedimenting at 
value with those described for 
literature CSecticn 2.2, Table 2.13 
that this peak corresponded to the 
form of AChE. In addition to this 
re also AChE species present 
5.5 and 4. OS. These were believed 
to represent G2 and GI respectively. Confirmation 
that these molecular Forms did indeed correspond 
to monomeric, dimeric and tetrameric AChE is 
described in Section 15.2, where it is shown that 
their molecular masses are approximately in the 
ratios 1: 2: 4. The five samples From pregnancies 
affected by exompahlcs showed small amounts of G 41 
which in all cases was less than that seen in the 
presence of NTO. The single case of intrauterine 
death, however, showed a markedly elevated level of 
G 4' possibly due to increased membrane permeability 
secondary to cell death. 
These results taken together, indicate 
the existence of an 'INTO -specific" Form of AChEj 
G 4' which is responsible For 60% of the AChE 
activity in the amnictic fluid of NTO affected 
pregnancies. The increase in G4 is statistically 
highly significant, p<0.001. There are also slight 
increases in GI and G2 in the presence of NTO but 
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these are less significant with p<0.05 and p<0.02 
respectively. 
It is not possible to directly ccmpare these 
results with those obtained elsewhere as sedimentation 
techniques have not previously been employed in 
this context. However, Biagicni et al, (10-64] 
comment upon the qualitative demonstration in 
amnictic fluid of a distinct band (corresponding to 
the 11secretory form" present in human CSF] separable 
by PAGE and characterised by the use of specific 
substrates and inhibitors. 
The demonstration by sedimentation of an NTD- 
ýspecific form of AChE is important for several 
reasons which will be discussed separately: 
il The existence of such a form could lead to 
the design of a more specific and sensitive 
assay. 
ii] Because eO% of the AChE activity accompanying 
NTO is attributable to one particular species 
this can be used to indicate the origin of 
the enzyme in amniotic fluid. 
iii) It enables direct comparison between the basis 
of the "gel-test" and quantitative techniques. 
This is discussed more fully in Section 17.3. 
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An NTO specific assay based on measurement 
cF G. -AChE 
Th-e potential advantages of such an improved 
assay for detection of NTO include: 
Increased Smecificit 
When the close association between amnictic 
fluid AChE and NTO was f irst noted it was anticipated 
that because AChE is derived from the nervous system 
it would prove a more specific marker for a fetal 
neural abnormality [Chubb et al, 1979 a]. This 
was later confirmed and there have been a number 
of reports suggesting that measurement of AChE, 
unlike AFP, will not give false positive results in 
the presence of some f etal abnormalities such as 
congenital nephrcsis [Brock and Hayward, ISSO; 
Collaborative AChE Study., 1261; Aitken at 
all IS84; Macri at all ISS13 and can differentiate 
abdominal wall defects from NTO lesions CBonham 
at all 1981; Dale at all IS81; Wald at all 19643. 
Despite this, measurement of AChE was proved 
somewhat disappointing with respect to its 
specificity toward NTO and this led Brock ClSe33 
to comment 11AChE does not contribute a great deal 
to the dif f erential diagnosis of f etal malf ormations". 
In addition, fetal blood staining in amniotic 
fluid can give rise to misleading results (Brock, 1983). 
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In this respect the "gel-test'? is less affected 
than the quantitative assay, Section 16.2, probably 
because it measures a specific secretcry form of 
the enzyme [Hodgson at al, ISSI; Biagioni at al, 
I SE343. 
In Section 10.1 it can be seen that if one 
particular form, G 4' associated with 
NTO alone, 
were measured, the specificity of the quantitative 
assay would be enhanced. Indeed, it is evident 
from the results shown in Section 10.2 that amnictic 
fluid from examphalos-affected pregnancies contains 
only traces of this form of AChE. 
In addition to increased specificity towards 
NTO malformations, assay of G4 would also exclude 
interference from AChE derived from other sources, 
such as the G2 found on erythrocyte membranes. 
Measurement of G4 -AChE would therefore be less 
affected by blood staining than measurement of 
total AChE activity. Nevertheless, problems may 
still be encountered by contamination with fetal 
plasma CEarlow et al, 1962b] known to contain 
G4 -AChE. 
In summary, quantitative assay of G 4- AChE 
would be expected to combine the specificity of 
the vIgel-test" with the objectivity of total 
AChE measurement. 
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Imoroved sensitivity 
While measurement of total AChE is already a 
sensitive means of detecting NTO, even in cases 
with borderline AFP results, measurement of G 4- 
AChE would further improve this sensitivity. The 
mean AChE level in NTO pregnancies in the 39 
samples studied was 3.6 x the mean level with 
normal outcome. The mean G4 -AChE in NTO affected 
pregnancies was 60 x that in ncrmals. This 
increase in sensitivity is particularly marked 
in borderline cases, e. g. SSI and SBS, with AFP 
results of 54 and 48 Itg/ml respectively. The 
total AChE in both. these cases was approximately 
2x the normal mean, whereas G4 -AChE showed an 
increase of 44 and 16 Fold respectively. 
From the Foregoing discussion it is clear 
that measurement of G4 -AChE improves both the 
specificity and the sensitivity of detection of 
NTO and should be accompanied by a decrease in 
both false positive and false negative results in 
practice. 
Possible means of selective G4 -AChE measurement 
While sucrose density gradient sedimentation 
allows identification and quantitation of G4 -AChE, 
this technique has limited practical value in routine 
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use, The centrifugation [approximately IS hcurs3, 
preparation of the Gradients, fractionation and 
subsequent assay of gradient Fractions are all 
lengthy procedures. It takes two full days to 
analyse only three amnictic fluid specimens and 
this precludes its use in the routine clinical 
chemistry laboratory. 
It is thereFore necessary to examine 
alternative means oF designing a suitable assay. 
Catalytically, the differences between GV r32, 
G4 are minor [Massouli'e, 1960). Consequently, it 
is unlikely that a sufficiently specific assay 
could be created by this approach. These species 
also show similar response to substrate 
concentration [Section 15.43, and there is little 
in the literature to suggest any other kinetic 
differences e. g. inhibitcr sensitivity. 
One interesting distinction between different 
forms is their sensitivity to heat denaturation 
(Edwards and Brimijoin, 19633. This is investigated 
in Section 15.3 and discussed more fully in Section 
20.3, results infficate that following incubation at 
49 0C for 30 min, GI activity is reduced by 50%, 
whereas G4 is reduced by less than 10%. While 
far from entirely selective, this will partially 
differentiate GI and G4 AChE. 
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From the evidence so far available neither 
minor catalytic differences nor differential 
behaviour toward heat denaturation, are sufficiently 
selective to allow the design of a specific assay 
for G4 -AChE. 
Two alternative approaches to this problem 
are density gradient PAGE and the preparation of 
monoclonal antibodies directed against individual 
AChE species. 
Density gradient PAGE will separate AChE 
molecular forms. However, the qualitative nature 
of this technique and the difficulty in 
automation make this method only marginally more 
desirable than conventional PAGE electrophoresis 
For routine use. 
Th'e-use of specific antisera to identify and 
differentiate AChE and EChE has been reported in 
the detection of NTO (Ncrgaard-Pederson, ISS2 
and Brock and Bader, ISE333. More recently, Brock at all 
(19851 has described a quantitative AChE technique 
using monoclonal antibodies: in this report the 
antibody was raised against erythrocyte AChE CG 23 
but cross reacted with the enzyme in amniotic 
fluid (predominantly G4 in the presence of NTO) 
and therefore does not offer any obvious advantage 
over enzymic determination of total AChE activity. 
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There have, hcwever, been several attempts 
CAbe et al, 1963; Taylor et al, 1964; Erimijcin 
and Mintz, ISEQ to produce monoclonal antibodies 
against individual molecular species of AChE. 
Taylor et al, CISSQ report antibodies with enhanced 
specificity towed G2 from the electric organ of 
Torpedo. Brimijoin and Mintz, CISS43. are currently 
endeavouring to raise specific antibodies against 
mammalian AChE. It is probable that selective 
measurement of AChE species will increasingly be 
approached in this way. Such assays are adaptable 
for routine diagnostic use and would offer specific 
quantitation of G4 -AChE for use with large numbers 
of sample. 
ii3 The cricin of AChE in amnictic fluid 
It has been suggested that in normal amnictic 
fluid, AChE activity is largely of placental origin, 
whereas in NTO the activity is enhanced by direct 
secretion from nerve trunks or by CSF leakage 
(Pilowsky et al, 1982; Smith, 19823. The results 
of this study support this hypothesis. 
It is known that the major form of AChE 
present in human CSF is a scluble. G 41 with a 
sedimentation coefficient of approximately 11.0S 
(Massculi'e and Son, IS823. This species also 
comprises the major form produced by nerve trunks 
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(Brimijoin, ISS33 and it is generally accepted that 
secretion by nerve cells is the means by which AChE 
activity is maintained in the CSF CBiaoicni at al, 
1-084; Scarsella at al, 197S]. 
Identification of G4 -AChE in the amnictic 
fluid of NTO affected pregnancies but not in normals 
indicates that the ultimate origin of the increased 
activity produced in NTO is nerve trunks. 
Not only is the enzyme of the same type as 
that secreted by nerves, but there is further 
evidence that the species present in amniotic fluid 
is indeed a secretory product. All membrane bound 
forms of AChE have their hydrodynamic properties 
altered, e. g. sedimentation coefficient, by the 
presence of Triton X-100, that is, they are "detergent 
sensitive" (Ercdbeck and Ott, ISS43. However, the 
secreted soluble Forms can include both detergent 
sensitive and insensitive components [Massoulie' 
et al, 19843. 
The results in Section 15.6 show that there is 
no difference between the S-value of G4 from amniatic 
Fluid whether it is measured in the absence or 
presence of 0.5% v/v Triton X-100. That is, this 
Form is detergent insensitive. These results are 
in accord with those of Ralston et al, ClSE353 who 
have purified a soluble G4 Form from fetal bovine 
serum and report that 1% Triton does not aFFect its 
sedimentation. 
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The available data therefcre suppcrts 
the hypothesis (Pilcwsky et al, ISS2; Smith, 1SE23 
that G4 in amnictic fluid is a soluble enzyme 
secreted from nerve trunks. 
These findings provide a firmer theoretical 
basis Ypon which to understand and interpret AChE 
results in the prenatal detecticn oF the disease. 
17.3 Polyacrylamide gel electrophoresis oF 
amniatic fluid 
The most widely used method oF measuring AChE 
activity in amnictic fluid for the detection of NTO 
is "gel-test" (Section 4.4]. 
In order to compare the sedimentation datas 
(Section 10.13, with this method cF demonstrating 
AChE heterogeneity, G4 prepared by density gradient 
sedimentation was subjected to electrcphcresis 
on 5% PAG by the method oF Euamah, [19603 used in 
the detection of NTO. In addition amnictic 
Fluid samples from two cases of exomphalos, spina 
bifida and anencephaly and three samples from normal 
pregnancies were analysed in the same way. 
The gels were stained and subsequently scanned 
in a laser densitometer, CSection 7.43 and the 
results are shown in Fig. 10.7. 
The amniotic fluid specimens from NTO affected 
pregnancies revealed a distinct band of AChE which 
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was absent in those with normal outcome or those 
affected by exomphalas. It can also be seen that 
this NTO-band occupies the same position on the cel 
as G4 -AChE prepared by density sedimentation [Fig. 10.73. 
It is therefore probable that the basis of the 
success of the "gel-test" is measurement of G4 -AChE. 
Larger membrane bound forms of AChE would be 
excluded from the gel [Webb et al, ISE313. However, 
other globular forms GI and G2 enter the gel. 
Because separation is on the basis of net charge and 
as these forms have similar charge characteristics, 
they may occupy the same position on the gel as G 4* 
It is probable that AChE activity in the "gel 
test" in cases of NTO results from G4, but the 
possibility of interference from other globular forms 
cannot be excluded. The test therefore may be less 
specific than measurement of G4 alone. 
17.4 Butyrylchclinestere3se in amnictic fluid 
There have been several studies reporting the 
useFulness oF total cholinesterase CAChE + BChE3 
measurement in the detection oF NTO CMilunsky et all 
1979; Oale et all 1981; Zeisel et all 1960; Lawton, 
1981; Hodgson et all 1981; Coombes; et all 1962). 
Among the advantages claimed are simplicity 
(Milunsky et all 19791 and the avoidance oF toxic 
inhibitors (Zeisel et all 19603. There is also some 
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evidence that the assay improves the sensitivity of 
detecticn cF NTO CLawtcn, ISSII. 
EChE exists in a series of molecular forms 
homologous with those of AChE (Brimijoin, ISS33. 
The heterogeneity of EChE in amnictic fluid of 
normal pregnancies and those affected by NTO and 
excmphalos is shown in Fig. 10.8. The results 
indicate that the increased activity seen accompanying 
NTO is largely attributable to the tetrameric, G4 
form of the enzyme. Unlike AChE this species is 
also increased in the presence of exomphalos, 
(Fig. 10.63. G4 -SChE is also present in high 
activity in both maternal and fetal sera (Lockridge 
et al, 1979). It would be anticipated that 
measurement of EChE or total cholinesterase activity 
CAChE + EChE) would be less specific than AChE 
alone in the identification of NTO and the exclusion 
of other fetal malformations. In addition it would 
be more liable to false positive results arising 
due to contamination with f etal or maternal blood. 
These views are supported by Davies et all 
(19793 who concluded that, if cholinesterase 
measurement is to be of any value in the detection 
of NTO it must be carried out using specific 
inhibition of the SChE fraction. The findings of 
I 
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Hodgson at al, CIES13 reflect the validity of 
this statement, they report that while EChE 
activity is increased in 11-he presence of NTO 
nevertheless it is a less useful marker than 
either AChE or AFP. 
Despite the evidence that BChE alone provides 
only poor detection of NTO and its theoretical lack 
of specificity in the presence of other fetal 
malformations or blood contamination, nevertheless 
its measurement may still occasionally prove 
valuable. For instance, a marked increase in 
BChE activity accompanied by a marginal increase in 
AChE, is very suggestive of contamination with either 
fetal or maternal plasma. Bonham at al, CISSII suggest 
that in cases of exomphalos Cwhich has an associated 
leakage of fetal plasma] the quantitative assay of 
EChE and AChE produces a ratio of greater than 10: 1. 
Similarly, quantitative densitcmetry has been used 
in the "Gel-test" to calculate the ratio of the 
densities of BChE and AChE bands. Goldfine at al, 
(1983b3repcrts this to be greater than 7: 1 in cases 
of excmphalcs and gastroschisis. This was further 
substantiated by Wald et al, (19e4l who reported 
ratios of grater than 10: 1 in these cases. Contamination 
with serum can also be detected by this means, where 
similarly high BChE: AChE ratios are produced (Peat 
and Brock, 1983; Barlow at al, 19843. 
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17. E Summary of the findings in the study of 
amnictic fluid 
In summary, the results [Section 10. il 
represent the first reported description of AChE 
molecular forms in amnictic fluid distinguished an 
the basis of their sedimentation coefficients. 
Three globular Forms were identified corresponding 
toG V 62 and 04 -AChE, asymmetric forms of the 
enzymes were not apparent. 
G4 -AChE was shown to be closely linked with 
the presence of NTO and can be regarded as 'INTO- 
specific" in this context (Bonham et al, 1963; 
Bonham and Dale, iSSSb3. It was found that the 
basis of both existing approaches to the detection 
of NTO using AChE, namely, the "gel-test" and the 
quantitative measurement of the enzyme, relied upon 
the increase in this particular species. The 
identification of this marker may well form the basis 
of a much improved diagnostic assay For NTO, when 
appropriate methodology becomes available. 
The G4 -AChE has the same characteristics as 
the major form of AChE found in CSF and also the 
predominant species secreted by nerve tissue. The 
data therefore support the widely held view that 
the exposed nerve tissue gives rise to the increased 
AChE activity in NTO. 
- 293 - 
EChE, an the other hand, is shown to be a 
less specific indicator of NTO as the particular 
f crm of the enzyme associated with NTO is also 
present in amnictic fluid from normal pregnancies 
and in fetal and maternal plasma. 
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section ie. Measurement of rectal biopsy AChE in 
the cliacncsis cF Hirschscrunals Disease 
1EB. I Diaoncsis cf Hirschsprunals disease 
Hirschsprung's disease is said to be the 
commonest single cause of admission to hospital 
for obstruction in the newborn period [Jones, 19703. 
The disease which occurs in approximately 1: 5000 
live births shows a male preponderance of 4: 1 
[Lavery, IS83; Section 3.3]. Once diagnosed its 
surgical co. rrection is both safe and effective, 
CSection 3.73. However, if the condition remains 
untreated during childhood, there is a gradual increase 
in the degree of constipation and a progressive 
distention oF the abdomen. In addition, entercolitis, 
which develops in 15-2S% of patients by the time of 
diagnosis CKleinhaus et al, 1979; Ikeda and Goto, 
ISS43 is a particularly dangerous complication with 
a 30% mortality CKleinhaus et al, 19793. If the 
incidence of entercolitis and its complications are 
to be effectively diminished, the diagnosis of 
Hirschsprung's disease must be established during 
the first month of life CKleinhaus et al, 19793. 
It is For this reason, and to avoid a potential 
period of chronic ill health, that interest has been 
ccncentrated cn establishing a safe and reliable 
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means of diagnosis that can be used in the newborn 
period. 
The techniques employed, which already have 
been described [Secticns 3.6[iD-Cvil have included 
a3 Radiology, rarely diagnostic by itself, is 
particularly difficult to interpret early in life 
(Lavery, 19S33. It is nevertheless a valuable 
additional investigation which can often give a 
measure of the length of the affected segment. 
b] Rectal manometry, introduced by Schuster 
at al, (19653 depends upon the demonstration of an 
abnormal response of the internal anal sphincter 
towards rectal distention produced by inflation of 
a balloon in situ. This widely used technique 
[Ikeda and Gctc, ISS43 has an established place 
as a diagnostic test in assessing rectal function 
[Davies at al, ISS13. It may however, be unreliable 
in the newborn period and requires a high level of 
operator skill to produce acceptable results. 
Recent technical developments in manometric detection 
equipment may avoid some of these problems (Tamate 
et al, ISS41 but at present this method cannot be 
depended upon as the sole means of diagnosis. 
cl Histological demonstration of the absence 
of ganglion cells in the affected segment is the 
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definitive technique. However, it requires full 
thickness biopsy and therefore is accompanied I=y 
the operative risks of an anaesthesia and tissue 
scarring which may prejudice further corrective 
surgery [Lake et al, IS783. It is therefore not 
a suitable screening test in the constipated 
neonate. 
d] The hazards encountered in obtaining a full 
thickness biopsy led Bodian, [19603 to suggest 
the use of mucosal biopsies to establish a 
histological diagnosis, this was accompanied by 
the disadvantage that such small samples, often 
produced equivocal results. Consequently, when 
Meier-Ruge, (19723 reported the demonstration of 
hypertrophied [cholinesterase-staining] nerve 
trunks as a recognizable Feature in suction biopsy 
specimens From the affected segment, this quickly 
became a widely adopted diagnostic procedure 
CChow at all 1977; Lake at all 1976; Patrick at all 
1980; Ardrassy at all 1981; NezloF at all ISSI; 
Kawakami, 1981; Hamoudi at all 1982; Veregas at all 
1982; Planet at all 1982; Lake and Claireaux, 1983; 
Ziegler at all 19643. False positive and False 
negative results do occur but these rates are 
acceptably low, 4.2% and 6.3% respectively (Table 3.13. 
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The majcr prcblems with the histcchemical 
approach are, its subjective interpretation, the 
number of equivocal results due to poor biopsy 
I 
specimens [6.9, %, Table 3.13 and the occasional 
need to resort to full thickness biopsy in some 
atypical cases [Coker-Huntley at al, ISS23. 
e3 It was in an attempt to overcome some of these 
drawbacks that Boston at al ,C 19753 used a direct 
method of quantitating the level of cholinesterase 
activity present in homagenates of rectal biopsy 
specimens. This has proved to be a simple, reliable 
and objective means of diagnosis. In particular 
the test is not dependent on the subjective 
interpretation required by qualitative histochemistry. 
A criticism of the method, levelled by Lake at all 
C19723, has been that the nature of the sample (i. e. 
whether it contains mucosa, submucasa, lymphaid 
follicles, etc3 remains unknown. In the studies so 
Far reported COale at all 1977; Dale at all 197Sa; 
Eajgar and Hak, 1979; Patrick at all 1980; Yangihara 
at all 1983; Rakonczay and Nemeth$ 1984; Bonham at all 1965c] 
this does not appear to have affected the usefulness 
of the test and it is doubtful whether this theoretical 
difficulty is. a significant practical problem. 
Nevertheless, it is part of the work of this thesis 
to include a larger series than any previously reported 
and comment further on this and other aspects of the 
assay. 
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F) In order to determine whether this increase 
in rectal tissue AChE is reflected by an increase 
in plasma and erythrocyte AChE activity-, several 
groups have measured the enzyme in these locations. 
The results have proven inconclusive; some groups 
have reported an increase in both plasma and 
erythrocyte. AChE activity [Boston et al, 19783, 
whereas others could demonstrate an increase in 
only one of these (Okasara et al, 1983; Ya-xiong, 
19843, Yanaoihara et al, [1993] found no 
increase in -either. The most recent report 
(Bamforth, 19853 could demonstrate no increase 
in erythrocyte AChE. At present there is no 
known link between ertythrocyte AChE and any local 
alteration in a disorder clearly limited to the 
distal gastrointestinal tract. It is unlikely 
that these results will have anything concrete 
to add to the diagnosis of the disease. 
The most promising diagnostic procedures 
are those using rectal suction biopsy specimens 
combined with both histochemical and quantitative 
AChE assays. These methods rely upon a less 
invasive technique than those requiring a full 
thickness biopsy and at the same time provide more 
accurate diagnostic information than either radiology 
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or manometry. They can be performed on an 
outpatient basis and give rapid and reliable 
results. It would be beneficial - firstly, to 
assess the benefits and limitations of tests of 
this kind in practice and secondly, to improve 
their existing performance. 
18.2 Measurement of rectal suction biopsy AChE 
There have been several large studies reporting 
the usefulness of the histochemical assessment of 
AChE activity in rectal biopsy specimens, notably 
a recent report by Lake and Claireaux, [19e3l 
included results from 600 patients. However, while 
quantitative AChE measurement is becoming widespread, 
[Section 3.6(v@ the largest series so far recorded 
comprised only 110 patients of which only nine had 
prcven Hirschsprung's disease (Patrick et al, ISSO). 
Therefore, it was decided to collect the data 
from the routine measurement of AChE in rectal biopsy 
specimens in this laboratory and compare these 
results with the eventual diagnosis arrived at in 
each case. 
18.3 Analysis of results from a series of 213 
patients 
The study group, collected over a seven year 
period (1976-19833 consisted oF 213 children aged 
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between two days and 13 years presenting with 
chronic constipation or failure to pass meccnium. 
Of -these, 164 cases were subsequently found not to 
have the disease and showed histological evidence 
of ganglion calls. In 45 casesl Hirschsprung's 
disease was confirmed by histological criteria and 
corrective surgery carried out in each case. 
The results of AChE measurement in these 
patients are shown in Section 11. There was a 
fiye-fold increase in AChE activity in the Hirschsprung's 
disease group when compared with the non-Hirschsprung's 
mean. This increase in AChE activity can also be 
reported as % AChE, i. e. AChE activity expressed 
as a percentage oF the total cholinesterase 
activity. As BChE remains relatively constant, 
% AChE increases when the AChE level is raised. An 
advantage.. of this. method of reporting AChE activity 
is its relative insensitivity to evaporative water 
loss from the biopsy specimen. A probable disadvantage 
is its expected imprecision compared with AChE alone, 
resulting from incorporating both the variation in 
both AChE and total cholinesterase estimation used 
in its calcLiation. AChE is thereFore more reliable 
when evaporative losses can be minimised and % AChE 
when this is difficult to avoid (for instance 
with very small biopsy specimens]. The mean AChE, 
- 301 - 
6.6 U/1, obtained from the present study group 
compared well with those reported earlier by 
Dale et al, [IS77 and 10-7Sal of 6.3 U/1 and 5.0 U/1 
respectively. 
Combining AChE and % AChEj in the interpretation 
of biopsy results improves the overall diagnostic 
accuracy of the test (Fig. ll. i3. In this way four 
grcups are generated: 
Group I: AChE and % AChE elevated (greater than 
2SO ebove the mean3 
Group 2: AChE elevated, % AChE normal 
Group 3: AChE normal, % AChE elevated 
Group 4' : Both AChE and % AChE within normal limits 
Group I is regarded as suggestive of Hirschsprung's 
disease, groups 2 and 3 as equivocal and group 4 as 
normal. On this basis the diagnostic sensitivity of 
the test is 73% and its specificity 100% [Section 113. 
The assay is therefore useful in identifying the 
disease in a group of chronically constipated 
children. On this evidence it will not wrongly classify 
normal children as having the disease, that is the 
false positive rate is zero. Equivocal results 
account for approximately 10% of specimens analysed 
and in these cases the test should be repeated 
oradditional evidence sought. 
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Sampling problems can produce misleading 
results in both histcchemical and quantitative AChE 
assays; among these are included superficial biopsy 
and specimens taken proximal to the affected region 
in short segment disease [Coker-Huntley et al, 19623. 
In the present series Four subjects gave discordant 
results. Of these two proved to have a very short 
affected segment and it is likely in these cases that 
the normal ganglionic region was biopsied. This is 
an acknowledged difficulty and frequently leads to 
the disease being missed in such patients [Orr and 
Scobie, IS833. 
In a further case in which a false negative 
result was recorded this was probably due to a 
superficial mucosal biopsy in a patient where the 
densely staining cholinesterase positive nerve 
fibres, characteristic of the disease did not extend 
into the lamina propria. 
The remaining biopsy sample with unexpected 
results was obtained from a patient in whom only a 
marginal increase in the number of nerve Fibres was 
visible despite clear aganglionosis. This may reflect 
an atypical underlying pathology and emphasises the 
requirement advocated by Morikawa et al, [19791 to 
perform conventional Full thickness biopsy where 
unusual pathology is suspected. There are several 
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such conditions including, hypaganglionosis, chronic 
adynamic bowel, colonic neuronal dysplasia, 
immature ganglia, abncrmality of the argyrcphil 
plexus and acquired aganglionosis secondary to 
ischaemia; these are reviewed by Nixon and Lake, 
19S2. 
The series reported here, the largest so far 
recorded, ccnFirms the value of quantitative AChE 
measurement-in the diagnosis of Hirschsprung's 
disease. It is simple and rapid [taking less than 
30 minutes From receipt of the sample3 and produces 
quantitative results not open to subjective 
interpretation (Oale et al, 19773. In this hospital 
it is used in conjunction with histochemistry and 
our Findings agree with those of Patrick et al, 
CiSSOI that the two techniques are useful complimentary 
procedures. Satisfactory results are obtainable an 
specimens as small as I mg and such samples can be 
provided by suction biopsy performed without the 
need for anaesthetic. In addition the results are 
found to be reliable in the neonatal period. On the 
basis of these results this test will continue to be 
of great value in the diagnosis of a potentially 
lethal disease among a relatively large population 
of chronically constipated children. The safety of 
the procedure permits its increasing use in neonates 
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as a means of excluding the possibility of 
Hirschsprung's disease, this in turn should avoid 
the development of entercolitis with its attendant 
high risk of mortality. 
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Section ls: Molecular Forms cF AChE and EChE in 
rectal tissue_in Hirschscrunals disease 
IS. 1 The importance of determining the heterogeneity 
of AChE forms present in rectal tissue 
The measurement of AChE in rectal biopsy 
specimens has proved to be invaluable in the diagnosis 
of Hirschsprung's disease. The histochemical 
demonstration of enzyme activity has been in. wide- 
spread use for almost fifteen years and the quantitative 
assay, using the methodology as outlined in the present 
research project has gained increasing popularity. 
Despite the established importance of these 
assays and the well known heterogeneity of AChE9 few 
reports have addressed themselves to the problem of 
identifying the particularfoms. of AChE increased in 
Hirschsprung's disease. Eajgar and Hak, CIS793 
described the presence of an extra-band of AChE 
activity in aganglionic rectal tissue homagenates 
when subjected to polyacrylamide gel electrophoresis; 
they went further to suggest that this finding might 
be "diagnostically useful". However, at the commence- 
ment of the present work, no reports existed describing 
the structural heterogeneity of AChE by density 
sedimentationor related techniques. 
NA 
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Knowledge of the forms of AChE responsible 
for the increase in AChE activity in Hirschsprung's 
disease would be expected to improve the under- 
standing of the assay currently used, leading to a 
further improvement in specificity based upon the 
measurement of species selectively augmented in the 
disease. There already exists strong histochemical 
evidence that the increase in AChE activity is due 
to nerve trunk hypertrcphy. In addition G4 -AChE 
is known to be the major form of the enzyme 
associated with nerve trunks (Brimijoin, 19833. 
It was therefore hardly surprising that during the 
period of this study Hakonczay and Nemeth, [19843 
were able to demonstrate an incre. ase in IOS CG 43 
AChE accompanying aganglionosis and nerve trunk 
hypertrophy in rectal biopsy specimens from patients 
with Hirschsprung's disease. 
The results discussed here conFirm and extend 
these Findings by documenting the variation in the 
activity oF AChE and BChE species in resected 
segments oF bowel From aganglionic and normal 
(ganglionic] regions. The ease oF extraction and 
the detergent-sensitivity oF these Forms are also 
discussed and this provides evidence indicating 
their likely cellular location. 
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IS. 2 Patients involved in the study 
Segments of terminal howel were obtained at 
operation From six patients, four showed a clear 
transition From normal (ganglionic3to aganglionic 
regions. In one oF the remaining two cases the 
entire colon was uniFormly aganglionic [long 
segment disease3 and the other contained ganglia 
throughout its length Canindependent control 
specimen3. 
In each case where the proximal region was 
ganglionic this provided a normal control tissue 
and was preFerable to comparison with bowel taken 
from patients without the disease, as it more 
closely defines the changes arising secondarily to 
aganglionosis and excludes individual variation. 
The single case without evidence of Hiri6chsprungls 
disease acted as an independent control. 
The specimens were divided transversely 
into a varying number of segments -and longitudinally 
into three strips, which were used for histological 
and histochemical assessment and for measurement 
of AChE and BChE molecular f orms. Therefore direct 
comparison between these three methods at each point 
along the sample was obtained. Further dissection 
was also necessary in some cases to separate 
muscle and mucosal layers. In all, 65 sections 
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were analysed by density gradient sedimentation, 
a considerable task For which autcmated AChE and 
BChE assay-was clearly desirable. 
iS. 3 The variation in AChE molecular forms in 
resected bowel segments 
In all cases, four forms of AChE were identifiable 
with sedimentation coefficient of 16.8,9.21 5.0 and 
3. SS. These were believed to correspond to A 12' G41 
G2 and GI respectively. It was demonstrated that 
the molecular mass of these forms was in keeping 
with this assumption, i. e. 11.6 : 4.0 : 1.9 : 1.1 
respectively [Section 15.23. 
There was a4 to 14-fold increase in the 
activity of G4 -AChE in both the muscle and mucasal 
layers, in the presence of aganglionasis when 
compared with the proximal ganglionic region. 01, 
G2 and A 12 showed no consistent changes. 
The magnitude of the change of G4 in the 
muscle layer, was greater than that in the muccsal 
layer [Fig. 12.23. In each case the variation was 
related to the transition from ganglionic to 
aganglionic region and corresponded to the change 
from the presence of normal nerve trunks into a 
region of distinct nerve trunk hypertrcphys typical 
of Hirschsprung's disease. The independent control 
case showed no evidence of consistent variation 
in any of the molecular forms. 
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These f indings agree with those oF Rakonczay 
and Nemeth, CISS43 who reported a relative 2.5 
fold increase in ICE EG 43 AChE in biopsy specimens 
from the aganglionic region compared with normal 
controls. They attributed this increase to the 
proliferation of nerve Fibres in the affected 
region. The technique which they employed did not 
however, adequately separate GI and G2 forms nor 
identify A 12 AChE. Consequently, the results 
cannot be compared directly with those presented 
here. Their report is also unclear.. about the total 
number of patients included in the study but there 
were not more than three with the disease. 
In the present study, it was not possible From 
the f our cases in which the disappearance of nerve 
trunk hypertrcphy coincided with the end of the 
aganglionic region to establish whether the observed 
increase in G4 AChE was due directly to aganglionosis 
or produced as a consequence oF the nerve trunk 
hypertrophy. The variation in G4 AChE activity 
in the segment of bowel resected from the patient 
with long segment disease [Fig. 12.4) helped 
resolve this uncertainty. 
The extrinsic sacral innervation which gives 
rise to the hypertrophied nerve trunks seen in 
Hirschsprung's disease (Okamoto at al, l9e23 is 
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confined to the distal colon and rectum. 
Consequently, while distally, acanclicnosis is 
accompanied by nerve trunk hypertrophy, in more 
proximal regions this is not the case. The 
transition in innervation occurs distal to the 
splenic flexure [Lake and Claireaux, IS63]. It 
can be seen from Fig. 12.4 that the level of 
G4 -AChE activity closely follows the transition 
from the region where thickened nerve trunks 
are visible to that, where, despite continued 
aganglionosis, they are no longer *evident 
indicating that nerve trunks are indeed the source 
of 04 -AChE. 
There is reliable histochemical evidence 
that in some cases of long segment disease, distinct 
nerve trunk hypertrcphy may even be limited to 
rectum alone. Consequently AChE measurement in 
the diagnosis of Hirschsprung's disease from 
biopsy specimens obtained proximal to the recta- 
ýiigmoid junction should be interpreted with caution. 
Nor should AChE measurement be used to assess the 
limit of aganglionosis in long segment cases For the 
purposes of corrective surgery. These limitations 
apply to both quantitative and histochemical assays 
of AChE activity. 
The gradual decline in the number of AChE- 
positive nerve fibres occurring between the rectum 
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and splenic flexure in Hirschsprung's disease 
CMeier-Ruce et al, IS723 is associated with the gradual 
decline in G4 -AChE [Fig. 12.43 - offering support 
for the proposed caudal-cranial direction of 
extrinsic sacral parasympathetic outflow postulated 
by Garret et al, (196S3. 
In two of the cases examined there was 
evidence that GI activity was slightly increased 
in the aganglionic region CFigs. 12.4 and 12.53 
these changes were however less consistent than 
those seen in G 4' It is probable that the changes 
in GI were secondary to those of G4 and simply 
represented an accumulation of a precursor or 
dissociation product of G4 -AChE. 
Itis suprising that the level of A 12 -AChE, 
present at synaptic junctions, was not altered in 
the aganglicnic region, where ganglionic synapses are 
absent. The maintenance of A 12 activity might well 
be attributable to the existence of synaptic 
junctions between the extrinsic parasympathetic 
nerve fibres and the smooth muscle of the gut wall. 
The level of A 12 AChE was however less than 2 U/1 
[the minimum recommended for reproducible 
quantitation, Section 7. IC! x3, so that a more sensitive 
means of detection must be employed before any firm 
conclusions can be drawn. 
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19.4 The sicnificance of increased G. - AChE 
in diaancsis of Hirschsprung's disease 
The distal enteric nerve plexuses are largely 
self regulating but their action is modified by 
extrinsic efferent nerves of sacral origin. In 
Hirschsprung's disease the normal plexus structure 
degenerates and inýermediary neurones and ganglia 
are absent (Fig. 3.3] and the extrinsic nerve 
Fibres ramify throughout both muscle and mucosal 
layers and even extend into the lamina propria. 
The increase in G4 -AChE acts as a specific 
marker for this extrinsic nerve trunk hypertrophy 
and is largely responsible for the increase in 
total AChE activity which can be assessed both 
quantitatively and histochemically. 
This information provides a clearer insight 
into the basis and limitations of AChE measurement 
in the diagnosis of Hirschsprung's disease. The 
detection of the disease can only be made using 
biopsies obtained from regions of nerve trunk 
hypertrophy where G4 -AChE is consequently increased. 
This excludes the use of AChE measurement in 
diagnosis of long segment Hirschsprung's disease 
from biopsies made proximal to the sigmaid colon. 
In addition, in a substantial proportion of cases 
(Chow et al, 1977; Coker-Huntley et al, 19621 the 
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thickened nerve trunks do not extend into the 
lamina propria, in these cases, superficial bicpsy 
may result in a false negative result. 
The means of designing an assay to determine 
04 -AChE selectively is discussed in Secticn 17.2. 
This would improve the specificity of the existing 
total AChE assay in identifying Hirschsprung's 
disease cases. Erythrocytes, inevitably contained 
within the biopsy specimen must contribute to the 
total AChE activity, despite centrifugation. 
Measurement of G4 -AChE wculd, howeveq be unaffected 
by this interference, as erythrocytes contain mainly 
G. -AChE. Structures such as lymphoid follicles 
known to contain some AChE activity (Lake at al , 19793 
would be less likely to affect the determination of 
one specific form of the enzyme. This might answer 
a theoretical criticism of the quantitative assay 
that, in contrast to the histochemical assay, the 
source of the AChE being measured cannot be -visualised 
CLake et al, 19793. 
The relative increase in G4 -AChE activity in 
the aganglionic region is greater than the increase 
in total AChE. Consequently, measurement oF G4 alone 
will improve the sensitivity of detection of the 
disease and reduce the false negative rate (currently, 
4.4%]. 
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The clinical presentation of Hirschaprung's 
disease is very variable and it is not possible to 
correlate the decree of intestinal obstruction 
simply with the length of affected bowel [Bodian 
et al, IS491. There have been several reports to 
suggest that the severity of obstruction correlates 
with the number of nerve fibres visible in the 
aganglionic region (Garret at al, 19693. The 
greatest number of AChE positive nerves are found 
in the circular muscle of distal aganglionic bowel 
from those children who had required a colostomy 
for severe intestinal obstruction in the neonatal 
period (Garret et al, ISE93. Measurement of G4 -AChE 
provides a direct quantitative means of assessing the 
decree of nerve trunk hypertrophy and the results 
can therefore be used not only to detect the 
disorder but also to- indicate its severity and the 
urgency of surgical intervention. 
In addition to these benefits G4 -AChE 
determination will also be oF value in helping to 
classiFy a variety oF conditions which present in a 
similar way to Hirschsprung's disease. These 
include, neuronal colonic dyplasia, chronic adynamic 
bowel, hypoganglionosis, immature ganglia, abnormality 
oF the argyrophil plexus, acquired aganglionasis and 
segmental aganglionosis [Lake and Nixon, 19e2]. 
Some oF these disorders, notably acquired- and 
segmental-aganglionosis are poorly understood. 
-315 - 
Having established a direct quantitative marker for 
nerve trunk hypertrcphy distinct from agan-clicncsis, 
this canncw be used to objectively assess chances 
in these disorders and to improve the understanding 
of the underlying pathophysiological changes in 
these cases. 
19.5 Oifferential extraction of AChE forms 
While it is clear that an increase in 04 -AChE 
activity is closely linked to the development oF 
nerve trunk hypertrophy, it is not obvious whether 
this form of the enzyme is bound to the nerve fibres 
or is a soluble, secretcry product. The sections 
from a segment of bowel containing both ganglionic 
and aganglionic tissue were subjected to mild 
homogenisaticn in pH7.3 phosphate buffer, followed 
by a more rigorous extraction with a buffer 
containing Triton X-100 [Fig. 12.53. There was a 
substantial amount of activity which was only 
released by the presence of detergent. This could 
be attributable to two distinct, but not mutually 
exclusive causes: - 
1. Triton, might simply help the dissociation 
of tissue Fragments during homogenisation 
and therefcre enhance the release oF already 
soluble enzyme. 
2. Triton may actually be responsible for 
the release of membrane bound enzyme. 
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To investigate this further, repeated hcmcgenisation 
was performed using three buffer systems, [Section 
12.73. This included successive homo-cenisation of 
tissue in Hanks medium, pHe. o phosphate buffer and 
finally buffer containing 1% w/v Triton. These 
experiments indicated that approximately SO% of the 
activity of all AChE forms are released by thorough 
homogenisation in a physiological buffer such as 
Hanks medium, and can therefore be regarded as 
soluble. However, thEre remains a proportion of 
AChE, which despite homagenisation twice in this 
media, followed by repeated homagenisation in pH8.0 
phopshate buffer, can only be released by the 
presence of Triton and can therefore be presumed to 
be membrane bound. In the case of G4 -AChE this 
accounts For approximately 30% of the total 04 activity. 
These findings are in accord with the proposal of 
Ka'sa and Rakonczay, (19823 that IOS AChE is associated 
with the external surface of the axolemma and has 
a substantial membrane bound component. 
The results indicate that the determination 
of AChE in the diagnosis of Hirschsprung's disease 
would be improved by inclusion of a detergent such 
as Triton to release membrane bound activity. 
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19.6 Triton reactivity of AChE forms in rectal 
tissue 
AChE exists in both Tritcn-reactive and non- 
reactive forms CMassoulli'e, ISS03. This can be readily 
demonstrated by the shift in S-value which occurs 
during sedimentation performed in the absence and 
presence of Triton [Lazar and Vigny, IS603. 
While all Forms requiring Triton For their 
release are Triton-reactive, soluble species may or 
may not be (Massoulli'e' et al, IS843. 
In amnictic Fluid the soluble AChE molecular 
Forms are Triton-insensitive [Section 17.23. AChE 
released from rectal tissue behaves somewhat 
differ. ently. Those forms, which are clearly membrane 
bound and released only by Triton, show a marked 
Triton reactivity (Section 15.53, the S-value of G4 
changing from 9.4 - 11.3S when the detergent is 
omitted [Fig. 15.73. - 
The enzyme released by O. IM pH8.0 phosphate 
buffer is also Triton-reactive, although in this 
case the shift in S-value of G4 S'S to 10'SS is less 
than that of the Triton extractable species. This 
may reflect a mixed population of G 41 including 
Triton-reactive and non-reactive forms. In this 
respect the G4 of rectal tissue is different from 
that found in amnictic fluid. This difference 
might indicate post-release modification of AChE 
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while in the amnictic flud, including proteolytic 
removal of -the Triton binding site [Outta-Choundhury 
and Rosenberry, ISS43. Alternatively, G4 in rectal 
tissue may be intrinsically different from that which 
is being secreted into, the amniotic Fluid. It is 
important to remember that the aganglionosis of 
Hirschsprung's disease represents a pathological 
state. The structure of the neural matrix is 
completely disrupted and extrinsic nerves present 
in the tissue are hypertrcphied. Consequently, the 
release of AChE may itself be disturbed, resulting 
in the secretion of immature molecular Forms of the 
enzyme. In order to resolve thisý comparison 
between the Triton sensitivity of AChE species 
in normal and acanglionic rectal tissue would be 
required. 
IS. 7 The effect of endogemous proteases on AChE 
molecular forms 
The distribution oF molecular Forms oF AChE 
obtained from skeletal muscle extracts can vary 
as a result of endogenous protease digestion 
[Silman et all IS78; Lyles et all IS82; Barnard 
et all IS643. In particular larger species can be 
converted into f orms of smaller molecular mass. In 
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order- to test the effect of protease dicestion in 
rectal tissue, minced tissue was homc-cenised: 
a3 Immediately in the presence of a cocktail of 
protease inhibitors [Barnard et al, ISe43. 
b3 Following a Four hour incubation at room 
temperature in a moist environment without 
such inhibitors., 
The resultsp Section 12.6, show a similar 
distribution of molecular forms, with no loss of 
G4 activity in favour of G, * Endogenous protease 
digestion of larger AChE species does not occur 
to any great extent in rectal tissue. Minor eFf ects 
occurring between surgical removal and storage in 
liquid nitrogen cannot be excluded, but this 
evidence indicates that s uch changes would be 
small and not materially alter the interpretation 
of the present data. 
1S. E3 BChE forms in rectal tissue 
BChE is present in rectal tissue, where 
normally it accounts for almost half of the total 
cholinesterase activity [Dale at al, 1977,1979a]. 
In the presence of Hirschsprung's disease there is 
a five fold increase in AChE with only a two fold 
increase in the BChE fraction. 
Just as in the case of amniotic fluid, the 
BChE present in rectal tissue exists in a set of 
- 320 - 
molecular forms similar to those of AChE- Three 
major EChE forms are identifiable, with sedimentation 
coefficients of 4.1, E. 2,11.4S respectively. These 
are slightly higher than those of the corresponding 
AChE species; this is consistent with the results 
of other studies (Lockridge et al, 19793. 
In order to determine how these BChE species 
change in the transition from ganglionic to 
aganglionic bowel, SChE was measured in each of 
the gradients in addition to AChE [Fig. 13.23. 
Unlike AChE there are no consistent changes in 
any of the SChE species in the aganglicnic compared 
with ganglionic regions. 
These results indicate that the hypertrophied. 
nerve trunks, typical of Hirschsprung's disease 
do not produce or release EChE to the same extent as 
AChE. Nor is any particular form of EChE closely 
identifiable with these thickened nerve trunks. 
This is the first study in which the change in EChE 
molecular forms in Hirschsprung's disease is reported, 
the earlier studies reporting AChE heterogeneity 
in Hirschsprung's disease, Bajgar and Hak, CIS7S3 and 
flakonczay and Nemeth, CISS43 do not comment an EChE 
and therefore these results cannot be compared. 
The moderate increase in overall SChE activity 
which occurs in Hirschsprung's disease cannot be 
0 
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utilised diagnostically, nor does the change in 
any EChE form correlate well with the changing 
I 
his-6. cchemical appearance. 
19.9 Summary of AChE and EChE molecular form 
changes in Hirschsprung's disease 
In summary, the data set out in Section 11, 
represent the largest study so far reported, in 
which AChE is measured quantitatively in the diagnosis 
of Hirschsprung's disease. The assay is found to be 
reliable in routine diagnostic use. Cver a seven 
year study period no patient was falsely classified 
as having Hirschsprung's disease [Bonham at al, 1985c]. 
From sedimentation analysis performed on 
tissue obtained from ganglionic and aganglionic 
regions, it is evident that the increase in AChE 
activity, upon which both the histcchemical and 
quantitative techniques rely is due to an increase in 
one particular AChE form, G 4' The level of G4 is 
shown to reflect the degree of nerve trunk hypertrophy 
and not aganglionosis directly. 
These investigations more closely define the 
nature and the source of the increased AChE activity 
seen in the disease and suggest a means of further 
refining the existing assay, by specific measurement 
of G4 -AChE CBcnham et al, ISSSc3. 
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EChE, while mcderately increased in the 
presence of Hirschsprungl-- disease shows no 
consistent change in any of its molecular forms. 
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Section 20: Characterisaticn of AChE molecular 
fcrms joresent in rect. 'al tissue and amnictic 
fluid 
20.1 Introduction 
The molecular forms of AChE identified 
(Sections 10 and 123 in rectal tissue and amniotic 
fluid, have depended for their demonstration upon sucrose 
density sedimentation. While this is currently the 
most widely used method of differentiating AChE 
species, other techniques have been used to demonstrate 
the heterogeneity of AChE. These have included gel 
electrophcresis, gel filtration, equilibrium 
sedimentation, iscelectric focusing and density 
gradient gel electrophoresis., The use of gel 
filtration in particular provides valuable extra 
information. 
a3 There is always the possibility that results 
obtained are merely arteFacts of that method of 
separation rather than those of the native enzyme. 
If consistent results are produced by an alternative 
means this offers confirmation that the molecular 
species observed reflect a genuine diversity of 
forms. 
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b] The use of an auxilliary method serves to 
establish the homogeneity of the peaks identified 
by the major technique. In this case, the homcceneity 
of peaks obtained from sucrose density sedimentation 
was tested by pooling the fractions corresponding 
to individual AChE species and examining these by 
gel filtration. 
03 Gel filtration permits determination of the 
apparent molecular mass and by combining these data 
with the results of sedimentation experiments the 
true molecular mass can be calculated (Ackers, 1964; 
Siegel and Monty, IS663. 
Gel filtration chromatography of AChE molecular 
forms has been described using several media 
including: Sepharose 68 [Chang and Blume, 1S76), 
Biogel A [Bon at all 1976) and Ultrogel AcA22 
(Rakonczay et all iSSIal. In this study Ultrogel 
AcA22 with a linear fractionation range of 100-11 200 k0al 
was employed. Samples included homogenates 
of aganglionic rectal tissue as wall as amnictic 
fluid specimens from NTO affected pregnancies. The 
profiles obtained (Figs. 15.1 and 15.43, closely 
followed those obtained by sucrose density 
sedimentation analysis of the corresponding tissue 
[Figs-10.1-5 and 12.1-5]. 
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When individual molecular species of AChE 
obtained by sedimentation were subjected to cel 
filtration chromatography they yielded single 
peaks with distinguishable elution volumes [Fig. 15.23, 
confirming their homogeneity. 
The resolution oF AChE species by gel 
filtration was less complete than obtained with 
density sedimentation so that GI and G4 did not 
entirely resolve. Nevertheless, the technique 
confirms the validity of the sedimentation data 
and also the homogeneity of the peaks obtained. 
20.2 Calculation oF molecular mass 
The apparent molecular mass oF the AChE Forms 
studied was estimated by comparison with protein 
markers. The apparent mass of the forms obtained 
from rectal tissue exceeded those oF*amnictic fluid 
species. G4 -AChE behaved as iF its mass were 
SSO KOa and 40S kOa in rectal tissue and amnictic 
Fluid respectively. These results are in accord 
with those obtained by Rakonczay et al, (1981al, 
who reported a Triton extractable G4 and a soluble 
G4 in mammalian brain, with apparent molecular masses 
oF 490 kOa and 342 kOa respectively. 
Applying the equation oF Ackers, [19643, 
enabled the eFfective gel pore size, r, to be 
calculated From the Kd values obtained with protein 
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markers of known Stokes radius, Re. Subsequently, 
usinc the values of r, and Kd of individual AChE 
molecular Fcrms, their Stokes radius was calculated. 
The results (Section 15.23 indicate that A 12 
from rectal tissue has an Re = 12. lSnm, consistent 
with the definition of asymmetric AChE species 
whose Re>12nm (Massoulie- et al, 19643. 
In the remaining species G,, G2 and G 41 there 
were differences between rectal tissue derived and 
amniotic fluid derived AChE. The Stokes radius 
oF the enzyme From rectal tissue was 15% greater, 
cn. average, than its counterpart obtained From 
amnictic Fluid [7. S4nm and 6.27nm respectively]. 
Rakonczay at al, CISE31al using a similar technique 
with enzyme derived From rat brain, identiFied 
Triton extractable and soluble G4 Forms with Stakes 
radius of 8.05 and 6.75nm respectively. Ban at al, 
CIS763 reported the same molecular Form EG 43 From 
Electrophorus to have a Stakes radius of a. 75nm. 
Allowing for species differences the results compare 
well. The results of Rakanczay at al, [1981a3in 
particular paralleled the Findings of this thesisl 
in that the soluble enzyme (From amniotic Fluid] has 
a smaller Stakes radius than the equivalent Form 
from rectal tissue which may include a membrane bound 
component. 
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Having ascertained the S-value and Stokes 
radius of each of the AChE molecular forms, their 
approximate -true molecular-mass was then calculated 
according to the equation: 
Re. S 20'W =F 
[Molecular mass3 
The forms from rectal tissue, G 11 621 04 and 
A 12' 
identifiable on the basis of their sedimentation 
coefficient were found to have molecular masses in 
the ratio of 1.1: 1. S: 4.0: 11. e while those of 
amnictic fluid, 0V G2 and 04 were in the ratio of 
1.2: 2.0: 4.0. 
The molecular mass of the monomer, Gi was 
74 and 78 kOa in rectal tissue and amniatic fluid 
respectively, these results were similar to the 8OkOa 
accepted for the monomeric catalytic subunit from 
Electrophorus [Massculie and Son, 19823. The mass 
determined for the dimerIG 2 from rectal tissue and 
amnictic fluid of 126 and 131 kOa respectively, was 
less than the 151 kOa reported by Ott at al, [1982) 
for G2 from erythrocyte membrane. The discrepancy 
might be due to innacuracy in the determination of 
Kd for G2 in the current studyl which was present in 
particularly low activity. 
The results obtained For G4 AChE are compared 
with those obtained for this Form from other sources 
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Table 20.1. The true molecular masses of G4 AChE 
form amnictic f luid and rectal tissue showed 
closer acreement [within 7%3 than their corresponding 
apparent molecular masses. This indicates that 
there are differences arising due to teriary or 
quaternary structural change. This would be 
expected to affect the degree of asymmetry and 
consequently their hydrodynamic properties without 
affecting their molecular mass. Rakonczay at al, 
(1981al, Table 20.1, have reported similar Findings 
for the soluble and membrane bound species of rat 
brain. The Stokes radius of the soluble species 
were smaller and the S-value greater than the 
corresponding membrane derived forms. As a 
consequence, the apparent molecular masses of these 
forms differed by almost 30% whereas their true 
molecular masses differed by less than 6%. It 
has already been demonstrated (Section 15.51 that 
amnictic fluid AChE does not react with Triton and 
is probably a soluble secreted enzyme. The hydro- 
dynamic behaviour of amniotic fluid AChE also 
supports this view, and in accord with the behaviour 
oF the soluble G4 -AChE investigated by Rakonczay 
at al, [1981a], it shows a smaller Stokes radius 
and higher sedimentation coefficient than the 
rectal tissue derived enzyme which contains a 
membrane bound component. More recently, 
Table 20.1 Molecular mass, Stokes radius, and S-value 
of G4 from several different species. 
Soluble and membrane bound forms are also 
differentiated. 
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Table 20.1 Themolecular mass. Stckes radius and S-value cf: 0 ACýnE 
fr=m difýerent scurces 
S Apparent True Fie 20'W molecular mass molecular mass 
Enm] [S-Units3 CK13a) CKOal 
Son et al, 1976 
Electrophorus a. 75 11.8 331 
Massoulle at al, ISeC 
Ox 8.1 10.5 - 341 
Makonczay at al, ISele 
Hat: Soluble 6.75 10.7 342 304 
Triton extractable a. 05 a. 48a 32e 
Ralston et al, 19e5 
Fetal bovine serum 7.5 iO. E3 340 
Gennari and Ercdbeck, ISS5 
Human caudate necleus: 
Salt soluble - 10.6 300 
Detergent soluble - 10.0 2SO 
Present Study 
Amnictic fluid 6.27 iC. 3 40S 25S 
Rectal tissue 7.54 9.2 S50 27S 
- 330 - 
f9alstcn at al, CISS53 have purified soluble 
a4 -AChE from fetal bovine serum and report that 
this enzyme sediments at IO. ES Cclcse to the 10.3S 
determined for the G4 of the amnictic fluid3 and 
is also insensitive to Triton X-100. 
20.3 Thermal inactivation of AChE molecular forms 
In a recent repcrt describing the thermal 
inactivation of AChE molecular forms derived from 
rat tissue, Edwards and Brimijoin, CIS833, 
outlined the relevance of studying the thermolability 
of proteins. They describe how this technique is 
"perhaps the most sensitive test for genetic variants 
that differ in primary structure" and that it is 
capable of detecting changes of only one amino-acid 
in certain instances. In addition to detecting 
primary sequence variation, differences in 
thermolability can also be attributable to tertiary 
or quaternary structural diversity. In particular 
the disulphide bond known to link the monomers of 
AChE within the 02 dimer is capable of conferring 
heat stability an the molecule. Also the non- 
covalent, hydrophobic forces, which are responsible 
for maintaining the association of the two dimers 
of the tetrameric G4 form contribute to the thermal 
stability of this structure. 
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For these reasons it is not surprising that 
Edwards and Erimijoin, CIS63), found monomeric AChE 
to be the -most thermally labil a AChE speci es and 
that Lcckridge at al, CIS-7S3, found the same to be 
true oF the BChE monomer. 
In the present study it is valuable to 
determine the thermolability of the forms described 
for the following reasons: 
a] It allows direct comparison with the results 
of other workers gained using AChE from 
different sources i. e. rat heart and 
diaphragm, Edwards and Brimijoin, C19631. 
Ey comparing the relative behaviour of 
molecular forms identified in this study 
with that seen in other reports may offer 
yet further confirmation of a monomer, 
dimer, tetramer series. 
C3 If the differential behaviour of AChE 
species is marked, it might be used as 
a means of selective measurement of 
individual species. 
These points are discussed in turn. 
The results [Section 15.33 show a marked loss 
of 61 AChE activity at 49 0C compared with G2 and 04 
- 332 - 
forms. These findings are consistent with those 
of Edwards and Erimijcin, [I-OS33, who describe a 
much more rapid loss in 01 activity at 4S 0C than 
found in G4 or A 12' In that report the fall in 
01 activity was even more marked than cur results 
suggest. This may reflect species variation in 
primary sequence, as mentioned earlier, single 
amino acid substitutions can result in temperature 
sensitivity differences. Nevertheless, the same 
trend is evident in both studies i. e. G1 is the 
most labile species and larger forms e. g. G4 
are increasingly resistant to inactivation. 
In both AChE and EChE, the monomers are linked 
by disulphide bonds to form the dimerg these are 
then joined by non-cC'valent hydrophobic interactions 
in the tetramer. It would be anticipated that the 
covalent disulphide bond would have relatively 
greater effect in stabilising the 02 structure 
than the non-covalent forces involved in the further 
formation of G 4' Consequently, GI would 
be the 
least resistant to heat inactivation and a considerable 
increase in stability would be conferred by the dimeric 
structure, a Further, relatively less pronounceds 
increase in stability would result from the formation 
of the tetramer, 0 4' This is exactly the behaviour 
observed, the greatest difference was noticable 
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between GI and G2 species. These findings suppcrt 
the sedimentation and gel filtration data, all 
oF which sug2est that 4S, , Sm and ICS AChE Fcrms 
correspond to a monomer, dimer, tetramer series. 
The differential behaviour toward heat 
inactivation indicates a means of designing a 
selective assay directed to individual forms. G4 
is the least thermally labile globular form and it 
may therefore be possible to measure this species 
alone following inactivation of GI and G2 by 
incubation at a suitable temperature. 
The present results suggest that such an 
assay For G4 -AChE would not be entirely selectivel 
however, by altering the experimental conditions 
more specificity may be attainable. It is 
particuarly fortuitous that G41 the species of 
diagnostic interest in Hirschsprung's disease and 
NTO, is the most heat. stable of the globular forms. 
20.4 Substrate inhibition oF AChE molecular Forms 
It is well established that AChE is inhibited 
by the presence of excess substrate (Section 1.5, 
Silvr=r, ClS74]]. The bell shaped curve oF Activity 
versus lcg (Substrate ccncentration3 CPS3 is 
characteristic of this behaviour, this is shown in 
Fig. 1.2 for bovine erythrocytes. In this instance 
optimal activity is achieved with an acetylcholine 
concentration of approximately 3. OmM. 
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In order to ascertain whether or not 
individual AChE species differed in this respect, 
rectal tissue derived forms were compared. In 
each case the cptimal substrate concentration was 
in the region of 2. OmM. These results are 
identical with those of 2. OmM obtained by 
Fernandez et al, [1981) using A from rat muscle 12 
and nerve, and Chubb and Smith, [19753 investigating 
the soluble and membrane found Forms oF the enzyme 
in bovine splanchnic nerve (predominantly G43. 
It would appear, as previously suggested 
by Massoulie, (19803 that the catalytic differences 
between AChE multimers are minor and that even 
between spec. ies similar characteristics are evident. 
This indicates the importance of this aspect of 
the catalytic behaviour of the enzyme in differing 
locations and species. 
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C0 N_C LUS10 N-S 
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CONCLUSIMS 
The ccnclusions made Frcm the present study 
can be summarised in three overlapping areas. 
E3 Measurement oF AChE and BChE in amniotic 
f luid 
The results presented in Section S, conFirm 
the value of amnictic fluid AChE determination 
in the pre-natal detection of neural tube defects. 
This assay offers several advantages over the use 
of alphaFetoprotein in the same context. An 
automated assay for AChE is described which shows 
excellent correlation with the manual technique 
and is ideally suited to routine diagnostic use. 
The structural heterogeneity of AChE and 
EChE in amnictic Fluid From normal and NTO affected 
pregnancies was investigated by sucrose density 
sedimentation. Three forms of AChE were identifiable, 
with sedimentation coefficients cF 4.0,5.5 and 10.3S-; 
it was assumed that these corresponded to a monomer, 
dimer, tatramer series: GV 02' and 64 respeotively, 
They were shown to have molecular masses of 76,126 
and 256 kDa respectively. Polyacrylamide gel 
electrophoresis of amniotic fluid samples from normal 
and NTO affected pregnancies showed an additional band 
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cF AChE activity which co-migrated with 04 -AChE 
obtained by pooling Fractions from density gradient 
sedimentation analyses. 
The results, which represent the first 
reported attempt to identify and quantitate the 
structural diversity of AChE forms present in 
amniotic fluid, indicate that one form of the enzyme 
i. e. the tetramer 0 4' is largely responsible for 
the quantitative increase in AChE activity and the 
additional band of AChE activity seen on gel 
electrophoresis in the presence of neural tube 
defects. This particular form is shown to be 
virtually neural tube defect specific. It did not 
react with the detergent Triton and is therefore 
probably a soluble enzyme secreted into the amnictic 
fluid by nervous tissue exposed as a result oF the 
lesion. 
Determination of G4 -AChE would improve both 
the sensitivity and specificity cf the existing AChE 
assay. The means oF designing such an improved 
assay are discussed. 
BChE activity, the likely source of which is 
fetal serum, despite being increased in the presence 
oF neural tube deFects is shown to be a less sPecific 
indicator of the lesion than AChE. 
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b3 Measurement cf AChE in rectal tissue in the 
diagnosis oF Hirschsprung's disease 
The results described in Section 11 represent 
the largest study so far reported in which AChE 
has been measured quantitatively in rectal biopsy 
specimens in the diagnosis of Hirschsprung's 
disease. The test is shown to be a reliable and 
sensitive indicator of the disease in routine 
diagnostic use. 
Sedimentation analysis of AChE from rectal 
tissue of patients with the disease identifies 
four distinct molecular forms with sedimentation 
coefficients of: 3.5,5. Os 9.2 and 16.6S. It 
was assumed that these corresponded to G1, G2' G4 
and A2 respectively. The molecular masses oF 
these species was 74,131,275 and 611 kOa 
respectively. These forms showed differential 
thermolability, with G, proving the most thermally 
labile. The substrate optima of each form was 
almost identical. 
In the aganglionic region of bowel from patients 
with Hirschsprung's disease, one particular AChE 
form, 04 showed consistently increased (4-14 Fold) 
activity. This Form is predominantly responsible 
for the increased AChE activity upon which both 
the quantitative and histochemical assays are based. 
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In contrast to the G4 -AChE of amnictic fluid 
the enzyme from rectal tissue did react with Triton 
resulting in a descrease in S-value. It is therefore 
probable that the enzyme possesses a membrane 
associating component. The increased activity of 
G4 in the disease was concomittant with histochemically 
demonstrated nerve trunk hypertrcphy suggesting that 
it was directly associated with nerve trunks, a view 
substantiated by histochemistry. 
The selective measurement of G4 -AChE, a 
specific marker for nerve trunk hypertrophy in this 
context, would improve both the sensitivity and 
specificity of the existing assays available for the 
diagnosis of Hirschsprung's disease. BChE molecular 
forms show no consistent change in activity in the 
disease. 
cl Characterisation oF AChE molecular Forms in 
rectal tissue and amnictic fluid 
In addition to sucrose density sedimentation, 
gel filtration was used to separate AChE species from 
rectal tissue and amnictic fluid. The results were 
in accordance with those obtained by density 
sedimentation and conFirmed the homogeneity oF the 
peaks obtained. 
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Combining the Stokes radius, determined by 
gel filtration, and the sedimentation coefficient 
of each of the AChE species identified enabled 
Wheir approximate true molecular mass to be 
calculated. The results were consistent with a 
monomer, dimer, tetramer series based upon a 
subunit weight of approximately 70 kOa. The 
asymmetric form A 12 had a molecular mass 
consistent with 12 such subunits. The results 
were in accord with those reported using AChE 
derived from other sources. 
The thermolability of AChE species from 
rectal tissue indicated that GI was the most 
thermally labile, all three globular forms behaved 
similarly with respect to substrate inhibition, 
with a maxima at 2. OmM, acetylthiccholine. These 
results too, were consistent with those obtained 
by other workers using AChE from different sources. 
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Appendix I: S-value calculation procram 
This program will calculate the S-value 
for sucrose gradients in swing cut rotcrs 
From basic run parametara and rotor 
dimensions. Adapted from Young, CISSOD 
1; ch. -I OPEWA 
11 C, REEN THIS PROGRAM CALCULATE, -' S-VALUES FOR SUCROSE GRADIENTS Itl S*lllItlG OUT 
FEN ROTORS. ANY ROTOR CAN B- USED , PROVIDED THE 111STANCEI: CM)FRON THE CENTP -r r 130 F-01 OF ROTATION TO THE BOTTOM 
1;. 10 FORI =1 TOP 
ýo bim 
17 Cl PRIHT 
1.0,21 PRIIIT#l, ++*--+*S-YALUE 
I --; 
el ppiuril 
. 2c, 
PRINT. - "RUN NO. 
"l INPUTJJ 
RUN t40. "; JJ 
.:;. 
Xl PRlt4T#l 
240 Zl=o 
'7 5 -. 3 DATA ,: z PRINT"IS SAMPLE DfJA7-(Y/f-J)'* 
270 It4PUTC* 
2 "S C, I FC*= '11 " THEI-1360 
2-ý Cl P. Rlt4T"ALKALIflE GRADIEtff? " 
300 ItIPUTC$ 
310 RESTORE 
lN IFC-W'Y"THEtJ350 
2.1 Cl READX11 zi I 340 GO TO 360 
. 350 
REFiDzl 1 22,1%, A 't; cl VLI-42 
170 REM THE FOLLONING DATA STATEME14TS 
0 REP, ccurAlf-I THE FPSIC INFORMATION 
4ýpcl REM FOR EACH ROTOR, I. E. DISTANCE 
00 REM FROM THE CE14rRE OF ROTATIOU TO THE TUBE BOTTOM AND THE INTERNAL TUPE 
L 1 -1 REM RADIUS , (CM) A MR-41NUM OF TEN 
REM ROTORS CAN BE STORED IN THIS PROGRAM. 
30 
- .1 t. 
IIATP 1*: ý. ý-". -1.30 44 cO DliTA, *3. L36, Cl. 6.25 
"N DR TRe-, 2,2. - 2,2. - 
4 15 Q REIN DATA STATEMENTS ABOVE 
ILI 
ML" 
42 0 FOR tl=l TO W 
c IC, PRINT N, AP(W 
51 
5 4" L-1 PRINT"NHICH ROTOR 110 YOU REQUIRE? " 
f 2, L-1 INPUT t4l 
f40 IF t4l)INO THEtl 530 
550 RESTORE 
-60 
READ , 
f-70 FOR tl=lTO t4l 
5cAl READ,,: ý, X 
'5 ý4 Ll 14EXTII 
600 READRl, R2 
510 PRINT"DO YOU NFWIT AUTO MODE? " 
620 GETZZý'-IFZZW"TH01620 
630 IF77$=llN"THEtJG5O 
4-. 10 IFEN="Y"THEN'350 
PRIMT "TOTAL VOLUME (ML)? " 
61ýzcl 114PUTUl 
-:, o PRINT "SAMPLE VOLUME? " 
6eo ! NPUT L12 
690 PRINT "FRACTION %, 'OLUME? " 
f CIO INPU%fl-l 
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74, P'1147ACCELERATIOU TIME 4JIMUTES. " 
73Q, 114FLITT! 
,11: 
71 :-'! Lill,, *. -To PRINT "PLIN TIME(H', - Fil IMPLITT4 
ic, T. 2-T4+60 
C, PPIfIr"DECELERFITION TIME (MINLITES)? " 
S ell INFLITT", 
7-K, FIRVIT"Fi'VERAGE SPEED (R P Pl. )? "Cl 
'Roo ItIPUTO 
; ': 1 -3 PPINT"TEPIPRATLIRE (DEG CY? " 
'7"; ' INPLITT5 
-KC, PRI14TTARTICLE DENSITY? " 
0: 40 INPLITP5-'GOTO'3%S'O 
ef. ) P. IRINT"SAMPLE VOL. 
S7 tZ, UI=5.0: L13=. 25 1 /L13 -T1 =20 : T4= 17: T-2=T4 *60. T3=20: 0 =3 71500 T!. =4: Ff. 13 
,: 30 
*ýý; cl I =1 5/r. M*M +T3)/3)*(P9+0) f2) 
,4C, C, PRINT"? %SUCROSE OF THE "; U3; "FRACTIOMSll 
, 11c, FQRJ=lTOtJ3 
INPUTPQ) 
NEXTJ 
J=j 
L. " J) =LOG (R1 -R2 +( J*U3-U 1 +2 *P9* R2 T3) /3 F-9+R2 TZ) > 
260 IFENPMD'e. 'ýRl-RME14990 
Bo GOT0950 
'4ý40 LM=0 
i Lic, cl 
1010 
1020 FORjl=2 TOJ 
10 3,01 MQ1) =L JA -L <J1-I V-0140 PEVTJ1 
Iuf, 0 FRI 14T 
10 o_-- . 10 P11-11 ItIT IQ 713 PRINT 
1) -S ir, PIUWAMID, "ROTOR" 
L 0-,; C, PPINT#1. -Aý041) 110 0 PRINT#l.. "USED AT"; Q; mRPPl FOR"; T4; "H. RS AT"; T5"lE,. 1 V 
1 11 C, PRINTU.. "PARTICLE DENSITY"; P'j; "TOTAL VQLUME"; Ul; "PlL SAMPLE VOLLrlE,,; Lf2,, ML,, 
1120 IF Z1=0 THEU 1150 
112 Ll PRIIIT#l, "FRACTION NO A"SUCROSE S-'VALUE MOL. 14T. 41 
A 40 00 TO 1170 1150 PRIMT#l 
1160 FRI MT# 1, SPM20); "FRACTION 140 e%SUCROSE S-YALUP 
1170 SO=@ 
41 7ý C, 
I, .1 FOR Jl-l TO J 
1190 AD=31 
1,: 100 CIOSUP 1790 
1; 110 SO=SO+M<Jl)+E 
Q8=so*I*lEl3 
10 IF Zl=CITHEI-11270 
IM, PRIlJT#1, Jl; PQl); QL;; Q-; 7,00TOl 2: 40 
0 P. RIIIT#1.. SM20); Jl,; P(Jl S@*I*lEl 3 
HEXTJ1 
00ý020420 4 -XIL 131%, REPISILCEPPOUTIME TO CALC DENSITY (D), YISCOSITY (Y) FROM TEPIP M AND 
12,20 PEPI SUCROSE PERCENTAGE (P) 
11.10 11A TA 1.00 Cl SS69 3-3.9 6 L:; 0504E-5., - 5. S-Z 13 2 71 E-6 
ýj40 DATA 
1,3510 DATA 0.1,. 'C"-175'-; 4o4. r'530C'31E-4, -e.. 9, '-'31-473-E-6 I I" G0 Ila TA 10.027525,4.331 3129E -4. - 7.73: 303557E 5 1370 DATa 342.3,10'. 032 
.6 DATA c'12.5s', M'-;, 0.133716, -2, -2.927644-qE-4 I ký C, DATA 146. C IS635,25.251`28,0.070674S42 
1,4 C, Q, 1: 1.11 TA -1.5- Ll I L332 -f. - -9.41121,53, -1.14 3.5574 1 E3 
"44 
1 -23' 4 Z- 141 DA TA 1. M041"TE5., -4.6_2271CIMS, 1 MLS 
ý4,4 .451 _9 11 EI. 003 14 D. Fl TA-I. I- .i1 E_ 4 47-1 ll 4TP-. 2 . `0 C, 4G4EI, 4.60 E', 6S, _; S, 
E :15.9 5 17 0E3 
I, 'o DA'A C,: 'I 45ýý4,0, C, r_-t 42 4 
1 4f 0 D. 173TR 1 'L E2, I. I. 6-41 161ES 
*L 4, EL, r, Fl TA I. "ll S4 137 E 7.. t3. C, 6,4 775E-12 _FS3 58 
3' 4E 10 
I 17 0 PA TA11, -5.4-'470416-El 11.3975,56. SE2 
'ýE3.. -7. 'L; 71 61 0'5E4. - 9. CV-7167557(CiE5 14 *2 0 LATA 6.6 Jf , 's "1 4 4ý -01.:. 45 I -41i 19- T.. 13 -5.52^032OE6,1.2451 2l-iE7. - 0,0 1 f@0 F. -_; =1 
1ý 1 13 i. 
44 
- 
15211.1 F. EAII. 91., A2, FI3. -Plltl2. -Cl, C2, C3 1540 READGI.. 02, G3 
55., Yl=p,, lcc, 
f 
. 
=10 IM30 THEM 16N, 
15_Po GO TO 1 G20 
416 01+(1 -Y) 012 *I ll=DL 1 61 C 'ilr', 'Y. + ýC1 4-C2 ; +T+C3*T f2l) +1 -Y) 1 +Fi2*T +A3 #T f2) > lse-0 R9=*nl 
40 IFP,,. '=4$ THEN 1670 
16fO R9 = 29 
166-0 GOSUP 1960 
1670 READ 
1 6, ýo H=DO+Dl*'? +I)2+, Y-L'+D3*Yt3+1)4*Y-t4+D-w'+Y-t. ". +Dg+Y-t6+Df-+Y t7 
16f4o R: )=, 7 
1700 GOSUB 1-960 
171LI IF P<=48, THEN1740 
1.72A R_; =45 
17213 oclsvi 1: ptgo 
1740 
1750 3= DO +D 1*Y +D2 +Y T2 +D 3*Y+D4*Y -1`4 +1) 5+Y I". - +D6 +Y't, 6 +D7 #Y t7 
17f 0 V=. *LO-f(A+Fil(T+C)) 
MO RETURN 
1720 REM SUPROUTIHE TO CALC. SEDIME> FROM PARTICLE lSt4SITY(Hl>, TEMP(Tl> AND 
'(Pl) ROSE'. le0o REM SUCA 
1810 Tl=T5 
le"o Pl=pQl> 
WS0 Hl=P5 
1 : 34 0 T=20 
1,321: 0 P=O 
i st-o oosup i -ýý io ic4TO H2=D 
1 C, 
1.8_, N) T=Tl 
! -'00 P=Pl i.; 19 1ý 10 Su2 13 10 
1.4*:, 0 H3=D 
v3=V 
1_, 40 E=(ýHl-H2)AHl-H3))+(V3/V2) 
1. ýýO RETURN 
1KO RESTORE 
'; 070 FOR 14=1 TO 13+R3 
1: 4130 PERI'M 
L `4c 4 IIE' TII 
2000 RETURN 
2010 OPENG. - 4. - 6: OPEI Il. - 4 P=AD 
2 0: 31 o ii=i 
20 40 FOR I =1 TOAD: X(I) =P<j 1 >: Y 1) =0 <j 1) Jl =J 1+1 14EXTI 
2050 PRINT"HOW MAINY PEAKS? " 
N 
., IN &L 4 PRINT"AT PHAT o*,. 'SUC. ARE THE PEAKS? " 
.; 000 FORS=lTOAB 
23-_, 40 ItIPUTAC(S) 
210. ) I! EXTS 
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2110 P. RINT#l : PR'IHT#l,,: PC-'-7*f); "+*INTERPOLATE. D 2 2 0. Z1 PRI NT# I, '-'-: PC ý'425) ; "%SLIC TAS < 13) S-V'ALLIE 
ýl .5 FORS=1TOAD 
2140 FORI =1 TOP F 21 71 IFXeI): RC<C, )THE-114 L 
1 E. I 1EX 
P. Rlt4T#l, SM26); AC(S); TALI( 10); 2 
tlFXT3- 
READY. 
'VALLIES-W : F. Rlt4T#l 
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Appendix 2: Sucrcse density sedimentaticn analysis prccram 
This procram will correct AChE and EChE 
activity for interference by sucrose and 
tabulate the results of culmulatively 
increasing AChE and EChE activity from the 
gradienz. The results are also given in 
graphic form. 
1 cut". 1 FEWTHIS PIRLIGRAll CALCULTES AND FLOTS Flt4AL. -COF, *F. ECTED: FiCHE.. PC. Hr---,,,. 'SLICROSE IF" 
110 REM"GIVEN 81--*HE, 'CHE,, *"'. -t:, Cr"OC-- III THAT FRACTION" 
E 1 CIPE141,4: CLOSE 6: OPEI 4G. - 4. - 6. 130 PRUIT-r-ATEE? " 
14121 INPLIT1114 
15 %71 PRINT"RUN 140.7" 
16 0 114PUT141 
PROFILE PRO0RAM+. '. *. *" 
PR, Itl_ 
<0 DIMP( 110), R(l 10), S<l IN, T(l 10), Ll<l 10>, Pl<l 10), Y(l 10). X(l 10), D 11 11 
210 P!; 'IIIT#l, 
4.7.1) DIMIlle - )lPI (I 10).. . -1 <1 10) "1 <1 I0), X2(l 10). - Y2(1 10), F<l 10). - 0<1 10). -K(40) 11,110 T 230DIf P-11"I 110 >, QP ( 110)., OR ( 110 , QS C 11 No IH(4 0), 1V<4n; ), AT<4 0). - 1(4 No YY <4 No XX <40 
7 40 PII SA 40) , CC ( 4' 0). - D. 1.1 <4 No EE <4 -3) , FF (4 0), 11 4 09 00 <4 0), H. 4 4 0) JJ 40 >j. KK 4 
0) 
ra,; O Is It140AP("0AC(4 C', AD( 40 ), V(40 
01 PRI'lýIT"HOW MAHY AT START OF GRADIENT" 
o It ir-Li rr- 
3 cl PRINT"FR. KTION NOS.? " 
4.90 FORB=lTOA 
2CI-10 ItIPUTC 
0C UP) = 1: 
NEXTB 
PRIlIT"e" OF SUCROIIE? " 
114PUTD 
DU)=D 
NE. "T2 
cl V-i-fl : 00SUIP, "240 
*2N, PRIUVWTS'. Or' FRACITIONSVIC0? " 
400 FOR2=1TOR 
410 1 f! 'P UT 
420 E2 E/1000 
430 E(P)=INT(E(P)*1000)/1000 
4 -4 0 NEXTP 
4 70 V7 = 2: G0S LIP 3 2- 40 
4U, FORF=lT0A 
470 
4SLV G(F) =E(P)IF(B) 
. 0). 4 N, G(2)=If4T(G(F)fl0000 0100000 
T El cl IH=IH+G(B) 
510 NEXTB 
520 PRIIIT"ACHE ACTIVITIES? " 
f : -o FORD= I TOA 'f 40 INPUTI 
0 FEM"ACHE INTERFERENCr- DUE TO SLlCROSE=Ll. O41U/L PER ;: 0.1, N)SLIC AT PH7.. V 
570 
5SO IFI(BX. 02THEI-II(B)=. 0l 
5:? cl HEIXTP 
COO V7=*3: 0OSUB3240 
610 PRIIIT"ECHE ACTIVITIESM' 
GX FQRB=lTOA 
6 1; t0 114PLITI'-. 640 KU)=K 
6 t", cl REM"PCHE VITERFERENCE DUE TO SUCROSE=0.0JS5LVL PER ,. lM/V>SL(C AT PH7.3" 6.60 fl)(D) 
6 70 IFK%'P) <. Qa6THEI4K(Z)=. 01 
CN) NEXTEr 
q. ý; o V7=4: 0 OS U 2-33 2.4 0 
700 FORB=lTOA 
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I C, x 77"'. J=J+,,, '4 
720 '(P)CK(P) 
4- , Xf `ýc , -, I NSXT 7 -, CLIT& Pý.. - -- -- - -- -- [IV. U- ION WHEN 
11"llp Ll 
fSLI PRINT"%* 0 SUCROSE lWHEII F- CTIONS=O? RAC t ;-%.. AI 
PRINT"HOW MANY FRACTIO1.11-1 ON 
e, 7, o INPLITO 137ý0 PIRINT"r-ACTION 1403.? " 
13_1 FORI ': =1 TOO 
114r-LITP 
e Pý PD=P C470 PER, ,p G Cri Vf-=, '- : COSLIP32240 
e0 FOU. -I TOO 
ý". X-i 0=14#PU)+PIl 
'741c, P(z')=;? 
'R20 
'ýýCf 14EV"TP 
ý440 PRINT"WTS. OF FRACTION'S(MCD-r' 
FC 'S =1T00 
*: 160 INPLITS 
S(p)='S/j0.. 3g 
1 C'CICI W-6: GOSUP, 124 0 
I Ell C, FOP P-lTOO 
1 CIA-0 
1 C, 31 C, 
1 E, 401 LI It4T(LI(2 10 C, Ci LI Ci 1 C-, LI ci Ct c. 't, f0 IV=IV+Lf(. P) 
C, E. 0 NEXT2 
1 C17c, FRINT"ACHE ACTIVITIE-37" 
1 . -j S, C, FC-R'C=lTQO I 0_ý@ INPUT14 
1100 14(P)=I. l 
10, REPPACHEE IUTEý'FERENCE BLIE TO 
i 131" IFWU)<. 02TIHE14W(I. ')=. 0l 1140 NEXTP 
11 !0 V7=7: 00SUBý1240 
i 160 PRINT"PCHE ACTIVITIESN'r'" 1170 FOR P=1'100 
11 E. 'O INPUMPI 
11 mpia)=mPI 
1 REM"PCHE ItITERFS-MICE DUE TO 1210 LIIC, 5+R(B) 1 Z;; 11 1 FMP1 (2) <. 02-THENPIM (P) 01 122c, HEI". 72 
t/7=S: GOSUP3240 
12'ýo FOPP=lT00 
1 ý, go X6=U(P)+14(B) 
1270 AT=AT+, "6', 
12;? Cl X77=L1 (P) VIPI (2) 
V ED ýTP 
ST. LINET, 
SLICROS27-0.041U/L PER , -GJ, "if)SUC AT PH7.3" 
PER %'OVY)SLIC AT PH"e. 3" 
1'11111'7ý ml LND OF RLINT, 13, I'l INIPLITPA 
13 ". --: Cl PRINT"FRACTION NO-, p'. 1340 FOt',, Z= 1 TOAR 
1 ^= ", C, INPLITCC 
1--,: Eo CC<B>=CC 
1 -cf-n ,j :- NEXTP ?n V-1=9: GOSLIP34240 
171 0 F'Rlt4T", *-. OF SLIROSE? ll 140C, FCiFB=l TCIAA 
- 34EB - 
44.1 
1 47-'Ll NEXT2 
1 ?. -1 1- %, 7= 10 :G0. SIU B'S., 24C, 
1 4f: ý0 FRINT'14TSI. Or' F'nC-Tl0J'-j'Q0l--Y" 14 60 FOF. 2- I T0F-, F3 
1470 11FUTEE-2 
14S., cl E=E: -: / I COO 
14 M0 EE < 2) = 114T < EE < B) 1 00 C, 
lf0c, NEXTP 
I Z-1 0 V7=1 1: GOSLIB, 32-40 
1520 F0FZ-=lTO. s3Fl 
530 FF<P)=0--. 
154Qi 0G<B)=EE<B)/FF(B) 
1 ý; E. o 14H=HH+GC, (10 
15.7 , --1 
1_,.: - Cl PRINT"ACHE ACTIVITIES? " 
1 f".? o FORB= 1 TORA 
1600 114PUTI I 
161c, II G')=I I 
1620 FSPI"ACHE RITERFERENCE DUE TO SLlCF-OSE-=0. O41Lle"L PER 
16: 4GIFIIU. ) <. 02THENI I< B) =. 01 
1 14-50 hEXTP 116 0 V-, = 12 :00LS3240 
10-570 FRINTWHE ACTIVITIES? " 
16--lao FCRZ=lTOA5 
1620 ItIPUTKK 
1700 KKU)=KK 
1 1-1 c, 
ý*Etl"BCHE INTERFEREUCE DUE TO SUC-RO': -. 'E_=Cl. 01S5Ll/L PEX 
1 720 KY(P)=KK<S)-G. Olo. "WiNP) 
17 301 IFKK<PX. O4'THE14KKG)=. 01 
17 4 :1RR=0 
e 50 
13: c 
1770 FOr. P. =lTOR'A 
17SO 
MCC 
Slo 
I $. 1,71 L, 0 NEEXTP 1 *3 Z,, ý 0 C! P=IH+Ily'+HH 1S4,21 F0RULl=lTO'e: PRII4T#l : 14EXT 
PRINT#l., "TOTAL V0LUllE="; QP; "JNLS:. " 
1 -: 6,0 C! F,, =. T+AT+, TJ 
NRINTU. - "TOTAL ACHE ACTIVITY="; QR; "MILLI. U" I ^K, 0 O.:: =L+Z+LL 
0 PRIIIT#1, "TOTAL SCHE U. " 
I CIO FRI tMil . -tio. wr< oms) VOLUME . "v'OLUt-lE ACHESCHE fif'. KIC 191C, FQRZ-lTC-A 
19"cl Z4= ý0 ýPVGP) # 100 
1 44 Cl YY < P) =z5 
1 S150 Z5=IIITf' *10CIN/10*00 
, ýZ'l 1S60 APE, < 2) =Z. 5 
1970 1 (2) CIO 
Z7=e--7+Zg 
1 ý--# 4@ Z"t=INT<Z7*10QOVl00O 
20 Z- 
eý 
Ol 0 z2=zp+zý2 
40r:, cl Z-q= It IT (Z-*ý4# 1 CLIO 000 
e- .1 &ý, - `014L NEXTP 
r-O., O A5=Z5 
OGO A7=4.7 
207 (OL A-9 = 2- q 0 -, S 01 FORB= 1 TOO 
A4=<U<B)/QP>*1OO 
KIC AT PH7.3" 
AT PH7.3" 
XACHE CHE 
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2110 ew, 
4' Z, - I 114 T1 el, cl 103 1 cl cl 
Z40. Av 
f0 A-7 =Fi-7 +i; 6 
+ Ll 
0, A-ý =It 4T A-z * 10 00 10 .0 c".. ) FRI 14T# 1P<P 13 (P U<PA 1-1 (S > MPI <2 RUA7; fi-F, t -0", T2 
tf 
0 FQRB=lTQPA, 
22 60 J4 =<GG<Z)/QP)*JoO 2470 J5=. T5+J4 
22-00 
J6 
J =J7 +J6 
0 . 17= INT Q7*1 000)/l 000 :40 (KY, CIO 
-L2, s, J T. 9=It4TQ2+lC*O)/jOOO 237 --;, Pm4tiTt"l,; CC<B); EE<. F); C; C, <B); j5 
El FRINT'" * 'OLLIME OF HOMOG. APPLIED TO 0PADIEl-IMILS. )? "' 114PUTAD 
2410 PRINT"ACHE ACTIVITY OF HOMO.? " 
e2-420 INPUTPC 
42,0 PRINT"KNE ACTI'VITY OF HOMOG.? " 
444-1 If, 'PUTCD 
. 2450 DE=(QR1<Ap*SC))+joO , 46. ^ 
2470 PPIMT# 1, "RECOVERY (ACHE)="; DE; ";. ' RZ-CO'Y'ERY(P-CHE)="; EF; "i,. ", 24SO FP=P+O+AA I-^ , *-lrZ, 0 2=1 "N I FO, I -, 'Rl= 1 TOR4? KI ý=l <. P): yýI. )=Yy<. p) : Z=Z+l : NEN'T: B=l 2510 FOR IA+1> TO <A+ 0) :X'I> =1.1 < P. Y<I)=,, - 
,T 
: 14EXT: B=O FOPLl=lTO3: PRIt4T",, l: t4EXT 
PRINTU, "ACHE lie'S 
e-, f vc, CLCI. 'Sc'-i; -'CIPE146,4. -S: PRlt4T#6, CHR$<16): CLOSE4: CIPE)-14.. 4: 'Y'L=0: 'Y'H=l : FP=<O+A+AA) 45T. ) 0OSLlP4S20: PP=Pr, -l 
, 570 FOR I =1 TOPP -'IFXT,, ', ', ll < 1. ) THENXT=, Xl (1) S NENTI 
00 FOR 11 TOPP: 1 T060 25 10 1 FX 11)C. = !, '. 74 XT HEI4, X, ' -'( 100T026 . 3,0 ". :Q `S, X TA' : X4 <IE. 0 
46"cl YT=YH-YL: Y1I=YT,, 60 
f. s!; o FQrRI=lTOPP: FORY=lTOG0 
e2i6cl IFY1 <I ý'%'ýYtl+YTHENY2 U> =Y: OOTO-2620 t-MiTY: Yf; 'f'V=6Ll : 61SO VEXTI -*W=61 : FORUf 1 TO2,: PR It IT#4: 1404T: FRI 14T#4. - W: PRII IT# 4 X C, FPlt-IT#4., ' "1 (PP) : FRINT#4. - "A I" CIL, 14=14- I: Z: 4=0: I FW=OTHE142720 
2710 MILIP, 27W COT02700 
7Z cil PRIIIT#4. - " - `NH 2V PRIt-IT#4. - " YOLLIPIE 2740 PRlt)T#l 
2,70 PRlt4T#l 
27ý0 PRINT#l 
2770 GOT02-02-0 
FORT=60TOOSTEP-1 
IF, ".:: '; ý. T)=! -ITHE14PRI14T#4, " 
2s, ". 0c, N'EXTT: IFZX'=OTHE14PRIt4Tn"4. - " V: RETURN 
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Pt' ETURtj 
-: S, 020 F0, --, l=lT0PP 
2- - 
VI FYH <Y (I) THEtq'r'H= Y(I 
,I '-=Ci: Y( pp: -=;:, p+j 2 Sl ftT''" (I., 
: F,, -D-r-Q4=0TOH - PI 14EXTQ 
; ý-`7* PI H) 2-- PI: NE,, ', TO 2 -, Zl C, H4=H4-1: H -3 =pI(H) -* I FH 3, < C, TH 2- NR ET LIFJ 4 I 2 10, (r, )=Y<H3) : B=B+l -C, PI<H3)=H4 
2ý 2940 H-^, =PP+H'3;. ': IFH; 3. ', HTHEt421-; 10 2f, 50 Hl=Pl(Q>: H-: ý=pj<Cj+jN 
2,19. ) lFH1 <OTHENP I 1-H2: GOTO2990 
4-,; 70 lFH. 2'lUTHEJ. IPl=Hl : GOTO29-90 ZKO GOSUB3000 
2 -9-': ý0 Pl(H3)=Pl: GOTO2940 St-A. -IL 
,j- PI=H2 
I PI=Hl -* lFX(H2) 0, (Hl )THEN ,. L I PULRN IL 
- 1: 197ý-L 20- Z% - ;, 
L, "' =Ll : "'l 
ý3040 RR-ruýl 
, 20-c; cl F! ý-, ItJT#G, CHRSP(24) 
MkF.., lFPP=2THE14GOTO31,70 
"C . 1,17,01 IFRP-33THENGOTO177`0 
'T 180 IFFUZ-5THEHOOT0,3170 
-0 ,: -, ýCl lFRR=6THEt4GOTO37fQ, 0 3100 B=l 
212c, F,. -, F,, I=ýri+o+lITO(A+O+'AA): ', J4 14 0 FOF', 'Ll=lTO3,: PRllIT#l : 14EXT ' 
11: 11 f cl PRINTU, "PCHE VS '"". "VOLUME" 3160 GOTO2550 
17,01 2=1 
21 eo 'r-2+1410 "T:, P= 1 
-I -*-- C, F-CIR IA+ITC, (A+ 0) t, '( IT R<P>Yr, 'l > XX, (P) 2 =2 +1 14E. X Tf2=1 
: NE, XT: P=l 1 TO, 1: PRI t IT# I 14EXT 
220 FRIIIT#I, -VOLUME" 
GOTQ22ý-, -O 
PRINT"DO yoU I-11SH S TO ALTER? -W TO CHA14CE GROUP)" OETZ-F: lFZ. f=""THElI3-f0 
e- E. Ll lrZt="14"THEf; FETUP14 
,' '-, IF 27, - F0 " Cc' " THEI 134. ý 0 
-: 11 INPLIT"GROLIP 14O. "; V-r 22 PRINV'141.1. TO ALTER? ": INPLITYS' 
POO 01"'700TO3,310,3L3, L0.,; 3':, GLl, 34010,3440,34-50. - 34.20,315,30,3570,3-5-30,35-PO, 3G, 30,3670 ?, -: PRI14T; D<'Y'C; >: lt4PLIT"I-IEI-I VALLlE? ll; D(, v, e): G0TO'3240 FF, 11; T. -*Ee, 'VS'): lt4F'LIT"t4'-rlI lVALLIE711; E(VOI) > 
41 14T E (VC4 000 0 OLI n5o GOTO3240 
33,6,01 PRllIT; lVVS-): 114PUT"14EJ-) 'VALLIEV'; Uye) I., - 0 IM3>=1 (YS)-0. C141#D(VL4) 
0 IFI (VS> <. 02THEM ( VR) =. 01 2-420 00TO3240, 
10 YALUE? "; C(YP> ^441 C, K(V*3)=MV8)-G. 01 --l, -*D(yCc) 
,.: 4.2'0 lFK0, ', PX. 02THE14K(VS)=. 01 3429 OOTO? 240 
2440 P-R'lt4T; MvR): lJIPUT"tIEJ4 VALUE? "; P(V3): GOTO3240 
,.: 450 FPIIIT; S(V, -, ): ZtIPUT"I-4EI-J YALLIE? "; MS) 
ý, 460 3(Vcq)=, Z, /J@oo 
,: 470 S<M=ltMS<V-, D*Jooo>/jCioLl 
,. WO COT03240 
,: '4 -7j 0 PRl14T; l-XVq): lMPLlT"t4El4 YALUE? "; WVV, -'; ) 5 C' C, " 0f'C' > =14 COS >-0.041 -+R ( VS) 
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02. THEM-1 ('03 
0 -1 T04 -3 
ýij pri < v-s) =tjJ 1 1% ý0 IF"' JT, C. 02THENPIN ( V; ' , 01 
IIIT; CC Cv t L7 " 1,,, ý1,1 "L V27 CC O'Cl T0 FRI 14T; 171IN " ): ItP Ll T" NO .1Y AL VE ?YS CUD T 03 42 4 C, , F2tl F*INT; E=eVe): It4PLrT"NEW 
60-0 z 
GOTO-3-240 
F-RItIT; 11'VL-): Ztir"UT"14EI4 VPLUE? "; II<VL: ý) 
-0.041 *ZT <VV-1) 
:, 6fO IFIIý VC, <. 042 THE141 I( Ve > 
GOT03240 
67, -'l PRINTMKOV-S) : INPUPHEW VALVIE-? "; KKC,, ý 'ED 2'5"- '1 M (V3, ) fKK ( VS) - Cl. 01o 51 WK (03) IFKK(V; 3X. 04-THE)4Kr(VL-, )=. 01 :17C, C, PRINT"WHAT IS t',. SUC. flT 0 FPACTION? " s( 19 INPLITAE 
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Appendix 3: Curvilinear interpolaticn program 
This program will estimate the S-value 
oF unknown peaks obtained on density 
gradient sedimentation by comparing their 
position C% Fraction vclumeD with markers 
of known sedimentation cceFficient. 
100 PRINT "CLIR'VILINEIAR INTERPOLATION" 
11c, PRI14T 
136 PRINT "11LIMBiR OF KNOWN POINTS"; 
14-3 INPLIT P 
150 FORI=l TO P 
160 PRINT "X, Y OF POIUMI 
170 111PUT X(IMM 
I G-1 0 HIDIT I 
15LI PRINT 
: 200 PRI11T "INTERPOLATE: X= "; 
21 C, INPUT A 
2S, cl 2=0 
-30 FOR J=l TO P -2 
240 T=l 
450 FOR I=l TO P 
2 . 60 IF I=J THEU 2SO 270 
.; ': : _: ý 01 IVXT 1 290 P=P+T+YM 
'00 tlEXT J ;IC, PRINT 
420 PRINT 
3,30 PPINT "MORE POINTS HERE? "; 
34 0 FRIUT'l C1 =YES, O=NO) 
350 VINT C 
G C-1 IF C-1 THEII 190 
C, PRItIT"AtIOTHER, CLlRVE? <l=YES', 0=NO)"; 
0 INPUT C 
"SO IF C=l THEN 1ý p -10 400 VID 
READY. 
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Appendix 4: Instrument and reagent suppliers 
Ancler, man and Ccmpany Ltd, 
Central Avenue, 
East Molesey, 
Surrey. 
KTe CQZ Tel: 01 979 8112/3 
BCH Chemicals Ltd, 
Broom Road, 
Poole, 
Dorset. 
SH12 4NN Tel: 
Jancons [Scientific) Ltdq 
Cherrycourt Way Industrial Estate, 
Stenbrid; e Road, 
Leighton Buzzard, Beds. 
LU7 eUA Tel: 0525 372010 
JT Baker Chemicals Ltd, 
Distributed by: Dimmed Diagnostics Ltd, 
Mast House, 
Derby Road, 
0202 737737 Bootle, 
Merseyside. L20 IAE 
Beckman - RIIC Ltd, 
Turnpike Road, 
Cressex Industrial Estate, 
High Wycombe, 
Bucks. 
HP12 3NR Tel: 0494 41181 
Bellingham and Stanley Ltd, 
LongField Road, 
Tunbridge Wells, 
Kent. 
TN2 3EY Tel% Oa92 3S444 
Calblochem - Behring Ltd, 
P0 Box 22, 
Bishops StortFord, 
Hertz. 
CM22 7RQ Tel: 027S SSOSi 
CI Electronics Ltd, 
Brunel Road, 
ChurchFields, 
Salisbury, 
Wilts. Tel: 0722 693a 
Commodore Business Machines Ltd, 
I Hunters Road, 
Wedon, 
Corby, 
Northampton. 
NN17 IQX Tel: 053S 205252 
Hoechst AG, 
Post F eO 03 20, 
0-6230 Frankfurt /M-E30, 
Federal Republic of Germany. 
Instrumentation Laboratory CIL) Ltd, 
Kelun Close, 
Birchwood Science Park, 
Warrington, 
Cheshire. Tal: 0925 810141 
LKS Instruments Ltd, 
232 Addington Road, 
South Croydon, 
Surrey. 
CH2 SYD Tali 01 657 Se22 
Pharmaoin Ltd, 
Pharmacia House, 
Midsummer Blvd, 
Milton Keynes, 
Sucks. 
MKS 3HP Tel: OSOS 661101 
Pys Unicam Ltd, 
York Street, 
Cambridge, 
CSI 2PX Telt 0223 5SSSS 
Floche Ltcl, 
Diagnostics Division, 
P0 Box a, 
Welwyn Garden City, 
Herts. 
AL7 3AY Tel: 07073 2BI28 
sartorius Instruments Ltd, 
18 Avenue Road, 
Belmont/Sutton, 
Surrey. Tel: 01 S42 GS91 
Sigma Chemical Cc Ltd, 
Fancy Hoed, 
Poole, 
Dorset. 
SH17 7NH Tel: 0202 733114 
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